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Role of the PAS2 domain of the NifL regulatory protein in redox signal 
transduction 
 
Abstract 
Per-Arnt-Sim (PAS) domains play a critical role in signal transduction in multi-
domain proteins by sensing diverse environmental signals and regulating the activity of 
output domains. Multiple PAS domains are often found within a single protein. However, 
the role of duplicate PAS domains in signalling is poorly understood. The NifL regulatory 
protein from Azotobacter vinelandii provides a typical example as it contains tandem PAS 
domains, the most N-terminal of which, PAS1, binds a FAD co-factor and is responsible 
for redox sensing, whereas the second PAS domain, PAS2, has no apparent co-factor and 
its function is unknown. NifL regulates the activity of the transcriptional activator, NifA, in 
response to changes in redox potential and fixed nitrogen status. Here, genetic and 
biochemical approaches were used to investigate the role of the PAS2 domain in the 
function of the NifL protein. Amino acid substitutions in the PAS2 domain were identified 
that either lock NifL in a form that constitutively inhibits NifA or that fail to respond to the 
redox status, suggesting that PAS2 plays a pivotal role in transducing the redox signal from 
PAS1 to the C-terminal output domains of NifL. A combination of biochemical 
experiments indicates that the isolated PAS2 domain is dimeric in solution. It was observed 
that PAS2 dimerisation is maintained in the redox signal transduction mutants, but is 
inhibited by substitutions in PAS2 that lock NifL in the inhibitory conformer. Limited 
proteolysis experiments suggest that the PAS2 substitutions influence conformational 
changes induced in response to the redox state of the FAD co-factor in the PAS1 domain. 
Further, mutagenic analysis of an inter-domain linker helix that connects the PAS domains 
of NifL suggests that this region of the protein is important in redox signalling. Overall, 
these results support a model for signal transduction in NifL, whereby redox-dependent 
conformational changes in PAS1 are relayed to the C-terminal output domains via changes 
in the quaternary structure of the PAS2 domain. 
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General Abbreviations 
 
AAA+   ATPases associated with various cellular activities 
AC   Adenylate cyclase 
ADP   Adenosine diphosphate 
AhR   Aryl hydrocarbon receptor 
AMP-PNP  5'-adenylyl-beta, gamma-imidodiphosphate 
ARNT   Aryl hydrocarbon receptor nuclear translocator 
ATP   Adenosine triphosphate 
AUC   Analytical ultracentrifugation 
BACTH  Bacterial adenylate cylase two-hybrid 
PBPb   Bacterial periplasmic substrate-binding domain 
Bph   Bacteriophytochrome 
BSA   Bovine serum albumin 
CBS   Cystathionine-beta-synthase domain 
Cu-Phe  Copper o-phenanthroline 
DGC   Diguanylate cyclase 
DHp   Dimerisation and histidine phosopho-transfer domain 
c-di--GMP  Bis-(3’-5’)-cyclic dimeric guanosine monphosphate 
DLS   Dynamic light scattering 
DNA   Deoxyribonucleic acid 
dNTP   Deoxy nucleotide triphosphate 
DOS   Direct oxygen sensor 
DTT   Dithiothreitol 
EBP   Enhancer binding protein 
EDTA   Ethylenediaminetetraacetic acid 
FAD   Flavin adenine dinuceotide oxidised form 
FADH2  Flavin adenine dinuceotide reduced form 
Fe (II)   Ferrous iron 
Fe (III)  Ferric iron 
FHA   Folkhead-associated domain 
FIST   F-box and intracellular signal transduction domain 
FMN   Flavin mononucleotide 
GAF   cGMP-specific and regulated cyclic nucleotide phosphodiesterase, 
Anabaena Adenylate cyclase and E. coli transcription factor FhlA 
GTP   Guanosine triphosphate 
GTP-TR Guanosine 5′-triphosphate- Texas red (sulphorhodamine 101 acid 
chloride) 
HATPase  Histidine kinase-like ATPase domain 
HIF   Hypoxia inducible factor 
HisKA  Histidine kinase A phosphoacceptor domain 
HPK   Histidine protein kinase 
HPt   Histidine phospho-transfer domain 
HTH   Helix-turn-helix domain 
IPTG   Isopropyl-β-D-thiogalactopyranoside 
Kd   Dissociation constant 
LB   Luria-Bertani broth 
NEM   N-ethylmaleimide 
NFDM  Nitrogen-free Davis and Mingioli medium 
NMR   Nuclear magnetic resonance  
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ONPG   ortho-nitrophenyl-β-galactoside   
PAGE   Polyaccrylamide gel electrophoresis 
PAS   Per-ARNT-Sim domain 
PCR   Polymerase chain reaction 
PDB   Protein data bank 
PDE   Phosphodiesterase 
Pfam   Protein families database      
pGpG   5'-Phosphoguanylyl-(3'-5')-guanosine 
PYP   Photoactive yellow protein 
REC   Response regulator receiver domain 
RR   Response regulator 
SAP   Shrimp alkaline phosphatase  
SDS   Sodium dodecyl sulphate 
SEC   Size exclusion chromatography 
SMART nrdb Simple modular architecture research tool non-redundant database 
sMMO  soluble methane monooxygenase 
STAS   sulphate transporter and antisigma factor antagonist domain 
TBE   Tris borate EDTA 
TCS   Two-component system 
TEMED  N,N,N',N'-Tetramethylethylenediamine 
TLC   Thin layer chromatography 
TM   Trans-membrane 
Tris   Tris (hydroxymethyl) aminomethane 
UTase/UR  Uridylyltransferase/uridylyl-removing enzyme    
WT   Wild type 
X-gal   5-bromo-4chloro-3-indolyl-B-D-galactopyranoside 
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Chapter 1 - Introduction 
1.1 Signal transduction in bacteria 
Signal transduction can be defined as the process by which organisms link 
environmental stimuli to adaptive responses. The evolution of prokaryotes has selected for 
microbes which are most competent to sense and respond to their environment. Thus, 
efficient signal transduction is crucial to bacterial survival. There are many molecular 
mechanisms by which this is achieved. Arguably the simplest of these is the “one-
component system”. One-component systems consist of a single modular protein that 
contains (at least) two domains: a sensory (input) domain responsible for detection of 
environmental stimuli and an output (effector) domain that, when activated, elicits a 
cellular response (Figure 1.1). This modular domain architecture allows for one-component 
systems to respond to an extensive repertoire of signal inputs. Indeed, a recent analysis of 
145 prokaryotic genomes revealed the presence of approximately 17,000 putative one-
component systems (Ulrich et al., 2005). In the archetypal one-component system, a 
membrane-permeable signalling molecule enters the cell via passive or facilitated diffusion 
and binds to the sensory domain of the cytosolic signalling protein. Subsequent intra-
molecular signal relay results in activation of the output domain, thus triggering a cellular 
response. By far the most common output from these systems is a change in gene 
expression, although other outputs include regulation of cyclic nucleotide levels and 
protein phosphorylation (Ulrich et al., 2005).  
There is one obvious disadvantage inherent to signal transduction by one-
component systems; stimulus detection is limited to the cytosol as the presence of 
transmembrane regions in the signalling protein would prevent the output domain from 
accessing its target. In the late 1980s researchers began using the term “two-component” to 
describe an emerging class of bacterial regulatory system in which the modules responsible  
13 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 Modular organisation of bacterial signal transduction systems. Figure adapted 
from Ulrich et al., 2005. 
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for sensing and output are distributed between two proteins (Ninfa and Magasanik, 1986; 
Nixon et al., 1986). Two-Component systems (TCSs) are now known to be prevalent in 
eubacteria and archaea, and can also be found in some eukaryotes. The archetypal TCS 
consists of a histidine protein kinase (HPK) and cognate response regulator (RR). The 
HPK senses environmental cues and subsequently relays the signal to the RR via a 
phospho-relay system (discussed in Chapter 1.3). The RR then induces a cellular response, 
usually through a change in gene expression (Figure 1.1). This uncoupling of the input and 
output functions allows the sensor protein (the HPK) to be embedded in the membrane and 
directly sense extracellular stimuli. In fact, the aforementioned analysis of 145 bacterial 
genomes indicated that over 73% of the putative HPKs identified were likely to be 
membrane-integral (Ulrich et al., 2005). The prevalence of proteins involved in two-
component signalling varies widely between different bacteria. Bradyrhyzobium japonicum 
has 80 HPKs and 91 RRs (Hagiwara et al., 2004), whilst two-component proteins appear to 
be absent in Mycoplasma genitalium (Mizuno, 1998). However, M. genitalium is atypical 
in this respect and the average bacterial genome contains 10-50 predicted TCSs. This is 
exemplified by Escherichia coli, which expresses 29 HPKs and 32 RRs (Mizuno, 1997; 
Szurmant et al., 2007). In total, several thousand genes are understood to encode proteins 
involved in two-component signalling systems in all denominations of life. 
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1.2 - PAS domains 
As mentioned above, sensory modules are widely utilised by bacterial signal 
transduction proteins. Sensory modules are extremely diverse, reflecting the vast array of 
signals they detect. An example of a prevalent sensory module is the Per-ARNT-Sim 
(PAS) domain. PAS domains are ubiquitous signalling modules found in all kingdoms of 
life. The acronym PAS is derived from the names of three proteins in which PAS domains 
were first identified: the Drosophila period clock protein (Per), mammalian aryl 
hydrocarbon receptor nuclear translocator (ARNT) and Drosophila single-minded protein 
(Sim) (Nambu et al., 1991). PAS domains can detect a plethora of stimuli including light, 
oxygen, redox potential, proton motive force, metal ions and various small molecules as 
well as modulating protein-protein interactions (Huang et al., 1998; Zhulin and Taylor, 
1998; Zhulin et al., 1997). In order to detect these stimuli, they can bind a variety of co-
factors including FAD, FMN, [4Fe-4S]
2+
 clusters, heme and 4-hydroxycinnamic acid or 
bind directly to signalling molecules (examples of all are discussed below). As a result of 
the extraordinary range of stimuli that PAS domains are able to detect, PAS-containing 
proteins have crucial roles in many cellular processes. For example, the Per and ARNT 
proteins mentioned above (from which the PAS acronym is derived) are involved in 
maintaining circadian rhythm and transcription regulation respectively. At the time of 
writing, PAS domains are recognised in around 14,000 proteins by the SMART (nrdb) and 
Pfam databases.  
In addition to signal perception, PAS domains modulate the activity of output 
(effector) domains. Figure 1.2 shows the domain architectures of selected proteins from the 
SMART nrdb in which PAS domains are coupled to various effector domains including: 
DNA binding domains, guanylate cyclases, exonucleases, methyl acceptors and 
transferases, phosphatases and kinases (of histidine and serine/threonine residues), c-di- 
16 
 
 
Figure 1.2. PAS-associated output domains. Domain architectures of selected PAS-
containing proteins (from the SMART nrdb) to show the variety of output domains with 
which PAS domains are associated. PAC domains are sequence motifs that form part of the 
3-dimentional PAS fold. 
  
c-di-GMP 
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GMP signalling domains and protein-protein interaction modules. Moreover, searches 
using the Pfam database also indicate that PAS domains are often located adjacent to σ54 
activating domains, ion transport domains, Kelch repeats and STAS (sulphate transporter 
and antisigma factor antagonist) domains
1
. In most cases the PAS domain is directly 
adjacent to the output domain. Although the proteins shown in Figure 1.2 are 
predominantly cytoplasmic, examples of proteins with similar architectures that contain 
additional trans-membrane (TM) domains are abundant (with the obvious exception of the 
transcription factors). Of the relatively few studied PAS-containing proteins with TM 
regions, the PAS domain is usually located on the cytoplasmic side of the cell membrane. 
However, PAS domains are not exclusively cytoplasmic and several are known to be 
located in the periplasm (Cho et al., 2006; Kaspar and Bott, 2002; Kaspar et al., 1999; 
Pappalardo et al., 2003). In such cases, signals must be relayed from the PAS domain 
through the trans-membrane regions of the protein and ultimately to cytoplasmic effector 
domains. In addition to the regulation of covalently attached output domains, some PAS 
domains occur as small, single domain proteins. Presumably, these PAS domains are 
involved in signal transduction via protein-protein interactions. In other words, they may 
exert in trans affects on the activity of output domains in other proteins. 
Multiple PAS domains are often present in tandem within a single protein. 
Examples of proteins containing 2, 3 or 4 tandem PAS domains are shown in Figure 1.3A. 
Proteins with 6 or more PAS domains are not uncommon (the SMART nrdb contains 95 
such proteins) and several proteins containing 10 or even 15 (UniProt indentifiers 
A0YNE5_9CYAN and A3IRJ7_9CHRO respectively) adjacent PAS domains can be 
found. The SMART and Pfam databases both indicate that a total of over 21,000 PAS 
domains are present in around 14,000 proteins, suggesting that a high proportion of PAS- 
                                                 
1
 Discrepancies between the two databases stem primarily from differences in recognition of the output 
domains. For example, the SMART database shows proteins containing PAS and AAA
+
 domains together 
but fails to recognise the adjacent HTH domain and thus σ54 activators are not detected. 
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Figure 1.3 Example domain architectures from the SMART nrdb of (A) proteins 
containing tandem PAS domains and (B) complex modular proteins in which PAS domains 
are combined with multiple sensory/signalling domains. PAC domains are sequence motifs 
that form part of the 3-dimentional PAS fold. 
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containing proteins have more than one PAS domain. In addition to their location 
alongside output domains, PAS domains are often found in complex multi-domain proteins 
with many sensory domains (Figure 1.3B). For example, the first domain architecture 
shown in Figure 1.3B is that of a sensor protein from Nodularia spumigena that contains 2 
PAS domains in combination with 4 cystathionine-beta-synthase (CBS) domains (which 
sense adenosine derivatives) and a GAF domain (a sensory module similar to a PAS 
domain). Other sensory modules found in combination with PAS domains include FHA 
domains (which recognise phosphopeptides) and FIST domains (thought to bind small 
ligands/amino acids). Combinations of PAS domains with various sensory modules and 
with other signalling domains, such as phosphate receiver domains (REC) and periplasmic 
substrate-binding (PBPb) domains, give rise to extremely complex modular proteins in 
which the activity of effector domains is regulated by many signals.     
PAS domains were originally recognised as imperfect sequence repeats termed 
“PAS repeats”, “S boxes” or the “PAS motif”. Further studies revealed that this motif was 
the most highly conserved region of a larger domain containing a second, less well 
conserved motif, called a “PAC motif” or “S2 box” (Ponting and Aravind, 1997; Zhulin et 
al., 1997). Thus PAS domains were originally defined on the basis of primary sequence 
motifs. As the availability of structural information increased, it became clear that these 
motifs represent a conserved three-dimensional fold and that PAS domains exhibit 
relatively little sequence homology. On average, the sequence identity between any two 
PAS domains is below 20% (Möglich et al., 2009b). Consequently, the definition was 
revised and classification of PAS domains now depends on conserved structural elements, 
specifically, an α/β fold of approximately 110 amino acids in which an anti-parallel β-sheet 
is flanked by several α helices.  (Hefti et al., 2004; Pellequer et al., 1998).  
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Figure 1.4 (A) Generalised PAS domain structure divided into four conserved regions: the 
PAS core (orange), the β-scaffold (blue), the helical connector (green) and the N-terminal 
cap (purple) (Pellequer et al., 1998). (B) Structure of Azotobacter vinelandii NifL PAS1 
illustrating the annotation of conserved secondary structure elements in PAS domains 
(Möglich et al., 2009). This domain contains a FAD co-factor (shown here as a ball and 
stick diagram).    
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The first PAS domain structure to be solved was that of Photoactive yellow protein 
(PYP) from Halorhodospira halophila (Borgstahl et al., 1995). Initially, PYP was 
considered the archetypal PAS domain (Pellequer et al., 1998). Based on PYP and several 
other early structures, PAS domains were divided into four main parts: the β-scaffold, the 
helical connector, the PAS core and the N-terminal cap (Figure 1.4A). Although this 
nomenclature has since been superseded by the labelling of secondary structural elements 
(Figure 1.4B), some of these terms persist in the literature and are therefore worthy of a 
brief explanation. The β-strands comprising the central β-sheet (Aβ, Bβ, Gβ, Hβ and Iβ in 
Figure 1.4B) are shared between the β-scaffold and the PAS core. The PAS core and β-
scaffold are connected by an extended α-helix called the helical connector. The N-terminal 
cap is a highly variable region located on the N-terminal side of the PAS core. However, 
the N-terminal cap is absent from several PAS domains (Vreede et al., 2003). At the time 
of writing, structures of 47 PAS domains had been deposited in the protein data bank 
(PDB). Figure 1.4B shows the structure of a PAS domain from the Azotobacter vinelandii 
NifL protein as an example of the more recent nomenclature used to describe PAS domain 
structures (Key et al., 2007a; Möglich et al., 2009b). Laboratories studying various PAS-
containing systems employ both sets of nomenclature and so both will referred to in this 
chapter. The conserved secondary structural features shown in Figure 1.4B are annotated 
Aβ to Iβ (β strands are shown in blue and α-helices shown in gold). The most N-terminal 
α-helix in the structure (shown in white), which may be described as belonging to the N-
terminal cap, is not conserved in all PAS domains and is therefore designated A’α. It 
should also be remembered that significant variation exists between PAS domains, 
particularly in the helical regions, and that small regions of secondary structure not shown 
in Figure 1.4B may be present in other PAS domains. Many co-factor binding PAS 
domains have a cleft between the inner face of the β-sheet and the Eα and Fα helices in 
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which the co-factor is located. These helices are among the most variable regions of the 
PAS fold to accommodate the diverse chemistry of the various prosthetic groups to which 
PAS domains bind (Möglich et al., 2009b).  
 
1.2.1 Gas sensing PAS domains  
(i) FixL 
FixL is an oxygen sensing histidine protein kinase (HPK) that regulates genes for 
nitrogen fixation (nif and fix genes) via its cognate response regulator (RR), FixJ. This 
system has been best studied in Sinorhizobium meliloti and Bradyrhizobium japonicum. 
FixL proteins derived from both species have an N-terminal cytoplasmic PAS domain that 
contains a covalently bound Fe(II) heme group, and is required for oxygen sensing (Gilles-
Gonzalez et al., 1991; Tuckerman et al., 2002; Tuckerman et al., 2001). However, the 
overall domain architectures of the FixL proteins from S. meliloti and B. japonicum are not 
identical. S. meliloti FixL (SmFixL) is a membrane-bound protein containing 4 N-terminal 
TM domains, a PAS domain and C-terminal histidine kinase effector domains. In contrast, 
B. japonicum FixL (BjFixL) is a cytoplasmic protein that lacks the TM regions found in 
SmFixL but contains an additional N-terminal PAS domain. This extra PAS domain in 
BjFixL has no known co-factor and its function is unclear.  
The crystal structure of the heme-binding PAS domain from BjFixL is shown in 
Figure 1.5A. Under low oxygen conditions (i.e. when the heme iron is unliganded) the 
HPK autophosphorylates, leading to transcription of nitrogen fixation genes. Therefore, the 
PAS domain negatively regulates the activity of the histidine kinase output domains in 
response to oxygen. In addition to the physiological ligand, oxygen, the heme group is able  
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Figure 1.5 (A) Ribbon diagram of the structure of the heme-binding PAS domain from B. 
japonicum FixL (Key et al., 2007b). (B) Model of the dimeric structure of this domain 
(Key and Moffat, 2005). The regions shown in red are those which exhibit the greatest 
displacement of main chain carbon atoms in response to ligand binding. Unlabeled arrows 
indicate the N-terminus.  
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to bind carbon monoxide (CO) and nitric oxide (NO) to influence kinase activity. It has 
been proposed that ligand binding induces a structural change in the loop joining the Fα 
helix (the helical connector) to Gβ strand (in the PAS core), known as the FG loop (Figure 
1.5A) and that this change is driven by a flattening of the porphyrin ring (Gong et al., 
1998). However, recent studies on CO-bound signalling intermediates in BjFixL have 
demonstrated movement of residues in the Hβ and Iβ strands (from the PAS core and β-
scaffold respectively) in response to ligand binding (Key and Moffat, 2005; Key et al., 
2007b). The signal is thought to be propagated via re-orientation of residues that are 
clustered around a conserved interaction surface found in several heme-binding PAS 
domains (discussed below) (Kurokawa et al., 2004; Park et al., 2004). This surface may 
serve as a dimerisation interface in FixL (Figure 1.5B) (Erbel et al., 2003; Key and Moffat, 
2005). These findings have prompted the suggestion that adjustments to PAS structure 
initiated by ligand binding may result in re-orientation of the kinase core domains relative 
to each other, thus inhibiting autophosphorylation (Key and Moffat, 2005).  
Ligand-dependent conformational changes in the BjFixL PAS domain are 
generated, at least in part, by an alteration in the position of a leucine side chain (Leu236) 
that sterically occludes the ligand binding pocket. The next step in the signal transduction 
pathway has been the subject of intense study. Specifically, the role of two arginine 
residues in the initial steps of signal propagation have been addressed. Substitution of a 
proximal arginine located in the Fα helix with alanine (R206A in BjFixL) impairs the 
transmission of signals between the PAS domain and the output domains. The wild-type 
protein exhibits a >2000-fold reduction in catalytic activity in response to ligand binding. 
This is reduced to a 140-fold reduction in the R206A variant (Gilles-Gonzalez et al., 2006). 
This arginine residue is well conserved in heme-binding PAS domains and the equivalent 
amino acid in S. meliloti FixL (R200) contributes to the kinetic stability of the inhibitory 
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conformer (Reynolds et al., 2009). The role of a second conserved arginine (R220 in 
BjFixL) in the early stages of signalling has also been studied. Several amino acid 
substitutions were made at position 220 in BjFixL and their influence on ligand (NO, CO 
and O2) release after photolysis was examined (Jasaitis et al., 2006). All substitutions 
diminished the strain placed on the heme molecule on dissociation of the NO and CO 
ligands and all mutant proteins differed from the wild-type in the absorption spectra 
obtained after decay of the O2 liganded complex. This implies that the distal R220 residue 
in BjFixL contributes to formation of the primary signalling intermediate. It was also 
observed that all substitutions increased the yield of dissociated O2 following decay. Wild-
type BjFixL allowed approximately 10% of dissociated O2 to escape whilst the yield from 
the R220A variant was almost 100%, suggesting that R220 cages the O2 molecule near the 
heme in the wild-type protein. Jasaitis and colleagues combined these results with 
molecular dynamics simulations to show that, in the first 50 ps following ligand 
dissociation, movement of the R220 side chain and the O2 molecule away from the heme 
binding pocket may constitute the second step in signal transduction (Jasaitis et al., 2006).       
It should be remembered that sensing and catalysis by FixL is likely to occur within 
the FixL-FixJ complex (Gilles-Gonzalez and Gonzalez, 2004; Saito et al., 2003; 
Tuckerman et al., 2002). Further, the presence of SmFixJ influences the regulation of 
SmFixL activity in response to O2 by the SmFixL PAS domain (Tuckerman et al., 2002). 
Several substitutions in the kinase domain of SmFixL have been shown to impair the 
inhibitory affect of O2 on FixL autophosphorylation in the presence of FixJ, whilst 
retaining O2 sensitivity when FixJ is absent (Saito et al., 2003). The activities of the output 
(kinase core) domains and the sensory PAS domain of SmFixL are also linked by the 
ability of ADP to allosterically reduce oxygen affinity (Nakamura et al., 2004). When ATP 
is hydrolysed in the kinase core region (discussed below) of one FixL subunit, the 
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remaining ADP molecule lowers the oxygen affinity of the PAS domain in the opposing 
subunit. This is assumed to stimulate ATP hydrolysis by the second subunit, thus 
connecting the sensory and catalytic functions of FixL. Taken together, these findings 
imply that PAS domains are capable of a form of bilateral inter-domain communication in 
which changes in the conformation of effector domains can be sensed as well as induced.  
 
(ii) EcDOS 
E. coli direct oxygen sensor (EcDOS) is a heme-regulated enzyme involved in bis-
(3’-5’)-cyclic dimeric GMP (c-di-GMP) signalling. Cyclic di-GMP was discovered as a 
ubiquitous second messenger and c-di-GMP signalling is now a rapidly progressing field. 
At the time of writing, c-di-GMP signalling has been implicated in biofilm formation, cell 
motility, long-term stress responses, secondary metabolite synthesis, cell cycle control and 
virulence (Schirmer and Jenal, 2009). EcDOS contains two C-terminal output domains, 
namely EAL and GGDEF domains. These function as a phosphodiesterase (PDE) and 
diguanylate cyclase (DGC) respectively. DGCs catalyse conversion of GTP to c-di-GMP 
and PDEs catalyse the degradation of c-di-GMP to 5'-Phosphoguanylyl-(3'-5')-guanosine 
(pGpG). Despite the presence of these two seemingly antagonistic effector domains, only 
PDE activity has been reported in EcDOS. This may be due to catalytic inactivity of the 
GGDEF domain, as there are many examples of proteins containing tandem GGDEF and 
EAL domains in which one domain is inactive (Schmidt et al., 2005). However, the 
possibility that the GGDEF domain is active under conditions not yet studied cannot be 
eliminated. Alternatively, an inactive GGDEF domain may retain the ability to bind its 
substrate (GTP) and modulate the PDE activity of the adjacent EAL domain in response to 
substrate binding. That is, the GGDEF domain could potentially regulate PDE activity in 
response to the changing GTP levels. Precedents can be found for tandem GGDEF and 
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EAL domain pairs that perform all the functions mentioned above (Christen et al., 2005; 
Kumar and Chatterji, 2008; Schirmer and Jenal, 2009). The PDE activity of EcDOS is 
regulated by a sensor region containing two PAS domains in tandem. The most N-terminal 
PAS domain, PASA, contains a covalently bound heme co-factor and is involved in signal 
perception, while the second PAS domain, PASB, has no apparent co-factor and its 
function is unknown. 
The activity of the output domains is regulated by binding of gases to the Fe(II) 
heme moiety of PASA (Sasakura et al., 2006). Specifically, the Fe(II) heme can bind O2, 
CO or NO (at similar affinities) to stimulate the PDE activity of EcDOS by up to 8-fold 
(Tanaka et al., 2007). However, the relative cellular concentrations of these molecules 
imply that O2 is the physiologically relevant ligand (Liebl et al., 2003; Sasakura et al., 
2006; Taguchi et al., 2004). Several structural studies have enhanced our understanding of 
the molecular mechanisms underpinning signal perception and transduction. The crystal 
structure of the PASA domain has been solved in the oxy and deoxy form (Park et al., 
2004). The EcDOS PASA domain forms a dimer, mediated by a dimerisation interface 
consisting mostly of residues in the A’α helix. One protomer of the PASA domain is 
shown in Figure 1.6A (the A’α helix is shown in white). In each protomer, the heme co-
factor is located between the Fα helix (on the proximal side) and the Gβ and Hβ strands 
(on the distal side). In the oxy and deoxy state, the heme is six-coordinate (in contrast to 
the FixL heme which is five-coordinate in the deoxy state) with H77 occupying the fifth, 
proximal, heme coordination site. Differences between the on (oxy) and off (deoxy) state 
arise from switching of the sixth distal ligand from O2 to M95 (Figure 1.6B). In the on 
state, O2 is the distal ligand and an arginine residue (R97) from the Gβ sheet forms 
hydrogen bonds with the O2 molecule (Park et al., 2004). Mutational studies have 
confirmed the importance of this arginine in the signalling mechanism and ligand  
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Figure 1.6 (A) Crystal structure of the EcDOS PASA domain (PDB entry 1V9Z) (Möglich 
et al., 2009b). (B) Comparison of crystal structures of the O2 liganded and unliganded 
heme from the EcDOS PASA domain (Ishitsuka et al., 2008). 
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recognition (El-Mashtoly et al., 2008; Ishitsuka et al., 2008; Tanaka and Shimizu, 2008). 
Dissociation of the O2 ligand results in numerous conformational changes. The side chain  
of R97 rotates by almost 180
o
 towards the protein surface to form a salt bridge with R112 
and E98 (from the Hβ and Gβ strands respectively). A second residue, M95, also 
undergoes a near 180
o
 rotation so that its sulphur atom may replace the O2 molecule as the 
distal ligand of the heme (Fig. 1.6B). The switching of heme ligands during the transition 
between the oxy and deoxy state is accompanied by movements in the FG loop (as in 
FixL), the Gβ strand and the loop connecting the Hβ and Iβ strands (the HI loop) (Park et 
al., 2004). 
Unlike the FixL Fe(II) heme discussed above, the EcDOS Fe(II) heme is relatively 
prone to autoxidation to form an Fe(III) heme complex (Taguchi et al., 2004; Tanaka and 
Shimizu, 2008; Tanaka et al., 2007). Oxidation of the heme group inhibits PDE activity 
and could potentially have a role in deactivating EcDOS under conditions of oxidative or 
nitrosative stress. Oxidation of the heme results in a replacement of M95 as the distal 
ligand (see above) with a water molecule (Kurokawa et al., 2004). This triggers a 
reorganisation of the hydrogen bonding network surrounding the heme moiety and a 
change in the rigidity of the FG loop. Further, it has been demonstrated that external 
ligands (cyanide and imidazole) can bind the heme Fe(III) complex in PASA to stimulate 
PDE activity in vitro (Tanaka and Shimizu, 2008), although the physiological relevance of 
this, if any, is unclear. Tanaka and Shimizu propose that EcDOS may exist in three states: 
(i) the inactive Fe(III) form, (ii) the resting Fe(II) form and (iii) the active Fe(II)-O2 form 
(Tanaka and Shimizu, 2008). However, this is not a universally accepted hypothesis and 
the relevance of heme autoxidation to signalling in vivo is still a subject of debate.    
Detailed studies on the EcDOS apo-protein, heme-free mutant proteins and N-
terminal truncations lacking the PASA domain have revealed that EcDOS is active in the 
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absence of heme (or the entire PASA domain) and that heme-bound PASA represses the 
activity of the EAL domain (Yoshimura et al., 2003). This inter-domain repression is then 
released by ligand binding to the heme Fe(II) complex. In other words, the PASA domain 
negatively regulates catalysis and binding of O2 relieves inhibition. 
 
(iii) NreB 
NreB is a cytoplasmic histidine protein kinase that regulates genes involved 
nitrate/nitrite respiration (narGHJI, narT and nirRBD) via its cognate response regulator, 
NreC (Fedtke et al., 2002). The NreB protein from Staphylococcus carnosus is the only 
member of its family to be studied, although homologs are present in all Staphylococcus 
species and many other Gram-positive bacteria. NreB consists of an N-terminal PAS 
domain and C-terminal histidine kinase domains. The PAS domain binds an oxygen liable 
[4Fe-4S]
2+ 
cluster. Exposure of anaerobically purified NreB to air results in degradation of 
the [4Fe-4S]
2+ 
cluster that correlates precisely with a decrease in kinase activity (Müllner et 
al., 2008). Additionally, in vitro insertion of the cluster restores kinase activity (Kamps et 
al., 2004). It is not clear whether the PAS domain inhibits kinase activity and incorporation 
of the [4Fe-4S]
2+ 
cluster is required to relieve that inhibition, or whether the presence of 
the cluster is necessary for kinase activity. NreB proteins contain four conserved cysteine 
residues (C59, C62, C74 and C77 in S. carnosus NreB) which ligate the [4Fe-4S]
2+ 
cluster. 
Substitution of any of these cysteines for alanine or serine results in a loss of activity in 
vivo (Müllner et al., 2008). It has been demonstrated that the [4Fe-4S]
2+ 
-containing form 
of NreB predominates in cells growing anaerobically, whilst the NreB apo-protein is 
prevalent in aerobically grown cells (Reinhart et al., 2009). The conversion between the 
apo-protein and cluster associated protein is therefore a physiologically relevant switch.  
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Figure 1.7 Prediction of the secondary structure features of the NreB PAS domain. The 
positions of the cysteine residues that coordinate the [4Fe-4S]
2+
 cluster are indicated by 
yellow circles (Müllner et al., 2008). 
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Figure 1.7 shows the predicted secondary structure of the NreB PAS domain and 
the positions of the cysteines that coordinate the [4Fe-4S]
2+ 
cluster (yellow circles). The 
cysteines are shared evenly between the C-terminal end of the Eα helix (in the PAS core) 
and the Fα helix (helical connector). The most N-terminal pair of cysteines is located in a 
region similar to that of the conserved proximal histidine residue that coordinates the heme 
group of EcDOS and FixL. The cysteine residues in the Fα helix may be located in a 
position analogous to that of the methionine residue from EcDOS PASA that ligates the 
(deoxy Fe(II)) heme (Müllner et al., 2008). These similarities imply that the NreB PAS 
domain may accommodate its co-factor in a similar manner to the PAS domains of FixL 
and EcDOS, despite the different chemical properties of these moieties. To date, NreB 
contains the only known [4Fe-4S]
2+ 
cluster-binding PAS domain.  
 
1.2.2 Ligand binding PAS domains 
(i) CitA and DcuS 
CitA is an integral membrane histidine protein kinase that senses extracellular 
citrate to regulate the transcription of genes involved in (anaerobic) citrate metabolism and 
transport, via its cognate response regulator, CitB. CitA activity is regulated by direct 
binding of citrate to a periplasmic PAS domain (PASp) at high affinity (Kaspar and Bott, 
2002). The structure of this domain from the Klebsiella pneumoniae CitA protein (shown 
in Figure 1.8A) was solved in 2003 and was the first example of a PAS domain located 
outside the cytoplasm (Reinelt et al., 2003). It was observed that the structure of PASp 
differed from the available structures of cytoplasmic PAS domains. PASp is dimeric in the 
crystal structure and two of the three N-terminal helices (that constitute the N-terminal 
cap) form the dimerisation interface. These α-helices of CitA are longer than their 
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Figure 1.8. Ribbon diagrams illustrating structures of the ligand binding PAS domains 
from (A) CitA and (B) DcuS. Ligand binding sites are labelled C1 – C3 and the key 
residues involved at each site are shown (Masher et al., 2006).   
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counterparts in PYP whereas PAS domains such as EcDOS PASA and NifL PAS1 
(discussed below) contain only one N-terminal helix (Key et al., 2007a; Kurokawa et al., 
2004; Park et al., 2004). The N-terminal cap α-helices are not necessary for PYP function 
(see below) and are completely lacking in FixL, whilst the N-terminal helices of NifL 
PAS1 and EcDOS PASA each contribute to an important dimerisation interface (Key et al., 
2007a; Kurokawa et al., 2004; Park et al., 2004; Vreede et al., 2003). The contrast between 
these PAS domains illustrates the structural and functional variability of the N-terminal 
cap. The PAS core region of CitA also differs notably from that of many cytoplasmic PAS 
domains. CitA lacks the Cα and Eα helices. Further structural differences accommodate 
citrate binding at three sites (C1, C2 and C3 in Figure 1.8). Smaller inter-strand loops in 
the characteristic PAS β-sheet, which forms the bottom of the citrate binding pocket, 
facilitate closer proximity of the ligand (to the β-sheet) and a more tightly closed pocket. 
The carboxylate groups of the citrate are each ligated by one basic residue (K152 at C1, 
R109 at C2 and H112 at C3) in addition to a minimum of one hydroxyl side chain (Figure 
1.8) (Reinelt et al., 2003). The binding site also includes an α-helix in the PAS core and 
two loops. These loops, termed the major and minor loops, form a tight lid over the bound 
citrate (Reinelt et al., 2003; Sevvana et al., 2008). 
A more detailed understanding of the signalling mechanism has been gleaned from 
a recent study, in which the structures of the citrate-bound and citrate-free K. pneumoniae 
PASp were examined by crystallography and nuclear magnetic resonance (NMR) 
spectroscopy (Sevvana et al., 2008). Several structural changes were found to accompany 
ligand binding (Figure 1.9). Residues 100-103 in the minor loop adopt a type I β-turn when 
citrate is bound and ligand dissociation appears to trigger a reorganisation of the loop to 
form a type II β-turn. This may be important in the signalling mechanism as the backbone 
amide of residue 102 and the side chain of residue 101 are involved in citrate binding  
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Figure 1.9. (A) Structure of the ligand bound CitA PASp protomer (light blue with 
differences highlighted in dark blue) superimposed onto the ligand-free CitA PASp 
protomer (cyan with difference highlighted in green). (B) Comparison of citrate-bound and 
citrate-free CitA PASp showing contraction of the domain in response to ligand binding 
(Sevvana et al., 2008). 
  
Membrane  
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(Sevvana et al., 2008). Movement in the minor loop is concomitant with a flattening of the 
central β-sheet (Figure 1.9A). Overall, the evidence implies that the β-sheet and minor loop 
adopt an open (or fluctuating) conformation in the absence of citrate and that ligand 
binding prompts a conformational change in these regions to form a lid over the binding 
pocket (Figure 1.9A). There are also ligand-dependent changes in the major loop. In the 
absence of citrate, the major loop is disordered in the crystal structure and appears to 
fluctuate between multiple conformations in solution. Ligand binding stabilises the 
structure of the major loop, which contributes significantly to ligation of the citrate moiety 
(Sevvana et al., 2008). Another potentially important observation is that PASp binds a Na
+
 
ion in the citrate-bound state but this ion is absent in the citrate-free structure. Although the 
failure to resolve the Na
+
 ion in citrate-free PASp does not strictly eliminate the possibility 
that one is present and the identity of the modelled ion cannot be completely certain, metal 
ion binding by PAS domains is not without precedent (Cheung et al., 2008; Cho et al., 
2006) and Na
+
 sensing by PASp would have a clear physiological purpose. Na
+
 is 
important in citrate transport and metabolism and CitB dependent gene expression requires 
both Na
+
 and citrate (Bott et al., 1995; Meyer et al., 2001; Pos and Dimroth, 1996; Sevvana 
et al., 2008). If Na
+
 binding is part of the signalling mechanism, CitA PASp would be the 
first example of a single PAS domain to integrate signals from multiple ligand binding 
events. Overall, citrate binding appears to induce a contraction of the central β-sheet that 
pulls the C-terminal region of PASp away from the membrane (Figure 1.9B). It has been 
postulated that this results in a “piston-type” movement of the TM regions that regulates 
activity of cytoplasmic output domains (Sevvana et al., 2008). 
In addition to the N-terminal periplasmic PAS domain, CitA has two TM regions, a 
cytoplasmic PAS domain (PASc) and C-terminal histidine kinase domains (Mascher et al., 
2006). The function of the PASc domain remains unclear. PASp is not required for kinase 
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activity as N-terminal truncations of K. pneumoniae CitA lacking PASc, the TM domains 
and the periplasmic region are active in vitro (Kaspar et al., 1999). This is particularly 
interesting given that citrate is required for CitA activity in vivo. A recent study has 
presented evidence that the activity of the cytoplasmic region of E. coli CitA (containing 
the PASc and histidine kinase domains) is dependent on redox conditions in vitro 
(Yamamoto et al., 2009). The authors showed that kinase activity increases concomitantly 
with increasing dithiothreitol (DTT) concentration whereas the protein is inactive in the 
absence of DTT. Substitution of a cysteine residue (C529) in the kinase domain for alanine 
results in constitutive kinase activity (i.e. DTT is no longer required for activity), implying 
a role for the kinase domain in redox sensing. However, these findings are contradictory to 
the work on the K. pneumoniae CitA mentioned above, in which activity was observed for 
the kinase domains in the absence of any reductant (Kaspar et al., 1999). Possible causes of 
this discrepancy include differences in the constructs tested (one of which lacks PASc and 
is fused to MBP) and mechanistic differences between the CitA proteins from E. coli and 
K. pneumoniae. Despite these uncertainties regarding redox sensing by the CitA protein, 
CitB dependent transcription is known to require a low oxygen tension in vivo (Bott et al., 
1995).  
DcuS, like CitA, is a membrane-embedded histidine protein kinase that contains a 
periplasmic ligand-binding PAS domain (DcuS PASp), a cytoplasmic PAS domain (DcuS 
PASc) and C-terminal histidine kinase domains. DcuS, together with its cognate RR, 
DcuR, regulates the transcription of fermentation genes (Golby et al., 1999; Zientz et al., 
1998). DcuS PASp binds a broader range of ligands than CitA PASp, including citrate and 
C4-dicarboxylates. The structure of the DcuS PASp domain from E. coli has been 
determined by NMR spectroscopy (Figure 1.8B) (Pappalardo et al., 2003). The topology of 
the three major β-strands in CitA PASp and DcuS PASp are similar and, in both proteins, 
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the central β-sheet is flanked by the N-terminal α-helices on one side and the PAS core on 
the other (Pappalardo et al., 2003). The residues shown in Figure 1.8B (R107, H110, R147 
and F120) are required for ligand-mediated activation of DcuS (Kneuper et al., 2005) and 
are homologous to the basic residues involved in ligand binding in CitA. Overall, the 
binding pocket of DcuS PASp bears a strong resemblance to that of CitA PASp (Mascher 
et al., 2006; Pappalardo et al., 2003; Reinelt et al., 2003). Ligand binding to DcuS PASp 
generates a signal that is relayed to the cytoplasmic PAS domain via two transmembrane 
helices. The PASc domain has no known role in signal perception but the plasticity of this 
domain is believed to be important for signal transduction to the histidine kinase domains. 
Several amino acid substitutions that result in ligand-independent (constitutive) activation 
of DcuS have been indentified in the PASc domain, implying that this domain is important 
in signalling. When DcuS PASc was modelled on the dimeric crystal structure of the NifL 
PAS1 domain (discussed below), it was observed that the substituted residues were located 
close to the α-helical N-terminal cap that forms part of the dimerisation interface (Etzkorn 
et al., 2008). This suggests a model in which signal perception by DcuS PASp impacts 
upon the stability of the dimer interface in DcuS PASc. Presumably, these changes in 
PASc modulate the activity of the C-terminal histidine kinase domains. Therefore, DcuS 
PASc is the first example of a PAS domain that appears to be involved in signal relay 
rather than stimulus perception. It is possible that the CitA PASc domain may have a 
similar function. 
 
(ii) Other ligand-binding PAS domains 
 Despite the relatively small number of PAS domains studied, a diverse range of 
ligands have been identified. These include carboxylic acids, amino acids, divalent metal 
ions and aromatic hydrocarbons (Cho et al., 2006; Denison et al., 2002; Glekas et al., 
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2009). It is likely that continued study of PAS-containing proteins will reveal new small 
molecule ligands. This section will summarise some examples of ligand-binding PAS 
domains from prokaryotic systems.  
In addition to the PAS domains mentioned above, which bind specifically to citrate 
(CitA PASp) or non-specifically to a broader range of carboxylic acids (DcuS PASp), there 
are ligand-binding PAS domains that respond specifically to C4-dicarboxylates. An 
example of this is the DctB protein. DctB is a histidine protein kinase that regulates the 
transcription of rhizobial C4-dicarboxylate transport (dct) genes. In contrast to CitA and 
DcuS, DctB has two periplasmic PAS domains, known as the membrane-distal and 
membrane-proximal PAS domains. The membrane-distal PAS domain binds C4-
dicarboxylates, while the membrane-proximal PAS domain is not associated with any 
ligand or co-factor (Zhou et al., 2008). Ligand binding to the membrane-distal PAS domain 
induces a tightening of the binding pocket and movements in several loop regions, 
mirroring the ligand-dependent conformational changes observed in CitA PASp (discussed 
above). 
The N-terminal PAS domains of CitA, DcuS and DctB are structurally similar to a 
periplasmic PAS domain found in the histidine protein kinase, PhoQ. This protein senses 
the extracellular concentration of divalent cations to regulate virulence and stress response 
genes in several Gram-negative pathogenic bacteria and the Mg
2+
 starvation response in E. 
coli (Monsieurs et al., 2005; Zwir et al., 2005). PhoQ activity is sensitive to changes in the 
concentration of Mg
2+
 and Ca
2+
 ions both in vitro and in vivo. The protein is active when 
extracellular concentrations of these ions are low, whilst increases in Mg
2+
 and Ca
2+
 levels 
result in diminished kinase activity (Sanowar and Le Moual, 2005; Vescovi et al., 1997). 
Crystal structures are available for the Ca
2+
-bound PAS domain from Salmonella 
typhimurium PhoQ and the E. coli PhoQ PAS domain bound to Ni
2+
 ions (Cheung et al., 
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2008; Cho et al., 2006). Both proteins contain a conserved cluster of acidic residues in 
close proximity to the inner membrane. These residues appear to directly bind divalent 
cations. It has been postulated that dissociation of the cations results in an electrostatic 
repulsion between the acidic surface of the PAS domain and the plasma membrane that 
might drive conformational changes leading to PhoQ activation (Cho et al., 2006).    
 Recent work on the Bacillus subtilis chemoreceptor McpB has revealed a 
periplasmic sensor region that is likely to contain tandem PAS domains, similar to those 
found in DctB (Glekas et al., 2009). This sensor region was shown to bind asparagine with 
a Kd of 14 μM. Mutations that decrease the affinity of the sensor region for asparagine 
were identified in the membrane-distal PAS domain. Moreover, the decreased affinity of 
the isolated sensor domain for asparagine in vitro correlated to reduced chemotactic 
responses in swarm plates and capillary assays (Glekas et al., 2009). These results suggest 
that the membrane-distal PAS domain in the periplasmic sensor region of McpB binds 
asparagine to regulate chemotaxis in B. subtilis.  
 Overall, subtle adaptations to the PAS fold can facilitate binding of chemically 
diverse ligands. These adaptations range from changes in the chemical properties of amino 
acid side chains located in the central cleft to the incorporation of clusters of charged 
residues on the outer surface of the domain. The mechanism by which ligand binding to 
PAS domains is coupled to conformational changes in output domains apparently varies 
between proteins. Diversity in the mechanisms by which PAS domains can sense ligands 
and relay ligand-binding events to output domains highlights their adaptability with regard 
to signalling. 
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1.2.3 Redox Sensing PAS domains  
(i) NifL 
The NifL regulatory protein controls the transcription of nif genes (required for 
biosynthesis of the molybdenum dependant nitrogenase) in γ-proteobacteria via 
interactions with the transcriptional activator, NifA. The NifL-NifA system is further 
discussed in section 1.4 whereas this section focuses on the N-terminal sensory region that 
contains two PAS domains in tandem. The most N-terminal PAS domain, PAS1, senses 
cellular redox status and binds a FAD co-factor. NifL is inactive when the FAD moiety is 
fully reduced (to FADH2). Oxidation of the PAS1 co-factor activates the NifL protein to 
inhibit transcriptional activation by NifA in the presence of excess oxygen (Hill et al., 
1996). The second PAS domain, PAS2, has no apparent co-factor and, prior to the work 
performed in this thesis, its function was unknown. 
The crystal structure of the PAS1 domain (residues 21 – 140 of A. vinelandii NifL) 
has recently been solved at 1.04 Ǻ resolution (Figure 1.10A). The structure reveals a 
typical α/β PAS fold that accommodates a non-covalently bound FAD co-factor and forms 
a dimer in the asymmetric unit. Dimerisation of the NifL PAS1 domain is mediated by an 
amphipathic A’α helix. The A’α helices of each protomer interact with each other as well 
as the hydrophobic surface of the β-sheet from the opposing subunit. This extended 
dimerisation interface buries 2066 Å
2
 of hydrophobic surface area and is highly similar to 
that observed in the crystal structures of EcDOS PASA and the SmFixL PAS domain (Key 
et al., 2007a). Association of the FAD co-factor is stabilised by an extensive hydrogen 
bonding network. Hydrogen bonds connect the isoalloxazine ring to an asparagine residue 
in the Gβ strand (N102) and the ribose and adenine portions of the FAD molecule to 
residues (W87 and R80) in the Fα helix (Key et al., 2007a). The co-factor is connected to 
the external environment via a cavity running through the protein, providing a possible  
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Figure 1.10. (A) Ribbon diagram of the NifL PAS1 domain and (B) the hydrogen bonding 
network within the oxidised flavin binding pocket (Key et al., 2007a). 
  
43 
 
route of entry for molecular oxygen. This cavity contains two water molecules that form 
hydrogen bonds with the FAD co-factor and several amino acid side chains (Figure 1.10B). 
Analysis of the PAS1 structure has led to a model of signal perception whereby diatomic 
oxygen attacks the C4α carbon atom of the isoalloxazine ring leading to deprotonation of 
the N5 atom and thereby triggering a re-organisation of the hydrogen bonding network 
(Figure 1.10B). It is this shift in the pattern of hydrogen bonding that constitutes the initial 
structural change associated with signal perception. Switching of FAD between its reduced 
and oxidised form necessitates generation of an intermediate hydroperoxy species. The 
structure suggests two possible catalysts for the production of this intermediate, the 
glutamic acid at position 70 or a nearby water molecule (Figure 1.10B). Substitution of this 
glutamic acid for alanine blocks redox sensing by NifL (Salinas P., Little R. and Dixon R., 
unpublished data). Changes in the position of side chains from several residues in the 
central β-sheet (E70, H133 and S39) have been observed after an extended period of X-ray 
illumination, indicating a structural change in the β-sheet upon photoreduction. This 
provides a potential mechanism by which signals may be propagated to influence the 
conformation of other regions of the protein (Key et al., 2007a).         
 
(ii) MmoS 
 MmoS is a sensor protein that regulates expression of the soluble methane 
monooxygenase (sMMO) in Methylococcus capsulatus (Bath). Under conditions of copper 
starvation, MmoS activates transcription of genes involved in sMMO biosynthesis (Csaki 
et al., 2003). MmoS is a complex modular protein that is predicted to contain nine discrete 
domains. The domain architecture of MmoS is shown in Figure 1.11A. The N-terminus of 
MmoS is anchored to the cell membrane via a transmembrane domain. The cytoplasmic  
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Figure 1.11. (A) Domain architecture of Methylococcus capsulatus (Bath) MmoS from the 
SMART nrdb. (B) Crystal structure of the MmoS PAS domains (Ukaegbu & Rosenzweig, 
2009). 
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portion of the protein contains tandem PAS domains, a GAF domain, histidine kinase 
domains (HisKA and HATPase modules), two phosphate receiver (REC) domains and a C- 
terminal histidine phosopho-transfer (HPt) domain (Figure 1.11A). It has been proposed 
that depletion of copper activates the kinase domains, resulting in autophosphorylation and 
subsequent phospho-transfer to the HPt domain. These events are likely to stimulate 
transcription of sMMO biosynthesis genes via the sequential activation of two further 
proteins (MmoQ and MmoR) (Ukaegbu et al., 2006).  
 The crystal structure of a fragment of the MmoS protein containing the two PAS 
domains was solved in 2009. This structure is of particular interest as it is the only one 
available to date showing two cytoplasmic prokaryotic PAS domains in tandem. The 
protein crystallised as a monomer in the asymmetric unit and the two PAS domains are 
connected by an α-helical linker (Figure 1.11B). The structure revealed that the N-terminal 
PAS domain (PASA) binds a FAD co-factor, while the more C-terminal PAS domain 
(PASB) has no co-factor or obvious ligand-binding pocket (Ukaegbu and Rosenzweig, 
2009). The redox potential of the MmoS FAD group is similar to that of NifL and it has 
been postulated that oxidation/reduction of the PASA co-factor in MmoS regulates the 
activity of the C-terminal output domains (Ukaegbu et al., 2006). The function of the 
second PAS domain remains unclear. However, given the lack of any co-factor or ligand 
binding pocket, it would appear that the PASB domain has a role other than signal 
perception.  
1.2.4 Light sensing PAS domains 
(i) PYP 
Photoactive yellow protein (PYP) was first discovered in Halorhodospira halophila 
and is thought to have a role in the phototaxis of purple bacteria; H. halophila are 
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negatively phototactic towards blue light (Meyer, 1985; Sprenger et al., 1993). However, 
PYP has also been identified in Rhodobacter capsulatus where pyp and its two 
biosynthetic genes are clustered with the gvp genes (encoding proteins required for gas 
containing vesicle formation) which determine cell buoyancy. Expression of gvp genes is 
responsive to changes in light availability in many bacterial species and it has been 
proposed that R. capsulatus PYP (RcPYP) may be involved in the regulation of cell 
buoyancy (Kyndt et al., 2004a). Differences in the proposed function of H. halophila PYP 
(HhPYP) and RcPYP in vivo correlate to biochemical differences between the proteins. 
HhPYP and RcPYP have differing absorption spectra and photocycle kinetics (Kyndt et al., 
2004a). PYP exemplifies a class of proteins that consist of a single PAS domain only and 
lack distinct output domains. It seems likely that proteins of this type transduce signals via 
stimulus-dependant interactions with cellular targets. However, at the time of writing, the 
details of signal transduction by PYP remain unclear. 
PYP is a small photoreceptor protein consisting of 125 amino acids. Exposure of 
PYP to visible light induces bleaching of the protein’s characteristic yellow colour and 
incubation of the bleached protein in the dark restores its colour within 1 second (Meyer et 
al., 1987). PYP contains a 4-hydroxycinnamic acid co-factor that is covalently attached to 
a conserved cysteine residue in the protein moiety via a thioester bond (Baca et al., 1994). 
This chromophore contains an isomerisable double bond and an ionisable oxygen atom. 
Light absorption results in protonation of the oxygen atom and concomitant isomerisation 
of the 4-hydroxycinnamic acid group from the trans form to the cis form (Figure 1.12A) 
(Genick et al., 1997; Genick et al., 1998; Kort et al., 1996). Co-factor isomerisation 
triggers an alteration in the hydrogen bonding pattern in the PYP active site (Figure 1.12B) 
and initiates a cycle of rapid chemical and conformational changes known as the 
photocycle. During the cycle, several transient signalling intermediates are formed before  
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Figure 1.12. (A) Chemical changes in the photoactive yellow protein (PYP) active site in 
the dark state and light state (Groot et al., 2003) and (B) PYP crystal structure showing the 
active site hydrogen bonding network (Brudler et al., 2006). 
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PYP reverts to the dark state (PYPdark). As no activity or downstream interactions have 
been identified it is difficult to discern which of these conformations represents the “on 
state”. The current hypothesis, based on spectroscopic analogies with rhodopsins, is that a 
signalling state known as PYPM (or I2) represents the active form of PYP. In this state, 
there are significant alterations in the global conformation and surface properties of PYP. 
Hydrophobic sites that are buried when PYP is in the dark state become surface exposed in 
PYPM and it has been postulated that this change in surface mediates interaction with a 
transducer protein (Hendriks et al., 2002; Hoff et al., 1999; Imamoto and Kataoka, 2007).   
Interestingly, PYP-like domains have also been found in larger proteins that contain 
additional output domains. Two of these “chimeric” proteins have been studied to date, 
namely PYP phytochrome-related (Ppr) protein from Rhodospirillum centenum and 
PYP/bacteriophytochrome/diguanylate cyclase (Ppd) from Thermochromatium tepidum 
(Jiang et al., 1999; Kyndt et al., 2004b). Both proteins contain an N-terminal sensor region 
consisting of a PYP-like domain adjacent to a bacteriophytochrome (Bph) domain. These 
two sensory domains regulate the activity of C-terminal output domains. Ppr contains 
histidine kinase effector domains and Ppd has C-terminal GGDEF and EAL domains. 
There is limited information on intra-molecular signal relay in Ppd, whereas inter-domain 
communication in Ppr has been the focus of several studies (Jiang et al., 1999; Kamikubo 
et al., 2008; Kyndt et al., 2007). The activities of the PYP-like and Bph domains of Ppr 
(which sense blue and red light respectively) appear to be antagonistic; activation of the 
PYP domain with blue light accelerates recovery (i.e. decay of the activated photocycle 
intermediate) of the Bph domain after illumination with red light. Conversely, the presence 
of a functional Bph domain accelerates recovery of the PYP domain after blue light 
illumination (Kyndt et al., 2007). These results strongly imply that a form of inter-domain 
communication occurs between the PYP-like and Bph domains of Ppr. Moreover, a recent 
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study of the full-length Ppr protein demonstrated that the presence of the C-terminal 
histidine kinase domains can accelerate recovery of the PYP-like domain in the absence of 
a functional Bph domain, suggesting communication between the PYP-like domain and the 
output domains (Kamikubo et al., 2008).  
PYP is an unusual PAS domain in that it is known to exist as both a distinct protein 
and a protein domain. The SMART and Pfam databases contain other examples of 
hypothetical proteins that appear to consist of a single PAS domain (or pair of PAS 
domains) but none have yet been characterised. PYP not only provides a valuable model 
for studying the mechanisms by which stimuli induce changes in the signalling state of 
PAS domains but also provides insight into how PAS domains can be incorporated into 
complex modular proteins to facilitate integration of multiple signals. 
 
 (ii) YtvA 
YtvA mediates induction of the general stress response in Bacillus subtilis in 
response to blue light (Akbar et al., 2001; Avila-Perez et al., 2006; Gaidenko et al., 2006). 
The B. subtilis general stress response is controlled by the alternative sigma factor σB. In 
unstressed cells, σB activity is inhibited by the anti-σ factor, RsbW. Exposure to a variety 
of stresses results in inhibition of RsbW by the anti-anti-σ factor, RsbV. Under these 
conditions, σB is released to promote transcription of stress resistance genes. RsbV activity 
is regulated by two discrete pathways responding to energy stress and environmental 
stress. YtvA activates the environmental stress pathway. Signal input to this pathway is 
multi-faceted and will not be discussed in depth in this chapter. One mode of 
environmental stress detection involves a large protein complex known as the 
“stressosome”, in which the phosphorylation states of several STAS (sulphate transporter 
and antisigma factor antagonist) domain containing proteins are thought to be responsive to 
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multiple forms of stress (Marles-Wright et al., 2008). The next step in signal transduction 
is the release of a “stressosome” component (called RsbU) that indirectly activates RsbV, 
resulting in activation of σB. YtvA has been shown to co-purify with several component 
proteins of the “stressosome”, although the relevance of this to signalling remains unclear 
(Gaidenko et al., 2006).  
The YtvA protein consists of two domains, a sensory N-terminal PAS domain (Y-
PAS) and a C-terminal STAS output domain. The STAS domain has been shown to bind 
GTP and could potentially mediate interactions between YtvA and “stressosome” proteins 
(Buttani et al., 2006). However, the function and molecular mechanism of signal 
transduction by the STAS domain are poorly understood. The PAS domain senses blue 
light via a flavin mononucleotide (FMN) chromophore (Figure 1.13A). The crystal 
structure of the YtvA PAS domain has been solved in both the illuminated state and the 
ground state (Möglich and Moffat, 2007). The domain is dimeric in the asymmetric unit 
and adopts the canonical PAS fold with an additional C-terminal α-helix, called the Jα 
helix, which extends outward from the globular dimer. Illumination results in the formation 
of a thioester bond between the C4a atom of the FMN co-factor and a cysteine residue 
(C62) in the Eα helix (Figure 1.13B). This initial structural change in the active site is 
propagated by movements in the Eα and Jα helices as well as several loop regions. Overall, 
signal perception triggers a quaternary structural change whereby Y-PAS subunits undergo 
a 5
o
 rotation relative to one another in a “scissor-like” movement (Möglich and Moffat, 
2007).  
Recent evidence suggests that the Y-PAS Jα helices form a coiled-coil α-helical 
linker between the PAS domain and the STAS domain in the dimeric YtvA protein and it 
has been postulated that signals are transmitted between these domains via changes in the  
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Figure 1.13. (A) Crystal structure of the YtvA PAS domain (Y-PAS). (B) Light dependent 
structural changes in Y-PAS. The panels on the left show electron density maps of the Y-
PAS FMN-binding cavity in the ground state (upper panel) and after blue light illumination 
(lower panel). C
α
 traces of Y-PAS in the illuminated state (yellow) and ground state (blue) 
are shown on the right. 
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quaternary structure or stability of the Jα helices (Möglich and Moffat, 2007). Moreover, 
Moffat and colleagues have demonstrated that a chimeric protein containing Y-PAS fused 
to the FixL output (histidine kinase) domains exhibits light dependant histidine kinase 
activity in vivo and in vitro (Möglich et al., 2009a). This supports the hypothesis that the Jα 
helix, which is present in both the native oxygen-sensing PAS domain of FixL and Y-PAS, 
has a role in signal relay that is conserved in these proteins. Further evidence for inter-
domain communication between the PAS and STAS domains of YtvA has been provided 
by spectroscopic studies using fluorescent GTP analogues (Buttani et al., 2007; Buttani et 
al., 2006). Light dependent changes have been observed in the spectroscopic properties of 
the GTP-TR bound protein, indicating that the sensory state of the PAS domain influences 
the conformation of the GTP binding site in the STAS domain. Moreover, mutational 
analysis indicates that light-dependant GTP binding is important for YtvA function in vivo 
(Avila-Perez et al., 2009). 
 
1.2.5 PAS domains and protein-protein interactions  
 In addition to their role in stimulus detection and signal relay, PAS domains can 
also mediate protein-protein interactions. Many PAS-containing proteins transduce signals 
via switching of binding partners and, in several systems, PAS domains are thought to 
modulate binding partner specificity (Huang et al., 1993; Lindebro et al., 1995; Pongratz et 
al., 1998; Rowlands and Gustafsson, 1997). A well studied example of this is the aryl 
hydrocarbon receptor (AhR). AhR is a eukaryotic transcription factor found in numerous 
species and diverse tissue types. AhR activity influences various signalling pathways 
involved in many cellular processes, including cell cycle regulation, development and 
apoptosis (Puga et al., 2009). However, AhR is best characterised for its role in the 
xenobiotic enzyme induction pathway, which has been studied since the 1970’s (Schmidt 
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and Bradfield, 1996). In its inactive state, AhR is found in the cytoplasm in complex with 
several other proteins (Petrulis and Perdew, 2002). Ligand binding to one of two PAS 
domains triggers a conformational change in the protein that exposes a nuclear localisation 
sequence, resulting in movement of AhR from the cytoplasm into the nucleus (Henry and 
Gasiewicz, 2003; Hord and Perdew, 1994). AhR then dissociates from the complex and 
dimerises with a second PAS-containing protein called ARNT (Aryl hydrocarbon receptor 
nuclear translocator) to form a transcriptionally active hetero-dimer (Hankinson, 1995). 
The N-terminal PAS domains of AhR are important in each of these signal transduction 
steps. They mediate protein-protein interactions with ARNT as well as at least one 
component of the cytoplasmic signalling complex (Perdew, 1988; Reisz-Porszasz et al., 
1994). ARNT, like AhR, contains two PAS domains that modulate switching of interaction 
partners. ARNT is capable of forming a homo-dimer or interacting with one of with three 
other PAS-containing proteins (including AhR) to form hetero-dimers (Lees and Whitelaw, 
1999; Moffett et al., 1997; Pollenz et al., 1994). Interaction with one of these partners, 
namely hypoxia-inducible factor (HIF-α), is achieved by hetero-dimerisation of the PAS 
domains from each protein (Erbel et al., 2003; Yang et al., 2005). Isolated PAS domains 
from these proteins also interact in vitro (Erbel et al., 2003). Therefore, the ARNT PAS 
domains play a role in the interactions with at least two of its three binding partners. Thus, 
PAS domains can function as protein-protein interaction modules and, in this capacity, 
they are important in many signalling pathways that control diverse biological processes 
including the hypoxic response and cell cycle regulation in eukaryotes. 
 
1.2.6 Common aspects of PAS domain signalling 
 Despite the versatility of PAS domains with respect to their biological function, 
their highly conserved structure implies that some aspects of the signal transduction 
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mechanism are likely to be, at least partially, conserved. Signal-dependant structural 
changes in the central β-sheet have been reported in PAS domains from a diverse range of 
proteins. These include light sensing PAS domains from plants (phototropins), fungi (N. 
crassa Vivid) and bacteria (YtvA and PYP) as well as bacterial ligand-binding PAS 
domains (CitA) and eukaryotic protein-protein interaction PAS domains (ARNT) (Evans et 
al., 2009; Harper et al., 2003; Möglich and Moffat, 2007; Rajagopal et al., 2005; Sevvana 
et al., 2008; Zoltowski et al., 2007). This is consistent with the importance of the β-sheet in 
co-factor binding and dimerisation of many PAS domains and implies that the central β-
sheet has a conserved role in signal propagation in PAS domains of varying function. This 
is particularly interesting given that the output domains of these proteins, to which the 
signalling state of the PAS domain(s) must be relayed, are dissimilar in structure and 
function. In a recent review, Möglich and colleagues note that the tertiary structural 
uniformity of the PAS core is in stark contrast to the structurally diverse output domains, 
suggesting that signal transmission is not dependent on tertiary structural recognition 
between domains (Möglich et al., 2009b). The authors also point out that the majority of 
PAS-associated output domains function as oligomers and that alterations in quaternary 
structure could therefore provide a common mechanism of signal transduction. There is a 
considerable body of evidence to support this hypothesis. Quaternary structural changes in 
PAS domains from FixL, CitA, DctB and KinA regulate the activity of histidine kinase 
output domains, whilst signal-dependent alterations in the quaternary structure of PAS 
domains from EcDOS and YtvA module the activity of EAL and STAS output domains 
respectively (Ayers and Moffat, 2008; Kurokawa et al., 2004; Lee et al., 2008; Möglich 
and Moffat, 2007; Zhou et al., 2008). The importance of quaternary re-arrangements to the 
signalling mechanism has also been demonstrated in PAS-containing proteins from plants 
and mammals (Erbel et al., 2003; Evans et al., 2009; Nakasako et al., 2008). Moreover, the 
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oxygen-sensing PAS domain from BjFixL can adopt two distinct quaternary structures 
with similar free energy (Ayers and Moffat, 2008). The authors also identified an extended 
dimerisation interface that is conserved in PAS domains from EcDOS, YtvA, AvNifL and 
CrPhot (Chlamydomonas reinhardtii phototropin) and may facilitate switching between 
alternative quaternary arrangements. Overall, the available information suggests a model 
for PAS domain signalling whereby signal perception induces changes in the association 
state or orientation of PAS subunits to influence the activity of output domains.    
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1.3 Histidine Protein Kinases 
 As discussed in section 1.1, bacteria utilise two-component systems (TCSs) to 
adapt their physiology according to changes in their environment. A typical two-
component system consists of a histidine protein kinase (HPK) and cognate response 
regulator (RR). The HPK phosphorylates the RR in response to environmental stimuli and 
the phosphorylated RR then elicits a cellular response, often via a change in gene 
expression. This section will focus on HPKs due to their relevance to the system studied in 
this thesis. RRs will not be considered in detail.  
Since their discovery in the 1980s, HPKs have been shown to control a plethora of 
cellular processes in bacteria, including motility, various metabolic switches, virulence, 
nutrient uptake and many aspects of development (Mascher et al., 2006). Several genome 
analysis studies have highlighted the importance of two-component signalling systems in 
model organisms (Fabret et al., 1999; Hutchings et al., 2004; Rodrigue et al., 2000). For 
example, analysis of the Streptomyces coelicolor A3(2) genome indicated the presence of 
at least 67 TCSs as well as 17 unpaired HPKs and 13 orphan RRs. Of the 84 HPKs, 74 
have unknown function. It is thought that the remaining 10 HPKs play roles in the 
regulation of development, aspects of secondary metabolism, responses to cell wall 
damage, osmoadaption and the osmotic shock response, the phosphate starvation response, 
chitinase production and vancomycin resistance (Hutchings et al., 2004). A similar 
genomic analysis revealed the presence of 36 HPKs and 35 RRs in Bacillus subtilis (Fabret 
et al., 1999). Microarray analysis has since been used to determine the regulons of 27 B. 
subtilis TCSs (Kobayashi et al., 2001; Ogura et al., 2001). The size of these regulons varies 
considerably between TCSs, ranging from 4 to 98 genes (Kobayashi et al., 2001). Overall, 
the genes that comprise these TCS controlled regulons are extremely diverse in function 
and impact most aspects of cellular physiology.  
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1.3.1 Phosphochemistry  
The reactions of HPKs can be split into two stages (Figure 1.14). The first stage is 
autophosphorylation of the HPK via conversion of ATP to ADP (Figure 1.14, step 1). 
During this step the γ-phosphoryl group is moved to a conserved histidine residue within 
the HPK. The second reaction is called the phospho-transfer reaction (Figure 1.14, step 2), 
in which the phosphate group is switched to a conserved aspartate residue in the RR. 
Divalent metal ions are a necessity for both reactions. There is a significant difference in 
the chemistry of phosphorylated histidines compared to their Ser/Thr/Tyr counterparts, 
namely they are phosphoramidates rather than phosphoesters. Hydrolysis of the 
phosphoester bond has a free energy (ΔGo) of between -6.5 and -9.5 kcal mol-1 in contrast 
to a ΔGo of -12 to -14 kcal mol-1 for the P-N bond of phospho-histidine (Stock et al., 1990). 
As a result, the physiological functions of HPKs tend to fill niches not suited to 
Ser/Thr/Tyr kinases. For example, the high energy N~P bond of phosphohistidines is 
apposite for phospho-transfer.   
 
1.3.2 Domain Architecture 
HPKs are modular proteins with highly variable domain architectures, reflecting 
the array of different signals they perceive and transduce. HPKs can also differ 
dramatically in size; the smallest are less than 40 kDa whilst larger HPKs can exceed 200 
kDa. Despite this variability, all HPKs consist of two main regions known as the sensor 
region and the core transmitter region. Both of these are discussed below in detail. HPKs 
are grouped into two distinct categories, namely orthodox HPKs and hybrid HPKs 
(Parkinson and Kofoid, 1992). In orthodox HPKs, the conserved histidine residue in the 
core transmitter region is the sole site of phosphorylation (Figure 1.15 and Figure 1.17). Of 
the 29 HPKs in E. coli, 24 are orthodox HPKs (Mizuno, 1997). In the second category,  
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Figure 1.14. The two reactions of histidine protein kinases: (1) autophosphorylation and 
(2) phospho-transfer.  
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Figure 1.15. Domain architectures of three well studied HPKs. All contain sensor regions, 
core kinase domains and a conserved histidine residue. EnvZ, like the majority of HPKs, 
has a periplasmic sensor region between two transmembrane helices (TM1 and TM2). 
NtrB is an entirely cytoplasmic HPK. ArcB is a hybrid HPK with two additional modules: 
the central receiver domain (or D1 domain) and the histidine phospho-transfer (HPt) 
domain. After autophosphorylation of the conserved histidine residue in the kinase 
transmitter region, the phosphate group is transferred first to an aspartate residue in the D1 
domain and then to the histidine of the HPt domain, before finally being switched to the 
RR. The two TM regions of ArcB are separated by only 16 amino acids and function as 
anchorage to the membrane rather than enclosing a periplasmic sensor region, as in EnvZ.      
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hybrid kinases (exemplified by ArcB in Figure 1.15), the site of autophosphorylation is not 
in the core transmitter region and/or there is a more complicated phospho-relay system 
involving other histidine-containing domains or proteins (Stock et al., 2000). Indeed, it is 
not uncommon for hybrid kinase systems to consist of more than two components. This 
chapter will focus on orthodox HPKs.  
In vitro, HPKs form homodimers and in most cases autophosphorylation (Figure 
1.14, step 1) is thought to occur in trans between subunits (Ninfa et al., 1993; Surette et al., 
1996; Swanson et al., 1993). It is also possible for HPKs to catalyse the dephosphorylation 
of their partnered RR (though most RRs exert their own autophosphatase activity) 
(Kanamaru et al., 1989; Keener and Kustu, 1988). The relative rates of these reactions 
determine the kinetics and efficacy of the response. These, in turn, are controlled via 
signals initiated by the sensor region of the HPK, in response to environmental cues.  
 
1.3.3 The Sensor Region 
Sensor regions are poorly conserved between different HPKs and there are no 
ubiquitous motifs. The mechanisms by which environmental signals are perceived are 
extremely variable, reflecting the diversity of the stimuli to which HPKs respond. The 
sensor regions of many HPKs incorporate more than one sensory module and integrate 
multiple signals. Modules commonly recruited to HPK sensor regions include PAS and 
GAF domains. In fact, 33% of HPKs contain a cytoplasmic PAS domain whilst 9% contain 
a GAF domain (Szurmant et al., 2007). It should be remembered that signal perception is 
not strictly limited to the sensor region. An example of this is the NtrB protein, a HPK that, 
together with its cognate RR (NtrC), regulates the transcription of genes involved in 
nitrogen metabolism and uptake in E. coli. The signal for nitrogen status that controls NtrB 
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activity is sensed by a PII signal transduction protein, which interacts directly with the 
kinase core region (Pioszak et al., 2000). 
 
1.3.4 The Kinase Transmitter Region 
The kinase transmitter region contains two domains: the GHKL domain and the 
dimerisation and histidine phospho-transfer (DHp) domain. In an orthodox HPK, the 
GHKL domain consists of approximately 250 amino acids and is responsible for nucleotide 
binding and kinase activity (Parkinson and Kofoid, 1992). The dimerisation domain 
contains a conserved His residue that is the site of autophosphorylation by the GHKL 
domain (Stock et al., 2000). The kinase transmitter region is more highly conserved than 
the sensor region and structural information is available on the GHKL and DHp domains 
from several HPKs. 
 
(i) Structure and function of dimerisation domains 
 As mentioned above, HPKs are homodimeric and proper dimerisation is required 
for activity. Dimerisation is mediated by the DHp domain (also known as the dimerisation 
domain). This domain also contains a conserved histidine residue which becomes 
phosphorylated when the HPK is active. To date, high resolution structures of only three 
DHp domains from orthodox HPKs have been characterised: those of E. coli EnvZ 
(Tomomori et al., 1999), Thermotoga maritima HK853 (Marina et al., 2005) and B. 
subtilus DesK (Albanesi et al., 2009). Dimerisation domains exhibit some sequence 
homology and contain a consensus sequence hxxxhxHahhpPhxxh (Figure 1.16). The 
histidine and proline from this sequence are conserved in all HPKs and there is a high  
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Figure 1.16. Multiple sequence alignment to illustrate the regions of homology in the 
dimerisation domains of various HPKs. Secondary structural elements are indicated above. 
Conserved residues are shown in red and partially conserved hydrophobic residues are 
indicated by an asterisk (Tomomori et al., 1999).   
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Figure 1.17. Ribbon diagram of the four helix bundle formed by two DHp domain 
subunits in EnvZ. The histidine residues that are autophosphorylated upon HPK activation 
are shown in green (Tomomori et al., 1999).   
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degree of sequence homology between HPKs in the surrounding hydrophobic residues. 
The secondary structure consists of two α-helices (helix I and helix II). Helix I contains the 
aforementioned consensus sequence, while helix II contains an additional patch of 
conserved hydrophobic amino acids (Tomomori et al., 1999).      
The first published structure of a dimerisation domain was that of E. coli EnvZ 
(Tomomori et al., 1999). EnvZ and its cognate RR, OmpR, regulate the transcription of 
genes involved in osmotic homeostasis (such as ompF and ompC which encode outer-
membrane porins) in response to changes in extracellular osmolarity. The DHp domains 
from each EnvZ subunit combine to form a symmetrical four helix bundle in the EnvZ 
homodimer (Figure 1.17). There are two inter-subunit surfaces on opposing sides of the 
four helix bundle (i.e. one from either subunit), each containing an acidic cluster, and two 
intra-subunit surfaces. The conserved histidines (H243 in E. coli EnvZ) are situated on the 
edge of the molecule, between these surfaces. The inter-subunit surface also incorporates a 
hydrophobic cluster which, together with the acidic cluster, has been postulated to mediate 
interactions with the GHKL domain (see below) and OmpR. Moreover, substitutions in the 
dimerisation domain that impede EnvZ function are predominantly located near the inter-
subunit surface, emphasising the importance of dimerisation to the kinase function of the 
GHKL domain (Portnoy et al., 1999; Tomomori et al., 1999).   
 
(ii) Structure and function of GHKL domains 
The catalytic domain of HPKs is called the GHKL domain. This domain binds ATP 
and catalyses hydrolysis of the γ-phosphate and phosphorylation of the DHp domain 
(Figure 1.14). The GHKL domain is defined by four conserved sequence motifs, namely 
the N, G1 (or D), F and G2 boxes (Figure 1.18). These motifs are not confined to kinase 
core domains in HPKs and form the ATP binding sites of structurally homologous domains  
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Figure 1.18.  (A) Sequence and secondary structure alignment of the GHKL domains from 
NtrB (or NRII), EnvZ and PhoQ with conserved boxes shown in red (Song et al., 2004). 
(B) Generalised topology of GHKL domains (Dutta and Inouye, 2000). β-strands are 
coloured gray, α-helices blue and the N, G1, G2 and G3 boxes are marked in orange. Fully 
conserved residues are red whilst partially conserved amino acids are shown in yellow.  
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in DNA gyrase B, Hsp90 and MutL (Bilwes et al., 1999; Marina et al., 2001; Tanaka et al., 
1998). A fifth region of homology, termed the G3 box (Figure 1.18B), was defined more 
recently (Dutta and Inouye, 2000). If the GHKL domains of EnvZ, PhoQ (an orthodox 
HPK involved in the phosphate starvation response) and CheA (a hybrid HPK involved in 
chemotaxis) are superimposed, approximately 70% of the residues are identically 
positioned in all three HPKs and the majority of these are clustered around the five 
conserved boxes. The identical residues outside of these regions are predominantly 
hydrophobic, buried amino acids that contribute to formation of the core of the molecule 
(Marina et al., 2001).    
 Crystal structures of the GHKL domains of DesK, CheA, PhoQ and (a mutant form 
of) NtrB are available (Albanesi et al., 2009; Bilwes et al., 1999; Marina et al., 2001; Song 
et al., 2004; Tanaka et al., 1998) in addition to the NMR structure of EnvZ (Tanaka et al., 
1998). All revealed an autonomously folding two-layer α/β sandwich. In EnvZ and PhoQ, 
this sandwich consists of a five stranded β-sheet (Figure 1.19A , EnvZ strands B, D, E, F 
and G and  Figure 1.19B, PhoQ strands βB, βD, βE, βG and βF) and 3 α-helices (α1, α2 
and α3 in Figure 1.19B) that enclose a central hydrophobic core. The non-hydrolysable 
ATP analogue (AMP-PNP) utilised in crystallisation is located in a deep cavity at one end 
of the molecule, while the opposing end is sealed by a small anti-parallel β-sheet 
comprised of strands A and C from EnvZ (Figure 1.19A) or βA and βC from PhoQ (Figure 
1.19B). The structure of EnvZ indicated a high degree of flexibility in this ATP binding 
region, and the adjacent loops are known to undergo structural changes in MutL upon ATP 
binding and hydrolysis (Ban et al., 1999). This has prompted the suggestion that nucleotide 
binding in HPKs may induce analogous changes in conformation (Stock, 1999). 
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Figure 1.19. (A)  Structure of the EnvZ GHKL domain bound to AMP-PNP as determined 
by NMR (Tanaka et al., 1998). (B) Structure of the GHKL domain of PhoQ complexed 
with AMP-PNP and a magnesium ion co-factor as determined by X-ray crystallography 
(Marina et al., 2001).   
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Figure 1.20. The carbon backbones of PhoQ (blue) and CheA (yellow) superimposed to 
illustrate the “open” and “closed” conformations of the ATP lid (Marina et al., 2001).    
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The extended loop that covers the AMP-PNP molecule in Figure 1.19b has been 
termed the ATP lid (Dutta and Inouye, 2000). It contains the G2 and F boxes. The ATP lid 
is highly flexible and its motility is aided by the three glycine residues that constitute the 
G2 box. The F box functions as an N-terminal anchor for the ATP lid in PhoQ and EnvZ. 
The C-terminal end is tethered by a conserved hydrophobic patch (Figure 1.20). In PhoQ, 
the γ-phosphate group forms hydrogen bonds with amino acid side chains from the ATP lid 
and the N box. Moreover, three residues make extensive contacts with both the ATP 
analogue and the chelated magnesium ion co-factor, indicating that ATP binding may 
encourage a more “closed” conformation (Marina et al., 2001). The difference between the 
“open” and “closed” positions of the ATP lid is clearest when comparing the AMP-PMP 
bound PhoQ structure to that of the ligand-free CheA protein (Figure 1.20). Nucleotide 
binding is believed to be the main effecter of this change in conformation as the anchoring 
residues at either terminus appear to be largely super-imposable (Marina et al., 2001). The 
ATP loop is thought to be vital for proper HPK function and mutagenesis of its proposed 
hinge region eliminates kinase activity in EnvZ (Yang and Inouye, 1993). 
Despite the characteristic sequence motifs of GHKL domains in HPKs, there 
remains some significant variability between them. 11 separate categories have been 
described (Grebe and Stock, 1999). NtrB contains a short β-hairpin between strands β4 and 
β5 which is comprised of two β-strands (β4’ and β4”) and is completely absent from all 
other HPKs of known structure (Figure 1.18A). This novel structural feature has been 
suggested as the site of NtrB interaction with the PII signalling protein, and several 
substitutions in this vicinity significantly impair PII binding (Pioszak and Ninfa, 2003; 
Song et al., 2004).  
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(iii) Domain interactions in the transmitter region 
In 2005 the crystal structure of the entire kinase transmitter region of a HPK from 
Thermotoga maritima (HK853) was published. As predicted, the dimerisation interface 
was confined to the DHp domain. Interactions between the GHKL and DHp domains occur 
via conserved, buried hydrophobic residues and a coiled coil linker region. Helix II of the 
dimerisation domain interacts with two helices in the GHKL domain analogous to the α1 
and α2 helices from the GHKL domains of PhoQ and EnvZ (Figure 1.19). Additionally, 
the phenylalanine residue that constitutes the F box of the GHKL domain is orientated 
towards a hydrophobic pocket in helix I. This extensive structural connection may allow 
for the large movement of the GHKL domain, relative to the H domain, that is necessary to 
bring the catalytic region into close enough proximity of the conserved histidine to achieve 
autophosphorylation. This led to a model of HPK autophosphorylation in which stimulus 
perception (or the absence thereof) causes the GHKL domain of one subunit to shift 
towards the DHp domain of the other (Figure 1.21). After autophosphorylation, a second 
shift in the position of the GHKL domain, away from the phospho-histidine, is required to 
allow docking of the RR for phospho-transfer. HPKs, therefore, must undergo large 
domain movements in order to adopt multiple conformational states (Marina et al., 2005).  
 Our understanding of domain interactions in the transmitter region has recently 
been enhanced by three further structural studies (Albanesi et al., 2009; Bick et al., 2009; 
Casino et al., 2009). The crystal structure of the cytoplasmic region of T. maritima HK853 
in complex with its cognate response regulator is now available (Casino et al., 2009). Thus, 
structures of the DHp and GHKL domain are known in two discrete signalling states. 
Comparison of these structures implies that, contrary to the accepted paradigm, the 
autophosphorylation reaction in the HK853 dimer occurs in cis. This observation was 
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Figure 1.21.  Model of the HPK domain re-arrangements that occur during the 
autophosphorylation (A→B), phospho-transfer (B→A*) and phosphatase (A*→A) 
reactions (Marina et al., 2005). HPK protomers are shown in yellow and green with the N 
and C termini indicated. The RR is red and the black star denotes a phosphoryl group. The 
approximate positions of the phospho-accepting histidine on the HPK (H) and phospho-
accepting aspartate on the RR (D) are also indicated.  
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confirmed biochemically in both HK853 and a second HPK that shares a high degree of 
sequence homology with HK853, Staphylococcus aureus PhoR (Casino et al., 2009). The 
relative frequency of this cis mechanism compared to the trans mechanism established for 
EnvZ, NtrB and CheA is not known (Ninfa et al., 1993; Surette et al., 1996; Swanson et al., 
1993). These results necessitate a minor refinement of the above model of HPK domain 
interactions (Figure 1.21). There is still thought to be a signal-dependent movement of the 
GHKL domain relative to the dimerisation domain. However, in some cases this may entail 
a shift in the position of the GHKL domain towards the conserved histidine residue in the 
dimerisation domain of the same protomer, rather than that of the opposing protomer as 
previously suggested. The recent structural data support a model for signal transduction in 
HK853 in which a series of rotational movements between pairs of helices, beginning in 
the transmembrane region and extending to the upper part of the dimerisation domain, 
result in altered interactions between the GHKL and DHp domains (Casino et al., 2009). 
This model is consistent with newly available structural information on two other HPKs, B. 
subtilis KinB and DesK (Albanesi et al., 2009; Bick et al., 2009). The structure of DesK is 
available in three discrete conformations, thought to correspond to the unphosphorylated, 
phosphorylated and phosphatase competent states (Albanesi et al., 2009). In this system, 
rotational movements in the DHp domain appear to mediate the transition between these 
states by modulating interactions between the DHp domain and the RR or GHKL domain. 
Overall, structural plasticity in the dimerisation domain is important to signal transduction 
in several systems and may allow HPKs to undergo the sizable conformational changes 
needed to accommodate multiple signalling states.  
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1.4 The NifL-NifA system 
Biological nitrogen fixation requires the reduction of atmospheric dinitrogen to 
ammonia under physiological conditions. Nitrogen fixation is an essential component of 
the nitrogen cycle and maintains nitrogen levels in the biosphere. In addition to its 
environmental importance, biological nitrogen fixation is of great consequence to 
agriculture as the availability of fixed nitrogen is often the limiting factor for crop yield. 
Biological nitrogen fixation relies on the enzymatic activity of nitrogenase and is an 
energetically costly and kinetically slow process (Thorneley and Lowe, 1983). Nitrogen 
fixation is thought to consume 40 mol of ATP per mol of ammonia generated in vivo and 
microbial growth in the absence of a fixed nitrogen source requires a high concentration of 
nitrogenase (Hill, 1992). Thus, biological nitrogen fixation is only advantageous in specific 
environments and may damage the competitiveness of the cell if attempted under sub-
optimal conditions. This, in conjunction with the irreversible inactivation of nitrogenase 
upon exposure to oxygen, necessitates stringent transcriptional control of nitrogenase 
biosynthesis genes in response to the cellular levels of oxygen, fixed nitrogen and carbon. 
Members of the γ-subgroup of proteobacteria achieve this using the NifL-NifA system.  
The NifL-NifA system is best studied in Azotobacter vinelandii. When first 
sequenced, the nifL was thought to encode a HPK on the basis of sequence homology 
(Blanco et al., 1993; Drummond and Wootton, 1987). However, mutational analysis of the 
conserved histidine residue in NifL demonstrated its redundancy in the signalling 
mechanism (Woodley and Drummond, 1994). NifA is a transcriptional activator that, 
under conditions conducive to nitrogen fixation, stimulates the transcription of nif genes 
(required for biosynthesis of the molybdenum-dependent nitrogenase). When 
environmental circumstances do not favour nitrogen fixation, NifL inhibits NifA activity 
via formation of an inhibitory protein-protein complex. The stability of this complex, and 
74 
 
thus the activity of NifA, is controlled in response to the redox, carbon and fixed nitrogen 
status of the cell (Dixon and Kahn, 2004; Martinez-Argudo et al., 2004c; Schmitz et al., 
2002). All these stimuli, together with the binding of small effector molecules to both 
proteins, are integrated on a molecular level by the NifL-NifA system via a complicated set 
of domain interactions that control nif gene transcription.     
 
1.4.1 Domain Architecture of NifL  
NifL is a modular protein that consists of four discrete domains. The C-terminal 
region of NifL contains a GHKL (nucleotide binding) domain (Figure 1.22B) with its 
characteristic N, G1, F and G2 boxes (Blanco et al., 1993; Drummond and Wootton, 1987). 
However, this domain does not hydrolyse ATP and no autophosphorylation reaction occurs 
in NifL (Söderbäck et al., 1998). A conserved histidine residue in a region similar to the 
DHp domains of HPKs is also apparent. However, the mechanism of signal transduction in 
NifL deviates from that of HPKs, as substitution of this histidine for alanine, 
phenylalanine, serine, lysine or valine (among others) has no effect on NifL-NifA 
interactions (Woodley and Drummond, 1994). This DHp-like domain in NifL is known as 
the H domain (Figure 1.22B). Secondary structure predictions indicate that the NifL H 
domain may form an anti-parallel four-helix bundle within the NifL dimer, similar to those 
found in HPKs. However, it should be remembered that evidence regarding the 
oligomerisation state of NifL is not conclusive. The sensory N-terminal region of NifL 
contains tandem PAS domains. As discussed in section 1.2.3, the most N-terminal of these 
PAS domains, PAS1, is responsible for redox sensing (Hill et al., 1996, Söderbäck et al., 
1998; Key et al., 2007a), whilst the function of the second PAS domain, PAS2, remains 
unclear. However, preliminary evidence suggests a role for PAS2 in signal relay (see 
section 1.5).  
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Figure 1.22 Domain architectures of the (A) NifA and (B) NifL proteins from Azotobacter 
vinelandii. 
  
1 2 
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1.4.2 Domain Architecture of NifA  
 The nif-specific transcriptional activator, NifA, is a member of the bacterial 
enhancer-binding protein (EBP) family. EBPs are transcriptional activators that recognise 
enhancer binding sites approximately 100 base pairs up or downstream of sigma54 (σ54) 
dependent promoters (Morett and Segovia, 1993). Transcription initiation at σ54 dependent 
promoters is atypical in that the RNA polymerase holoenzyme alone is not competent to 
initiate transcription. An additional transcriptional activator, specifically an EBP, is 
absolutely required in order to generate an open promoter complex. The EBP utilizes the 
energy from ATP hydrolysis to catalyse isomerisation of the σ54-RNA polymerase 
complex, into a transcriptionally competent state (Buck et al., 2000). Nucleotide hydrolysis 
and interaction of the EBP with σ54 are mediated by a protein domain that is conserved in 
all EBPs, and belongs to the AAA+ (ATPases associated with various cellular activities) 
superfamily of ATPases (Buck et al., 2000; Zhang et al., 2002). These domains are found 
in all kingdoms of life and are involved in numerous cellular processes. Their primary 
function is to convert the chemical energy stored in ATP into mechanical work. In EBPs, 
ATP hydrolysis drives a series of conformation changes that promote interaction between a 
conserved (GAFTGA) motif in the AAA+ domain and σ54 (Morett and Segovia, 1993; 
Neuwald et al., 1999; Rappas et al., 2005). NifA is a typical EBP, consisting of three 
domains: a C-terminal helix-turn-helix (HTH) domain, a AAA+ domain and an N-terminal 
GAF domain (Figure 1.22A). The HTH domain is a DNA-binding module that recognises 
specific enhancer elements 100 base pairs upstream of nif promoters (Morett and Segovia, 
1993; Ray et al., 2002). The GAF domain of NifA binds 2-oxoglutarate and modulates the 
response of NifA to NifL (Barrett et al., 2001; Little and Dixon, 2003; Martinez-Argudo et 
al., 2004a). GAF domains have a similar tertiary structure to that of PAS domains (see 
above) and are thought to be of shared ancestry (Ho et al., 2000).  
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1.4.3 Factors influencing NifL-NifA interactions  
(i) Nucleotide Binding 
As mentioned above, the GHKL domain of NifL binds adenosine nucleotides but 
does not hydrolyse ATP (Söderbäck et al., 1998). NifL is incompetent to bind NifA in the 
absence of nucleotide in vitro (Eydmann et al., 1995) and ADP binding has been shown to 
stabilise the NifL-NifA binary complex (Eydmann et al., 1995; Money et al., 1999). NifL 
has a higher affinity for ADP (Kd = 16 μM) than for ATP (Kd = 130 μM). However, the 
relevance of this in vivo is unclear as the cytoplasmic concentrations of both nucleotides 
are significantly above the dissociation constants for their interactions with NifL 
(Söderbäck et al., 1998). Moreover, the proportion of cellular nucleotide that is unliganded 
(i.e. available for interaction with NifL) is not accurately known. Partial protease digestion 
experiments indicate that nucleotide binding to the GHKL domain of NifL induces a 
conformational change in the C-terminal region of the protein (Söderbäck et al., 1998). 
Mutant NifL proteins that are deficient in nucleotide binding are incompetent to inhibit 
NifA activity in vivo and show diminished affinity for NifA in vitro. Furthermore, limited 
proteolysis experiments indicate that the conformational changes in NifL associated with 
ADP binding are absent in these mutant proteins (Perry et al., 2005). Taken as a whole, the 
available data indicate that adenosine nucleotides bind to the GHKL domain of NifL 
causing a conformational change that significantly increases the affinity (and stability) of 
the NifL-NifA interaction. NifL may or may not sense changes in the ATP/ADP ratio as an 
indication of energy status in vivo.   
 
 (ii) The redox signal 
Owing to the extreme sensitivity of nitrogenase to oxygen, transcription of nif 
genes may be disadvantageous to the cell under oxidising conditions, even when other 
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environmental factors dictate that nitrogen fixation is favourable. Therefore, it is 
appropriate that NifL is competent to inhibit NifA under oxidising conditions. 
Spectroscopic studies of the N-terminal PAS domain (PAS1) of NifL show absorption 
peaks at 360 and 445 nm, and shoulders at 420 and 470 nm. These spectral features are 
characteristic of flavoproteins. Denaturation and further TLC analysis indicated that the 
prosthetic group is FAD (Hill et al., 1996). Oxidation of this prosthetic group induces a 
conformational change in NifL that promotes formation of the inhibitory NifL-NifA 
complex. Upon full reduction of FAD (to FADH2), this inhibition is removed (Hill et al., 
1996). Reduction of this redox-sensing group can be achieved in vitro using several redox 
donors and enzymes. The redox potential of these reactions is around ~225mV at pH 8 
(Macheroux et al., 1998). However, the relevant redox donor and oxidant in vivo are not 
known. Molecular oxygen is a plausible candidate for the role of electron acceptor as NifL 
is quickly oxidised upon contact with air to yield hydrogen peroxide (Little et al., 1999). 
Regardless of the oxidant, oxidation of the PAS1 co-factor is thought to trigger a 
conformational change in the PAS1 domain via re-organisation of a hydrogen bonding 
network that surrounds the FAD moiety (Key et al., 2007a). The molecular events that 
underpin signal perception by the PAS1 domain are discussed in detail in section 1.2.3. 
The physiological redox donor for the Klebsiella pneumoniae NifL (KpNifL) protein is 
likely to be the menaquinone pool (Thummer et al., 2007). In K. pneumoniae, the reduced 
form of NifL associates with the plasma membrane. This redox-dependent membrane 
sequestration is important for the release of KpNifA from inhibition by KpNifL under 
nitrogen fixing conditions (Klopprogge et al., 2002). By contrast, the Azotobacter 
vinelandii NifL protein remains in the cytoplasm irrespective of environmental signals and 
regulation of NifA activity is mediated solely through signal-dependent conformational 
changes (Klopprogge et al., 2002).  
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(iii) GlnK Interactions 
In 1998, it was demonstrated that Azotobacter vinelandii NifL can sense the 
cellular nitrogen status independently of the redox signal. Truncated constructs of NifL, 
lacking the flavin-containing PAS1 domain, are competent to inhibit NifA in response to 
excess fixed nitrogen (Little et al., 2000; Söderbäck et al., 1998). This is consistent with 
the large and unnecessary energetic cost that would be incurred by a cell producing 
nitrogenase in nitrogen-replete conditions, whatever the cellular redox and carbon status. 
In the Azotobacter vinelandii NifL-NifA system, nitrogen sensing occurs via GlnK, a 
member of the PII signal transduction protein family (van Heeswijk et al., 1995). Under 
conditions of fixed nitrogen excess, GlnK binds NifL to promote formation of an inhibitory 
ternary complex with NifA (Little et al., 2002; Little et al., 2000; Rudnick et al., 2002). 
GlnK is covalently modified by the uridylyltransferase/uridylyl-removing (UTase/UR) 
enzyme (encoded by the glnD gene) depending on cytoplasmic concentrations of 
glutamine (Arcondeguy et al., 2001). Glutamine is a common signal of cellular nitrogen 
status and its concentration within the cell increases in proportion to the availability of 
fixed nitrogen in enteric bacteria (Hu et al., 1999; Ikeda et al., 1996). Under nitrogen-
limiting conditions, when cytoplasmic glutamine levels are comparatively low, the UTase 
activity of GlnD is favoured, resulting in uridylylation of GlnK. This prevents interaction 
of GlnK with NifL in vitro, allowing NifA to dissociate from NifL (and thus activate 
transcription) if the oxygen and carbon signals are appropriate (Little et al., 2000). By 
contrast, when fixed nitrogen is readily available, glutamine interacts with GlnD to 
increase UR activity. Hence, GlnK is deuridylylated and is able to promote formation of 
the inhibitory GlnK-NifL-NifA ternary complex (Figure 1.23). Uridylylation of GlnK is 
vital for the release of NifA from inhibition by NifL in vivo as strains with impaired UTase 
activity are not capable of fixing nitrogen. Nitrogen fixation can be restored by insertion 
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mutations that inactivate NifL (Contreras et al., 1991). GlnK is a trimeric protein with 
three uridylylation sites (one on each subunit), located on tyrosine residues in a surface-
exposed loop (known as the T-loop). Substitutions in the T-loop result in forms of GlnK 
that are deficient in their interactions with NifL (Little et al., 2002). When deuridylylated, 
native GlnK interacts specifically with the GHKL domain of A. vinelandii NifL and neither 
of the N-terminal PAS domains, nor the central H region, are required for this interaction 
(Little et al., 2002).  
 The GlnK trimer, like other members of the PII protein family, contains three 2-
oxoglutarate binding sites and three ATP binding sites. These low-molecular-mass effector 
molecules modulate the activity of the PII protein (Ninfa and Atkinson, 2000; Radchenko et 
al., 2010). Increasing levels of 2-oxoglutarate have been demonstrated to promote 
interaction between A. vinelandii GlnK and NifL in vitro (Little et al., 2002). This affect 
occurs within the physiological range and, contrary to the PII proteins from E. coli, there is 
no negative co-operativity in 2-oxoglutarate binding to A. vinelandii GlnK. It is possible 
that more than one molecule of 2-oxoglutarate is required to significantly increase the 
affinity of GlnK for NifL. Although ATP and Mg
2+
 are required for the GlnK-NifL 
interaction in vitro, the presence of nucleotide binding sites on both NifL and GlnK makes 
it difficult to dissect the role of ATP in their association (Little et al., 2002).  
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Figure 1.23. Influence of nitrogen availability on GlnK interactions with NifL/NifA.  
Glutamine levels dictate the uridylylation state of GlnK via affects on UTase/UR activity 
of GlnD. In its deuridylylated form GlnK promotes assembly of the inhibitory NifA-NifL-
GlnK ternary complex. Covalent modification of GlnK prevents the NifL-GlnK 
interaction, allowing NifA to escape inhibition if 2-oxoglutarate levels are sufficiently high 
(Martinez-Argudo et al., 2005).  
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(iv) 2-Oxoglutarate 
2-oxoglutarate is an intermediate in the tricarboxylic acid cycle making it an 
appropriate signal of the carbon status. However, its occurrence in cellular metabolism 
extends to nitrogen assimilation and thus 2-oxoglutarate can also be thought of as an 
indirect signal of the nitrogen status. It provides the carbon skeletons for nitrogen 
assimilation, and so forms a nexus between carbon and nitrogen metabolism. The 2-
oxoglutarate concentration within the cell increases with carbon availability and diminishes 
when fixed nitrogen is replete.  
In addition to its role in activating the GlnK signal transduction protein, 2-
oxoglutarate binds to the GAF domain of NifA, inducing a conformational change in NifA 
that antagonises the effect of nucleotide binding to NifL. At high concentrations of 2-
oxoglutarate, this allows dissociation of NifA from the reduced, nucleotide-bound form of 
NifL (Little and Dixon, 2003). However, when 2-oxoglutarate concentrations are relatively 
low, reduced NifL is competent to inhibit NifA when nucleotide is present (Little et al., 
2000). This influence of 2-oxoglutarate on NifA activity is only evident in the presence of 
NifL. Hence, 2-oxoglutarate must influence the stability of the NifL-NifA binary complex 
rather than directly altering NifA activity (Martinez-Argudo et al., 2004c). 2-oxoglutarate 
binds the NifA GAF domain with a Kd of 60 μM in vitro (Little and Dixon, 2003). It has 
been suggested that the physiological concentration of this effector molecule in E. coli 
ranges from 100 μM to 1 mM, depending on carbon and nitrogen status of the cell (Senior, 
1975). However, more recent work indicates that the minimum cellular concentration 
under conditions of nitrogen excess may be <50μM (Reyes-Ramirez et al., 2001) and a 
decrease in 2-oxoglutarate concentration from 1.4 mM to 0.3 mM occurs within 2 minutes 
of administering an ammonium shock to N-limited E. coli cells (Radchenko et al., 2010). 
The responsiveness of the system to this effector is, therefore, within the physiological 
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range. Moreover, a variant form of the NifA protein, containing an amino acid substitution 
in the GAF domain that eliminates 2-oxoglutarate binding (F119S), is hypersensitive to 
inhibition by NifL in vitro and is unable to escape inhibition sufficiently to allow 
measurable NifA activity in vivo, even under conditions appropriate for nitrogen fixation 
(Martinez-Argudo et al., 2004b). Taken together, this data suggests that the elevated level 
of 2-oxoglutarate present when carbon supplies are replete and fixed nitrogen is limiting 
allows NifA to free itself from inhibition by reduced NifL. In other words, 2-oxoglutarate 
binding to NifA provides the final “push” necessary to initiate nif gene transcription under 
nitrogen fixing conditions.     
 
1.4.4 Inter-domain interactions in NifL 
The interaction between the NifL and NifA proteins may be analogous to the 
docking of a RR to its cognate HPK in the phosphatase conformation (Little et al., 2007; 
Marina et al., 2005; Martinez-Argudo et al., 2004a). Based on this analogy and 
experimental evidence indicating that neither the N-terminal region of NifL nor the GHKL 
domain alone is competent to bind NifA, it has been suggested that the H domain may 
provide a surface for NifL-NifA interactions. This necessitates inter-domain 
communication between the H domain and the sensory modules of NifL in order to 
transduce oxygen and fixed nitrogen signals. Additionally, the broader analogy between 
the signalling states of NifL and the conformational changes associated with signalling in 
HPKs (see section 1.21) implies that transition between the inhibitory and non-inhibitory 
conformers of NifL may involve movement of the GHKL domain relative to the H domain. 
Recent mutagenic studies have identified two distinct classes of amino acid 
substitution of the H domain of NifL (Little et al., 2007; Martinez-Argudo et al., 2004a). 
Substitutions belonging to the first class cause NifL to inhibit NifA activity irrespective of 
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environmental conditions. That is, they lock the NifL protein in an inhibitory conformation 
(these are referred to as “locked-on” mutants). Substitutions belonging to the second class 
give rise to a form of NifL that does not inhibit NifA activity in the presence of excess 
oxygen but responds normally to fixed nitrogen. The identification of substitutions in the H 
domain that prohibit transduction of the redox signal, whilst leaving GlnK mediated 
signalling unaffected, indicates that the conformational states required for inhibition in 
response to oxygen and fixed nitrogen are not equivalent (Little et al., 2007). The NifA 
variant Y254N is capable of discriminating between these states (Reyes-Ramirez et al., 
2002). NifA-Y254N is resistant to inhibition by NifL under conditions of excess fixed 
nitrogen but is relatively sensitive to inhibition by the oxidised conformer of NifL. 
Additionally, a variant form of the NifL protein that fails to bind adenosine nucleotides 
(containing the G480A substitution in the GHKL domain), can inhibit 2-oxoglutarate 
bound NifA in vitro in the presence of deuridylylated GlnK, but is unable to do so in 
response the redox signal (Perry et al., 2005). Thus, the GlnK bound form of NifL (present 
under conditions of fixed nitrogen excess) appears to have a diminished requirement for 
nucleotide binding when compared to the oxidised form of NifL. Overall, broad analogies 
with HPKs and the likelihood that NifL accesses different conformations when in the 
binary and ternary inhibitory complexes, suggests that the oxygen and nitrogen stimuli 
may result in movement of the GHKL domain, relative to the H domain, via different 
mechanisms.       
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1.5 Introduction to this work  
The Azotobacter vinelandii NifL protein contains two N-terminal PAS domains 
and, prior to the work in this thesis, the function of the second PAS domain (PAS2) was 
unknown. The first evidence concerning the function of the PAS2 domain was obtained 
from a mutagenic study of domain interactions in NifL. As mentioned in section 1.4.4, 
several “locked-on” NifL variants containing substitutions in the H domain have been 
characterised. One such mutant protein is NifL-R306C (Martinez-Argudo et al., 2004a). 
By performing random mutagenesis of the nifL gene it has been possible to select for 
secondary substitutions in NifL that suppress the “locked-on” phenotype of the R306C 
variant. Two such second-site suppressor mutations (encoding L199P and C237R) are 
located in the PAS2 domain of NifL. In other words, mutant NifL proteins carrying R306C 
in combination with L199P or C237R in the PAS2 domain allow NifA activity under 
certain conditions, whereas NifL-R306C does not. Given that the PAS2 domain is not 
directly required for the NifL-NifA interaction, this implies that PAS2 can influence the 
conformation of the H domain. Colleagues in the Dixon laboratory have since substituted 
the leucine at position 199 by arginine or glutamic acid, both of which display “locked-on” 
phenotypes (i.e. they inhibit NifA activity under all conditions) similar to those exhibited 
by substitutions of R306. Therefore, PAS2 has a role in the conformational changes in 
NifL that occur during the transition between the inhibitory and non-inhibitory state. Taken 
together, the available evidence indicates that the PAS2 domain may have a role in inter-
domain communication and signalling in NifL. As mentioned in section 1.2, it is extremely 
common for modular signalling proteins to contain multiple PAS domains. In many 
studied proteins containing tandem PAS domains, one domain has a role in signal 
perception whilst the function of the second domain is poorly understood. The NifL PAS2 
domain is typical in this respect and further investigation into its role in signalling may 
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provide clues regarding the function of tandem PAS domains in modular proteins. The aim 
of this work was to elucidate the function of the NifL PAS2 domain using a combination of 
genetic and biochemical techniques. It was hoped that random mutagenesis of the DNA 
sequence encoding the PAS2 domain would yield mutations in nifL with interesting 
phenotypes and that biochemical analysis of the resulting NifL variants would provide 
insight into the function of the PAS2 domain. 
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Chapter 2 - Materials and methods 
2.1 Suppliers 
 All chemicals were purchased from Sigma-Aldrich, Severn Biotech, Fisher, 
Melford, Bio-Rad or Merck unless otherwise stated. Restriction enzymes and other 
molecular biology reagents were obtained from Roche, Invitrogen or New England 
Biolabs. Disposable columns for DNA purification or protein buffer exchange were 
purchased from Qiagen and Thermo-Scientific respectively. 
 
2.2 Strains and plasmids 
All E. coli strains and plasmids used in this work are listed in Table 2.1.  
Strain or Plasmid Description Reference/Source 
      
 
E. coli Strains     
DH5α 
sipE44 ∆(lacU169 hsdR17 recA1 endA1 
gyrA96 thi-1 relA1) 
(Hanahan, 1983) 
ET8000 rbs lacZ::IS1 gyrA hutC
c
k  
(Reyes-Ramirez et al., 
2001) 
BL21 (DE3) 
pLysS 
F- ompT hsdSB(rB
-
mB
-
)gal dcm(DE3) carrying 
pLysS, which encodes T7 lysosyme   (Studier et al., 1990) 
BTH101 
F- cya-99 araD139 galE15 galK16 rpsL1 
(Str
r
) hsdR2 mcrA1 mcrB1 (Karimova et al., 2000) 
 
Plasmids     
pPR34 
pT7-7 derivative carrying A. vinelandii NifLA 
 
(Söderbäck et al., 
1998) 
pPR54 
pPR34 derivative encoding NifL(147-519) and 
NifA 
(Söderbäck et al., 
1998) 
pPRT22 
nifH-lacZ reporter plasmid (in pACYC184) 
 
(Tuli and Merrick 
1988) 
pPR39 
pPR34 derivative encoding NifL(454-519) and 
wild-type NifA 
(Söderbäck et al., 
1998) 
pNLG480A NifL-G480A in pPR34 (Perry et al. 2005) 
pNSK1 NifL-L199E in pPR34 This Work 
pNSK2 NifL-L199R in pPR34 This Work 
pRL46 NifL-L199P in pPR34 Richard Little 
pUT18 
BACTH system plasmid with CyaA(225-399), 
ampicillin resistance marker and MCS.   (Karimova et al., 1998) 
pT25 BACTH system plasmid with CyaA(1-244), (Karimova et al., 1998) 
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chloramphenicol resistance marker and MCS.   
pPS1 NifL-L199E, G480A in pPR34 This Work 
pPS2 NifL-L199R, G480A in pPR34 This Work 
pPS3 NifL-L199E in pPR54 This Work 
pPS4 NifL-L199R in pPR54 This Work 
pPS5 NifL-L199G in pPR34 This Work 
pPS6 NifL-L199Q in pPR34 This Work 
pPS7 NifL-L199A in pPR34 This Work 
pPS8 NifL-L199V in pPR34 This Work 
pPS9 NifL-L199W in pPR34 This Work 
pPS10 NifL-L199F in pPR34 This Work 
pPS11 NifL-L196A in pPR34 This Work 
pPS12 NifL-L200A in pPR34 This Work 
pPS13 NifL-R201A in pPR34 This Work 
pPS14 NifL-V165D in pPR34 This Work 
pPS15 NifL-V165I in pPR34 This Work 
pPS16 NifL-E202A in pPR34 This Work 
pPS17 NifL-E202K in pPR34 This Work 
pPS18 NifL-E194K in pPR34 This Work 
pPS19 NifL-L200E in pPR34 This Work 
pPS20 NifL-V166M in pPR34 This Work 
pPS21 NifL-R240W in pPR34 This Work 
pPS22 NifL-L200F in pPR34 This Work 
pPS26 NifL-S192G in pPR34  This Work 
pPS27 NifL-S193G  in pPR34  This Work 
pPS28 NifL-S195G  in pPR34  This Work 
pPS29 NifL-V166D  in pPR34 This Work 
pPS30 NifL-V166A  in pPR34  This Work 
pPS31 NifL-V166M, E70A  in pPR34  This Work 
pPS32 NifL-V166M, I26A  in pPR34 This Work 
pPS33 NifL-L199Q, E70A  in pPR34 This Work 
pPS34 NifL-L199Q, I26A  in pPR34  This Work 
pPS35 NifL-L200A, E70A  in pPR34  This Work 
pPS36 NifL-L200A, I26A  in pPR34  This Work 
pPS37 NifL-L200A, F27A  in pPR34  This Work 
pPS38 NifL-L200A, I22A  in pPR34  This Work 
pPS54 NifL(143-519) in pPR34 This Work 
pPS55 NifL(143-519)-L200A in pPR34 This Work 
pPS39 NifL-L196P in pPR34 This Work 
pPS40 NifL-L200P in pPR34 This Work 
pPS42 NifL-L235P in pPR34 This Work 
pPS43 NifL-F253L in pPR34 This Work 
pPS44 NifL-A302T in pPR34 This Work 
pPS45 NifL-I304T in pPR34 This Work 
pPS46 NifL-Q308E in pPR34 This Work 
pPS47 NifL-N177S in pPR34 This Work 
pPS48 NifL-E291A in pPR34 This Work 
pETM11 pET24d (Novagen) derivative with a TEV Pinotsis et al., 2006 
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protease cleavage site, polyhistidine tag and 
MCS 
pETNdeM11 
pETM11 with a Nde 1 site replacing the Nco 1 
site for more convenient cloning 
(Tucker N., 
Unpublished work) 
pPS50 NifL(143-284) in pETM11  This Work 
pPS51 NifL(143-284)-L200A in pETM11  This Work 
pPS52 NifL(143-284)-I153A in pETM11  This Work 
pPS53 NifL(143-284)-V157A in pETM11  This Work 
pPS56 NifL(143-284)-L199R in pETM11  This Work 
pPS57 NifL(143-284)-N177S in pETM11  This Work 
pPS61 NifL(147-284)-L199R in pT25 This Work 
pPS62 NifL(147-284)-V157A in pT25 This Work 
pPS63 NifL(147-284)-V166M in pT25 This Work 
pPS66 NifL-S236P in pPR34 This Work 
pPS69 NifL(279-519) in pT25 This Work 
pPS70 NifL in pETNdeM11 This Work 
pPS71 NifL(143-519) in pETNdeM11 This Work 
pPS72 NifL-V166M in pETNdeM11 This Work 
pPS73 NifL(143-519)-V166M in pETNdeM11 This Work 
pPS74 NifL(143-284)-V166M in pETM11 This Work 
pPS75 NifL(143-284)-F253L in pETM11 This Work 
pPS76 NifL(143-519)-V157A in pPR34 This Work 
pPS77 NifL(143-519)-V166M in pPR34 This Work 
pPS78 NifL-L167P in pPR34 This Work 
pPS79 NifL-L271P in pPR34 This Work 
pPS80 NifL-L283Q in pPR34 This Work 
pPS81 NifL-286P in pPR34 This Work 
pPS82 NifL-K284E in pPR34 This Work 
pPS83 NifL-Q308R in pPR34 This Work 
pPS84 NifL-G295Q in pPR34 This Work 
pPS85 NifL-L292P in pPR34 This Work 
pPS86 NifL(147-284)-V166M in pUT18 This Work 
pPS87 NifL(147-284)-L199R in pUT18 This Work 
pPS88 NifL(147-284)- L200A in pUT18 This Work 
pPS89 NifL(147-284)-V157A in pUT18 This Work 
pPS90 NifL(157-278) in pUT18 This Work 
pPS91 NifL(279-519) in pUT18 This Work 
pPS92 NifL(147-284)-N177S in pUT18 This Work 
pPS93 NifL(1-146) in pUT18 This Work 
pPS94 NifL(1-278) in pUT18 This Work 
pPS95 NifL(147-284)-I153A in pUT18 This Work 
pPS96 NifL(147-284)-C237S in pUT18 This Work 
pPS97 NifL(147-284)-F253L in pUT18 This Work 
pPS98 NifL(1-146) in pT25 This Work 
pPS99 NifL(1-278) in pT25 This Work 
pPS100 NifL(147-284)-N177S in pT25 This Work 
pPS101 NifL(147-284)-L200A in pT25 This Work 
pPS102 NifL(147-278) in pT25 This Work 
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pPS103 NifL(147-284)-I153A in pT25 This Work 
pPS104 NifL(147-284)-C237S in pT25 This Work 
pPS105 NifL(147-284)-F253L in pT25 This Work 
pPS106 NifL(1-278)-L200A in pT25 This Work 
pPS107 NifL(1-278)-V157A in pT25 This Work 
pPS108 NifL(1-278)-V166M in pT25 This Work 
pPS109 NifL(1-278)-I153A in pT25 This Work 
pPS110 NifL(1-278)-F253L in pT25 This Work 
pPS111 NifL(1-278)-L200A in pUT18 This Work 
pPS112 NifL(1-278)-V157A in pUT18 This Work 
pPS113 NifL(1-278)-V166M in pUT18 This Work 
pPS114 NifL(1-278)-I153A in pUT18 This Work 
pPS115 NifL(1-278)-F253L in pUT18 This Work 
pPS116 NifL(1-284)-V166M in pETM11 This Work 
pPS117 NifL(1-284)-I153A in pETM11 This Work 
pPS118 NifL(143-284)-C181S, C237F in pETM11 This Work 
pPS119 
NifL(143-284)-C181S, C237F, V157C in 
pETM11 This Work 
pPS120 
NifL(143-284)-C181S, C237F, V166C in 
pETM11 This Work 
pPS121 
NifL (143-284)-C181S, C237F, R240C in 
pETM11 This Work 
pPS122 
NifL (143-284)-C181S, C237F, N177C in 
pETM11 This Work 
pPS123 NifL-E70A, V157A in pPR34 This Work 
pPS124 NifL-V166M, G480A in pPR34 This Work 
pPS125 NifL-V157C in pPR34 This Work 
pPS126 NifL-V166C in pPR34 This Work 
pPS127 NifL-R240C in pPR34 This Work 
pPS128 NifL-V157C in pRL125 This Work 
pPS129 NifL-V166C in pRL125 This Work 
pPS130 NifL-R240C in pRL125 This Work 
pPS131 NifL-L175A in pPR34 This Work 
pPS132 NifL-V251A in pPR34 This Work 
pPS133 NifL-L261A in pPR34 This Work 
pPS134 NifL-L262A in pPR34 This Work 
pPS135 NifL-L263A in pPR34 This Work 
pPS136 NifL-T264A in pPR34 This Work 
pRL125 NifL-C181S, C237F, C380S, C507T in pPR34 
(Little R., unpublished 
work) 
pPS138 NifL(143-284)-L175A in pT25 This Work 
pPS139 NifL(143-284)-L262A in pT25 This Work 
pPS140 NifL(143-284)-L175A in pUT18 This Work 
pPS141 NifL(143-284)-L262A in pUT18 This Work 
pPS142 NifL- E70A, V166M in pPR34 This Work 
pPS143 
NifL(1-284)-C181S, C237F, V157C in 
pETNdeM11 This Work 
pPS144 NifL- L144P, V166M in pPR34 This Work 
pPS145 NifL- H133R, V166M in pPR34 This Work 
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pPS146 NifL- L48P, V166M in pPR34 This Work 
pPS147 NifL- Y110C, V166M in pPR34 This Work 
pPS148 NifL- F54L, V166M in pPR34 This Work 
pPS149 NifL(1-278)-V119A in pUT18 This Work 
pPS150 NifL(1-278)-L130A in pUT18 This Work 
pPS151 NifL(1-278)-M132A in pUT18 This Work 
pPS152 NifL(1-278)-V119A in pT25 This Work 
pPS153 NifL(1-278)-L130A in pT25 This Work 
pPS154 NifL(1-278)-M132A in pT25 This Work 
pPS155 
NifL-E70A, V157C, C181S, C237F, C380S, 
C507T in pPR34 This Work 
pPS156 
NifL(1-284)-E70A, V157C, C181S, C237F in 
pETNdeM11 This Work 
pPS157 
NifL-V157C, C181S, C237F, C380S, C507T 
in pETNdeM11 This Work 
pPS158 
NifL(143-519)-V157C, C181S, C237F, C380S, 
C507T in pETNdeM11 This Work 
pPS159 
NifL-E70A, V157C, C181S, C237F, C380S, 
C507T in pETNdeM11 This Work 
pPS160 NifL-E70A, V157C in pPR34 This Work 
pPS161 
NifL-C181S, C237F, C380S, C507T, R240C 
in pPR34 This Work 
pPS162 NifL(147-284)- R240W in pUT18 This Work 
pPS163 NifL(147-284)- R240W in pT25 This Work 
pPS164 NifL(1-284)- L175A in pETNdeM11 This Work 
pPS165 NifL-I153A in pETNdeM11 This Work 
pPS166 NifL(1-145, 273-519) (PAS2 deletion ∆146-272) This Work 
pPS167 NifL(1-145, 276-519) (PAS2 deletion ∆146-275) This Work 
pPS168 NifL(1-147, 271-519) (PAS2 deletion ∆148-270) This Work 
pPS169 NifL(143-271) in pETNdeM11 This Work 
pPS173 NifL-L139A in pPR34 This Work 
pPS174 NifL-L142A in pPR34 This Work 
pPS175 NifL-V146A in pPR34 This Work 
pPS180 NifL-E143A in pPR34 This Work 
pPS181 NifL-R145A in pPR34 This Work 
pPS182 NifL-N148A in pPR34 This Work 
pPS183 NifL-Q149A in pPR34 This Work 
pPS184 NifL-R150A in pPR34 This Work 
pPS185 NifL-E154A in pPR34 This Work 
pPS186 NifLΔL151 in pPR34 This Work 
pPS187 NifLΔR150-L151 in pPR35 This Work 
pPS188 NifLΔQ149-L151 in pPR34 This Work 
pPS189 NifLΔN148-L151 in pPR34 This Work 
pPS190 NifLΔN147-L151 in pPR34 This Work 
pPS191 NifL(143-519)-ΔN147-L151 in pPR34 This Work 
 
Table 2.1 E. coli strains and plasmids used in this work. 
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2.3 Buffers and solutions 
2.3.1 Media 
 Liquid media were prepared by dissolving the appropriate amount of the 
reagents stated below in distilled water and autoclaving at 121
o
C and 15 psi for 15 
minutes. For solid media, 1% (w/v) bactoagar was added to liquid media prior to 
sterilisation.  
LB broth     1% (w/v) Tryptone 
(pH 7.0)     0.5% (w/v) Yeast extract 
      0.5% (w/v) NaCl 
NFDM      2.1% (w/v) glucose 
(pH 7.0)     173 μM FeSO4 
      875 μM MgSO4 
      128 μM Na2MoO4 
Hino and Wilson buffer   1.38 M K2HPO4 
(pH 7.0, for use with NFDM)    0.5 M KH2PO4 
2 x YT broth     1.6% (w/v) Tryptone 
(pH 7.0)     2.0% (w/v) Yeast extract 
      0.5% (w/v) NaCl 
 
2.3.2 Antibiotics 
 Where appropriate, antibiotics were added to the media at the following final 
concentrations: 
Carbenicillin     100 μg ml-1 
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Kanamycin     50  μg ml-1 
Chloramphenicol    35 μg ml-1 
 
2.3.3 Buffers for DNA work 
TBE buffer      135 mM Tris 
      45 mM Boric acid 
      2.5 mM EDTA 
Loading dye for electrophoresis (5x)   0.5% (w/v) Xylene cyanol ff 
      0.25% (w/v) Bromophenol blue  
      50% (v/v) Glycerol 
 
2.3.4 Buffers for protein work 
(i) Buffers for SDS-PAGE 
Resolving buffer (4x)    1.5 M Tris-HCl (pH 8.8) 
Stacking buffer (4x)    0.5 M Tris-HCl (pH 6.8) 
Sample buffer (loading dye)   63 mM Tris-HCl (pH 6.8) 
      2% (w/v) SDS 
      10% (v/v) Glycerol 
      5% (v/v) β-Mercaptoethanol 
      0.001% (w/v) Bromophenol Blue 
Tank buffer (running buffer)   25 mM Tris  
      192 mM Glycine  
      0.1% (w/v) SDS 
SDS-PAGE stain    5% (v/v) Methanol 
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      16.5% (v/v) Acetic acid 
      0.1% (w/v) Coomassie blue 
SDS-PAGE destain    5% (v/v) Methanol 
      16.5% (v/v) Acetic acid 
       
(ii) Buffers for chromatography and protein storage 
Nickel affinity loading buffer   25 mM KH2PO4 (pH 8.0) 
      200 mM NaCl 
      20 mM Imidazole 
Nickel affinity elution buffer   25 mM KH2PO4 (pH 8.0) 
      200 mM NaCl 
      500 mM Imidazole 
Analytical gel filtration buffer  50 mM Tris-HCl (pH 8.0) 
      100 mM NaCl 
      5% (v/v) Glycerol 
 Storage buffer    50 mM Tris-HCl (pH 8.0) 
      50 mM NaCl 
      1 mM DTT 
      50% (v/v) glycerol 
 
(iii) Buffers for western blotting 
Transfer buffer     25 mM Tris (pH 8.0) 
      190 mM Glycine 
      20% (v/v) Methanol  
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TBS buffer     10 mM Tris-HCl (pH 7.5) 
      100 mM NaCl  
Blocking buffer     3% (w/v) BSA in TBS 
TBS-Tween/Triton buffer    20 mM Tris-HCl (pH 7.5)  
      500 mM NaCl  
      0.05% (v/v) Tween 
      0.2% (v/v) Triton X-100  
 
(iv) Buffers for limited proteolysis experiments 
TA buffer (5x)    250 mM Tris-acetate (p.H 7.9) 
      500 mM Potassium acetate 
      40 mM Magnesium acetate 
      5 mM DTT  
 
(v) Buffers for β-galactosidase Assays 
Z-Buffer      60 mM Na2HPO4 
      40 mM NaH2PO4.2H2O 
      10 mM KCl 
      1 mM MgSO4.7H2O  
Lysis Buffer     0.27% (v/v) β-Mercaptoethanol  
      0.005% (w/v) SDS  
      In Z-Buffer 
Start buffer     13.3 mM 2-Nitrophenyl-β-galactoside   
      In Z-buffer 
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Stop buffer     1 M Na2CO3 
2.4 Microbiological methods 
2.4.1 Preparation of chemically competent E. coli  
 A culture of the appropriate E. coli strain was grown overnight in a universal 
tube containing 5 ml LB at 37
o
C. A 250 ml conical flask containing 50 ml LB was 
then inoculated with 500 μl of the overnight culture and grown at 37oC until the 
optical density at 600 nm (OD600) reached 0.3 - 0.4. Cells were then harvested by 
centrifugation at 3500 rpm (in a Sorvall Biofuge primo centrifuge) for 7 minutes at 4
 
o
C. The cell pellet was gently resuspended in 12.5 ml of ice cold 0.1 M MgCl2. The 
centrifugation step was then repeated and the resulting pellet was gently resuspended 
in 25 ml of ice cold 0.1 M CaCl2. This cell suspension was incubated on ice for 20 
minutes. Cells were then harvested by a final centrifugation at 3500 rpm for 7 
minutes at 4
 o
C. The pellet was resuspended in 1 ml 0.1 M CaCl2 and 20% (v/v) 
glycerol. Competent cells were stored in 150 μl aliquots at -80oC until required.   
 
2.4.2 Transformation of competent E. coli 
 Plasmid DNA (100 ng - 300 ng) was added to a 1.5 ml eppendorf tube 
containing 50 μl of chemically competent cells and incubated on ice for 45 minutes. 
The cells were then heat shocked at 42
o
C for 90 seconds and subsequently incubated 
on ice for 1 minute. Next, 950 μl of 2 x YT broth was added and the cells were 
placed at 37
oC for 1 hour. 50 μl and 100 μl aliquots of the transformed cells were 
then spread onto agar plates containing the appropriate media and antibiotics. The 
agar plates were incubated at 37
o
C overnight (except for the indicator plates used for 
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screening randomly generated mutants in strain ET8000, which were incubated at 
30
o
C for 72 hours).   
 
2.4.3 Electroporation of E. coli 
 A 500 ml conical flask containing 250 ml LB was inoculated with 2.5 ml of 
an overnight culture (grown in a universal tube containing 5 ml LB at 37
o
C) of E. 
coli strain DH5α and grown at 37oC until the OD600 reached 0.5 - 0.7. The cells were 
then incubated on ice for 15 minutes. Next, the cells were harvested by centrifugation 
at 4000 rpm (in a Sorvall RC 5B plus centrifuge fitted with a SLA-3000 rotor) for 10 
minutes at 4
o
C. The supernatant was carefully discarded and the pellet was 
resuspended in 400 ml cold sterile water. The suspension was centrifuged again 
under the same conditions and this cycle of resuspension in water and centrifugation 
was repeated 3 times. Finally, the cells were resuspended in 500 μl cold sterile water. 
3 μl (~75 ng) of butanol precipitated DNA (see below) and 200 μl of the cell 
suspension were mixed in a 2 mm electroporation cuvette (Geneflow Ltd.) and 
electroporated at 2.5 Kv, 400 Ω and 25 μF. 1 ml LB was then added and the cells 
were incubated at 37
o
C for 1 hour. Transformed cells were then grown in selective 
media as appropriate.  
  
2.5 DNA purification and manipulation methods 
2.5.1 Purification of plasmid DNA 
 Preparations of plasmid DNA were carried out from 5 ml overnight cultures 
using the QIAprep spin miniprep kit (Qiagen) as directed by the manufacturer.  
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2.5.2 Butanol precipitation of DNA 
 DNA samples (50 – 100 μL) were thoroughly mixed with 1.2 ml butan-1-ol, 
and incubated at room temperature for 10 minutes. Samples were then centrifuged 
at 13000 rpm (in a Thermo Scientific Heraeus Pico bench-top centrifuge) for 4 
minutes and the supernatant was discarded. Next, 1 ml 100% Ethanol (-20
o
C) was 
added. The sample was then briefly mixed using a vortex and incubated at -20
o
C 
for 20 minutes. Following this incubation, the mixture was centrifuged for 5 
minutes at 13000 rpm and the supernatant was carefully discarded. 1 ml 70% 
Ethanol (-20
o
C) was added to the pellet and the sample was vortexed briefly and 
incubated at -20
o
C for 10 minutes. The centrifugation step was repeated once more 
and the pellet was dried in a Speedivac rotary evaporator for 10 minutes. Finally, 
the pellet was resuspended in 5 μl sterile water. 
 
2.5.3 DNA sequencing 
 Dye-terminator DNA sequencing was used to ensure that mutant nifL genes 
carried no additional mutations and to identify the sequence changes that emerged 
after random mutagenesis (see below). Sequencing reactions were carried out using 
BigDye Terminator 3.1 (Applied Biosciences) as instructed by the manufacturer. 
Completed reactions were submitted to Genome Enterprise Ltd. for capillary 
electrophoresis and florescence detection.   
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2.5.4 Restriction endonuclease digestion 
 DNA samples were incubated for 3 hours with 1-10 U of the relevant 
restriction enzyme/s per μg of DNA. Reactions were performed in 1x buffer provided 
by the manufacturer at the appropriate temperature for each enzyme.  
 
2.5.5 Agarose gel electrophoresis 
  Agarose gel electrophoresis was used for size determination and purification 
of DNA fragments. TBE buffer containing 1% (w/v) agarose was melted using a 
microwave and allowed to set in a gel mould from VWR International. DNA samples 
were mixed with 5x loading dye and gels were run in TBE buffer at 80 V - 100 V for 
between 45 minutes and 1.5 hours, depending on DNA size. Ethidium bromide was 
then added to the electrophoresis buffer to a final concentration of 5 μg ml-1 and the 
gel was stained for 15 minutes before visualisation on a short wavelength UV 
transilluminator. A longwave UV transilluminator was used to visualise fragments 
for gel excision.  
 
2.5.5 Purification of DNA fragments 
 Gel slices containing the appropriate DNA fragment were excised after 
electrophoresis and the DNA was extracted from the gel slice using the QIAquick gel 
extraction kit (Qiagen) as instructed by the manufacturer. DNA fragments from PCR 
were purified using the QIAquick PCR purification kit (Qiagen) as directed by the 
manufacturer. 
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2.5.7 Dephosphorylation of DNA 
 Shrimp alkaline phosphatase (SAP) is routinely used to catalyse the removal 
of the 5’ phosphate from DNA molecules to prevent re-circularisation of vector DNA 
in ligation reactions. DNA samples were incubated in 1x SAP reaction buffer 
provided by the enzyme manufacturer (Roche) with 2 U SAP per μg of DNA for 45 
minutes at 37
o
C. The enzyme was then inactivated by heating to 75
o
C for 15 
minutes.   
  
2.5.8 Ligation of DNA 
 T4 DNA ligase is routinely used to join DNA molecules via formation of a 
phosphodiester bond. A 1:5 ratio of vector to insert was ligated using T4 DNA ligase 
(NEB) in the buffer supplied by the manufacturer. Ligation reactions were carried 
out overnight at 16
o
C.     
 
2.5.9 Site directed mutagenesis 
 All site directed mutations were constructed using a two-step PCR technique 
(Figure 2.1). This method generates point mutations in a cloned DNA fragment 
(carrying unique restriction sites for further cloning) and requires two pairs of 
primers. The first set of primers anneals either side of the region of interest. These 
are called external primers (Figure 2.1, red arrows). The second pair of primers are 
complementary to each other and carry the required mutation/s. These anneal within 
the region of interest and are known as mutagenic (or internal) primers (Figure 2.1, 
blue arrows). This method requires three separate PCR reactions in two stages (called 
step 1 and step 2). The first step involves two PCR reactions, each using one external  
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Figure 2.1. Two-step PCR method for site-directed mutagenesis. Individual DNA 
strands are represented as black lines and (perpendicular) green lines indicate unique 
restriction sites. External primers are coloured red whilst mutagenic primers are blue. 
The yellow stars denote point mutations. Step 1 consists of two separate PCR 
reactions using primer set A or B whereas step 2 consists of a single amplification 
using the external (red) primers and the purified PCR products from step 1.    
  
102 
 
primer and one mutagenic primer, to introduce the desired mutation into the region 
of interest (Figure 2.1, step 1, PCR reactions are carried out using primer pairs A and 
B). The second step involves combining 50 ng - 100 ng of the purified PCR products 
from step 1 and using this mixture as the template for another PCR amplification 
using the external primers, thus reassembling the mutated region of interest (Figure 
2.1, step 2). To minimise the risk of unwanted mutations, high fidelity Accuzyme 
mix (Bioline) was used for all PCR reactions as directed by the manufacturer. All 
primers used for mutagenesis are listed in Table 2.2.  
 
Primer Name 
 
Sequence (5’ - 3’) 
 
Nic1 GATCATGCTGCGCAGGCTGCTTTC 
L1x CCGCCGCAAGGACAAGACC 
L199Ea GGTGGCGGAGCTGCGGGAAAAC 
L199Eb GTTTTCCCGCAGCTCCGCCACC 
L199Ra GGTGGCGCGCCTGCGGGAAAAC 
L199Rb GTTTTCCCGCAGGCGCGCCACC 
L199Ga GGTGGCGGGCCTGCGGGAAAAC 
L199Gb GTTTTCCCGCAGGCCCGCCACC 
L199Qa GGTGGCGCAGCTGCGGGAAAAC 
L199Qb GTTTTCCCGCAGCTGCGCCACC 
L199Aa GGTGGCGGCGCTGCGCGAAAAC 
L199Ab GTTTTCCCGCAGCGCCGCCACC 
L199Va GGTGGCGGTGCTGCGCGAAAAC 
L199Vb GTTTTCCCGCAGCACCGCCACC 
L199Wa GGTGGCGTGGCTGCGCGAAAAC 
L199Wb GTTTTCCCGCAGCCACGCCACC 
L199Fa GGTGGCGTTCCTGCGGGAAAAC 
L199Fb GTTTTCCCGCAGGAACGCCACC 
V165Da GCGATGGACGTGCTCGAC   
V165Db GTCGAGCACGTCCATCGC   
L200Fa TGGCGCTGTTCCGGGAAAAC   
L200Fb GTTTTCCCGGAACAGCGCCA   
E194Ka CAGCAGCAAGAGCCTGGTGG   
E194Kb CCACCAGGCTCTTGCTGCTG   
L200Ea TGGCGCTGGAACGGGAAAAC 
L200Eb GTTTTCCCGTTCCAGCGCCA 
E202Ka CGCTGCTGCGGAAGAACCTC   
E202Kb GAGGTTCTTCCGCAGCAGCG 
E202Aa CGCTGCTGCGGGCGAACCTC   
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E202Ab GAGGTTCGCCCGCAGCAGCG   
L200Aa TGGCGCTGGCGCGGGAAAAC   
L200Ab GTTTTCCCGCGCCAGCGCC   
R201Aa TGGCGCTGCTGGCGGAAAAC   
R201Ab GTTTTCCGCCAGCAGCGCC   
L196Aa AGCGAGAGCGCCGTGGCGC   
L196Ab AGCGCCACGGCGCTCTCGC   
L151Aa CAGCGCGCGATGATCGAG 
L151Ab CTCGATCATCGCGCGCTG 
I153Aa CTGATGGCCGAGGCGGTG 
I153Ab CACCGCCTCGGCCATCAG 
V157Aa GAGGCGGTGGCCAACGCC 
V157Ab GGCGTTGGCCACCGCCTC 
S192Aa GATGGCGGCAGCGAGAGCCTG 
S192Ab CAGGCTCTCGCTGCCGCCATC 
S193Aa GATGGCAGCGGCGAGAGCCTG 
S193Ab CAGGCTCTCGCCGCTGCCATC 
S195Aa CAGCAGCGAGGGCCTGGTG 
S195Ab CACCAGGCCCTCGCTGCTG 
V166Aa GCGATGGTGGCGCTCGAC 
V166Ab GTCGAGCGCCACCATCGC 
V166Da GCGATGGTGGACCTCGAC 
V166Db GTCGAGGTCCACCATCGC 
V166Ca   GCGATGGTGTGCCTCGAC 
V166Cb  GTCGAGGCACACCATCGC 
V157Ca GAGGCGGTGTGCAACGCC 
V157Cb GGCGTTGCACACCGCCTC 
R240Ca CACGGCTGCGCCATCCAC 
R240Cb GTGGATGGCGCAGCCGTG  
L175Ab GGGTTGGAGGCCATCACC 
V251Aa GGCCCACGCGTTCTTCGC 
V251Ab GCGAAGAACGCGTGGGCC 
L261Aa ACGCTACGCGCTGCTGAC 
L261Ab GTCAGCAGCGCGTAGCGT 
L262Aa GCTACCTGGCGCTGACCA 
L262Ab TGGTCAGCGCCAGGTAGC 
L263Aa CCTGCTGGCGACCATCAA 
L263Ab TTGATGGTCGCCAGCAGG 
T264Aa GCTGCTGGCCATCAACGA 
T264Ab TCGTTGATGGCCAGCAGC 
L139Aa CAGCGAAGCGCACGAACT 
L139Ab AGTTCGTGCGCTTCGCTG 
L142Aa  GCACGAAGCGGAACAACG 
L142Ab CGTTGTTCCGCTTCGTGC 
V146Aa  GAACAACGCGCCAACAACC 
V146Ab GGTTGTTGGCGCGTTGTTC 
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E143Aa CACGAACTGGCGCAACGCGTC 
E143Ab GACGCGTTGCGCCAGTTCGTG 
R145Aa CTGGAACAAGCCGTCAACAACC 
R145Ab GGTTGTTGACGGCTTGTTCCAG 
Q149Aa GTCAACAACGCGCGCCTGATG 
Q149Ab CATCAGGCGCGCGTTGTTGAC 
R150Aa CAACAACCAGGCCCTGATGATC 
R150Ab GATCATCAGGGCCTGGTTGTTG 
E154Aa CTGATGATCGCGGCGGTGGTC 
E154Ab GACCACCGCCGCGATCATCAG 
N148Aa CGCGTCAACGCCCAGCGCCTG 
N148Ab CAGGCGCTGGGCGTTGACGCG 
Table 2.2. Primers for mutagenesis. 
2.5.10 Random mutagenesis of the PAS2 domain 
 PCR mutagenesis was carried out with Taq DNA polymerase (Roche) under 
standard reaction conditions. Reaction mixtures contained 75 ng of template pPR34, 
100 ng of each primer (primers L1x and Nic1 were used, Table 2.2), 0.2 mM dNTPs, 
1.5 mM MgCl2 and 5 units of enzyme in a final volume of 50 μl. PCR products were 
purified (Qiagen kit) and cut with restriction endonucleases Mlu I and Apa I 
(Invitrogen) and subsequently recloned (after gel purification using a Qiagen kit) into 
pPR34 vector which had been cut with the same enzymes. Ligation mixtures were 
then butanol precipitated and electroporated into E. coli strain DH5α (see sections 
2.5.2 and 2.4.3). The electroporation procedure described in section 2.4.3 yielded a 
1.2 ml culture of transformed cells (in LB broth) containing the mutagenised pPR34 
plasmid. Next, 3.8 ml of LB broth supplemented with carbenicillin (100 μg ml-1) was 
added in order to facilitate the growth of a 5 ml overnight culture and subsequent 
recovery of the plasmid DNA using a QIAprep spin miniprep kit (Qiagen). The 
resultant plasmids (containing the PCR-generated insert) were transformed into E. 
coli strain ET8000 which contains the reporter plasmid pRT22 (carrying a nifH-lacZ 
fusion). Transformants were screened on solid NFDM medium supplemented with 
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Hino and Wilson buffer (5% v/v), casein hydroxylate (200 μg ml-1), X-gal (5-bromo-
4chloro-3-indolyl-B-D-galactopyranoside, 40 μg ml-1), chloramphenicol (35 μg ml-1) 
and carbenicillin (100 μg ml-1). Mutations in nifL that resulted in altered NifA 
activity were selected (see Chapter 3.2) and their plasmid DNA recovered and 
sequenced to identify mutations. Plasmids of known sequence were then transformed 
back into the host strain for further phenotypic analysis (see section 2.9.2).    
 
2.6 Construction of plasmids 
2.6.1 Plasmids for analysis of NifL activity in vivo 
 All plasmids used to investigate NifL activity in vivo were derived from 
pPR34. The pPR34 plasmid is a pT7-7 derivative carrying transcriptionally coupled 
(and independently translated) copies of the A. vinelandii nifL and nifA genes under 
the control of a constitutive promoter (Söderbäck et al., 1998). Plasmids encoding 
truncated forms the NifL protein starting at residue 143 (pPS54, pPS77 and pPS191) 
were generated by PCR amplification using pPR34 (or a mutant derivative) as 
template DNA. The forward primer pPS54a was used to introduce an Nde I site 
immediately prior to the codon for NifL residue 143. The reverse primer was 
MS2rev, which anneals downstream of a unique Not I restriction site in nifL (primer 
sequences are shown in Table 2.3). PCR products were purified, digested with Not I 
and Nde I, and ligated into pPR34 vector which had been cut with the same enzymes 
and treated with SAP (section 2.5.7). Ligation mixtures were used to transform E. 
coli strain DH5α. Transformed cells were spread onto LB agar plates supplemented 
with carbenicillin (plasmid pPR34 carries a carbenicillin resistance cassette). This 
selection method was used to obtain all the pPR34 mutant derivatives created in this 
work. Plasmids encoding alternative truncations of the NifL protein starting at 
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residue 147 (pPS3 and pPS4) were created by site directed mutagenesis (described in 
section 2.5.9) of plasmid pPR54 (a pPR34 derivative which encodes NifL(147-519)) 
(Söderbäck et al., 1998). 
 To create variant forms of the NifL protein containing two amino acid 
substitutions, plasmids carrying the mutations of interest were digested at unique 
restriction sites and the resulting DNA fragments were purified and appropriate 
combinations were ligated to yield the required double mutant. In detail, plasmid 
pPS124 (encoding the NifL-V166M, G480A double substitution) was constructed by 
digesting pPS20 (encoding the NifL-V166M variant) with the restriction 
endonucleases Nde I and Not I, gel purifying the resultant nifL fragment (Qiagen kit) 
and cloning this into plasmid pNLG480A (encoding the NifL-G480A variant, Perry 
et al., 2005) which had been digested with the same enzymes and gel purified.  
 Deletion mutants in nifL (encoding NifL variants lacking the PAS2 domain or 
residues in the inter-domain region between PAS1 and PAS2) were cloned using a 
two-step PCR technique similar to that described in section 2.5.9. As previously, two 
pairs of primers, including external primers that flank the region of interest, were 
used to generate the required DNA fragments. However, the mutagenic (or internal) 
primers differed from those used to generate point mutations. The forward primers 
consisted of two sequence elements; they contained a 3’ annealing region that primed 
the PCR reaction and a 5’ non-annealing tail (Figure 2.2). This 5’ tail contained the 
appropriate deletion and was complementary to the reverse (internal) primer. Apart 
from these differences, the PCR mutagenesis was carried out as described in section 
2.5.9. All constructs were confirmed by DNA sequencing. 
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Figure 2.2. Two-step PCR method for deletion mutagenesis. Individual DNA strands 
are represented as black lines and (perpendicular) green lines indicate unique 
restriction sites. The region of the DNA sequence to be deleted is coloured yellow 
and the orange sequence elements are complementary to one another. External 
primers are coloured red whilst internal primers are blue. One of the internal primers 
contains a 5’ “non-annealing” sequence that is complementary to a region upstream 
of the DNA sequence to be deleted. Step 1 consists of two separate PCR reactions 
using primer set A or B whereas step 2 consists of a single amplification using the 
external (red) primers and the purified PCR products from step 1.    
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Primer Name 
 
Sequence (5’ - 3’) 
 
P145r GCGTTGTTCCAGTTCGTG 
P147r GTTGACGCGTTGTTCCAG 
145tail-273fw 
CACGAACTGGAACAACGCCAGAAGCAGCAGGATTCG
CGGCTCA 
145tail-276fw 
CACGAACTGGAACAACGCCAGGATTCGCGGCTCAACG
CGCTGA 
147tail-271fw 
CTGGAACAACGCGTCAACCTGCGCCAGAAGCAGCAG
GATTCGC 
Nic1 GATCATGCTGCGCAGGCTGCTTTC 
pPS54a GCGAATTGCACCATATGGAACAACGC 
Pa1 CTAGAGAATTCGGATAGACGAGGCACC 
D1f 
CGCGTCAACAACCAGCGCATGATCGAGGCGGTGGTCA
ACGCC G 
D2f 
CAACGCGTCAACAACCAGATGATCGAGGCGGTGGTCA
ACGCCG  
D3f 
GAACAACGCGTCAACAACATGATCGAGGCGGTGGTCA
ACGCCG 
D4f 
CTGGAACAACGCGTCAACATGATCGAGGCGGTGGTCA
ACGCCG  
D5f 
GAACTGGAACAACGCGTCATGATCGAGGCGGTGGTCA
ACGCCG  
D6f 
CACGAACTGGAACAACGCATGATCGAGGCGGTGGTCA
ACGCCG  
D1r GCGCTGGTTGTTGACGCG 
D2r CTGGTTGTTGACGCGTTGTTC 
D3r GTTGTTGACGCGTTGTTCCAGTTC  
D4r GTTGACGCGTTGTTCCAGTTCG  
D5r GACGCGTTGTTCCAGTTCGTG  
D6r GCGTTGTTCCAGTTCGTGCAATTC  
Table 2.3. Primers used for construction of pPR34 derivative plasmids  
2.6.2 Plasmids for bacterial adenylate cyclase two-hybrid (BACTH) analyses 
 DNA fragments encoding the protein of interest flanked by a 5’ BamH I site 
and a 3’ Kpn I site were generated by PCR. Primers NifL-BTH-F and PAS1-BTH-1F 
were used to amplify the nifL gene from sequence encoding NifL residues 1 and 147 
respectively and to introduce a 5’ BamH I site. The reverse primers PAS2-BTH-2R 
and PAS1-BTH-1R were used to amplify to residues 284 or 146 of NifL respectively 
(the sequence of each primer is shown in Table 2.4). Plasmid pPR34 or derivative 
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plasmids containing the desired mutation/s were used as template DNA for PCR 
reactions using appropriate combinations of the primers mentioned above. PCR 
products were purified (Qiagen kit), digested with Kpn I and BamH I, and cloned 
into the BACTH vectors pT25 and pUT18 (see section 2.9.3) which had been cut 
with the same enzymes and dephosphorylated. All constructs were confirmed by 
DNA sequencing.  
Primer Name 
 
Sequence (5’ - 3’) 
 
NifL-BTH-F GAGGATCCCATGACCCCGGCCAACCCGAC 
PAS1-BTH-2R CTTAGGTACCCGGTGCAATTCGCTGGT 
PAS1-BTH-1R CTTAGGTACCACGCGTTGTTCCAG 
PAS2-BTH-1F GAGGATCCCAACAACCAGCGCCTG 
PAS2-BTH-2R CTTAGGTACCTTCAGCGCGTTGAG 
Table 2.4. Primers used to clone plasmids for bacterial two-hybrid work 
2.6.3 Plasmids for protein overexpression 
 All plasmids for protein overexpression were derived from pETM11 
(EMBL). DNA fragments encoding the required region of NifL were PCR amplified 
using primers with appropriate restriction sites engineered at their 5’ ends (primer 
sequences are shown in Table 2.5), enabling directional cloning into the 
overexpression vector. For overexpression of Nhis6NifL(143-284), Nhis6NifL(1-284) and 
mutant derivatives, DNA fragments encoding the appropriate NifL residues flanked 
by a 5’ Nco I site and a 3’ BamH I site (preceded by a stop codon) were generated by 
PCR using the forward primers Nco1-E143-NifL (for constructs starting at residue 
143) or NifLNcoFor (for constructs starting at residue 1) and the reverse primer 
NifL-284-TGA-Bam. Plasmid pPR34 or derivatives from mutagenesis (see above) 
were used as template DNA. The Nco I-BamH I digested fragments were then cloned 
into the plasmid pETM11, which had been cut with the same enzymes and 
dephosphorylated. For overexpression of Nhis6NifL(143-519), Nhis6NifL and mutant 
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derivatives, fragments encoding the appropriate NifL residues flanked by a 5’ Nde I 
site and a 3’ BamH I site were PCR amplified from pPR34 (for Nhis6NifL), pPS54 
(for Nhis6NifL(143-519)) or mutant derivatives. The forward primer Pa1 and the reverse 
primer NifL2 were used in the PCR reaction and the products were then digested 
with the restriction endonucleases Nde I and BamH I. The resultant DNA fragment 
was cloned into a plasmid derived from pETM11 (called pETNdeM11) in which the 
Nco I site in the multiple cloning region was mutated to yield a Nde I site via the 
two-step PCR mutagenesis technique described in section 2.5.9. All constructs were 
confirmed by DNA sequencing. 
Primer Name 
 
Sequence (5’ - 3’) 
 
Nco I-E143-NifL CAAGCGCCATGGAACAACGCGTCAACAACC 
NifL-284-TGA-Bam GCAAGGATCCTCACTTCAGCGCGTTGAGCCG 
Pa1 CTAGAGAATTCGGATAGACGAGGCACC 
NifLNcoFor CGCATCCATGGCCACCCCGGCCAACCCGACCCT 
NifL2 CGAAGGATCCTCAGGTGGAGGCCGAGAAGGG 
Table 2.5. Primers used to clone of plasmids for protein overexpression  
 
2.7 Protein methods 
2.7.1 SDS Polyacrylamide gel electrophoresis (SDS-PAGE) 
 SDS-PAGE is routinely used to separate proteins on the basis on molecular 
weight. 12.5% polyacrylamide gels were used in this work unless otherwise stated. 
The resolving gel was prepared by mixing 7.5 ml of 4x resolving buffer with 9.5 ml 
of distilled water, 12.5 ml of 30% acrylamide (Severn Biotech), 0.3 ml of 10% (w/v) 
SDS solution and 150 μl of 10% (w/v) ammonium persulphate solution. 25 μl 
TEMED (N,N,N',N'-Tetramethylethylenediamine) was added to initiate acrylamide 
polymerisation and the mixture was immediately poured into the assembled gel 
mould (Atto corp.). For the stacking gel, 6.1 ml distilled water was mixed with 2.5 
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ml of 4x stacking buffer, 1.33 ml of 30% acrylamide, 0.1 ml of 10% SDS and 100 μl 
of 10% ammonium persulphate. 15 μl TEMED was then added and the solution was 
mixed and poured into the gel mould. The gel comb was inserted into the gel mould 
to create the wells and the gel was allowed to set. Samples for SDS-PAGE were 
prepared by mixing with an equal volume of SDS sample buffer and boiling for 3 
minutes at 100
o
C. Electrophoresis was carried out at approximately 170 V (constant 
voltage) for 45 - 60 minutes. Gels were stained in 20 ml SDS-PAGE stain for 15 
minutes and subsequently destained in 40 ml SDS-PAGE destain overnight. 
Alternatively, protein bands were visualised by staining in 15 ml InstantBlue 
(Expedeon Ltd.) for 2 hours. Where pre-cast gels were used, 12% RunBlue pre-cast 
gels were purchased from Expedeon Ltd. and SDS-PAGE was carried out as directed 
by the manufacturer.   
  
2.7.2 Overexpression of proteins for purification 
 All proteins were expressed from pETM11 derived plasmids in E. coli strain 
BL21 (DE3) pLysS. Chemically competent cells were transformed with the 
appropriate plasmid and plated onto solid LB supplemented with kanamycin and 
chloramphenicol (pETM11 and pLysS carry kanamycin and chloramphenicol 
resistance markers respectively). A single colony was used to inoculate 5 ml liquid 
LB medium with the same antibiotics and the culture was incubated for 
approximately 8 hours at 37
o
C (with shaking). A 250 ml conical flask containing 50 
ml LB and appropriate antibiotics was then inoculated with 500 μl of this culture and 
grown at 30
o
C overnight. Two 12.5 ml aliquots of this overnight culture were used to 
inoculate two 2 L conical flasks containing 1 L LB supplemented with kanamycin 
and chloramphenicol and grown at 30
o
C (with shaking) until OD600 reached 0.6. 
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Isopropyl-β-D-thiogalactopyranoside (IPTG) was then added to a final concentration 
of 1 mM to induce protein expression and cultures were incubated under agitation for 
a further 2 hours. Cells were then harvested by centrifugation for 10 minutes at 5000 
rpm (in a Sorvall RC 5B plus centrifuge fitted with a SLA-3000 rotor). Cell pellets 
were resuspended in 30 ml nickel affinity loading buffer and stored at -20
o
C until 
required.  
 
2.7.3 Protein purification 
 Cells from overexpression (see above) were thawed mixed with 0.3 ml 
protease inhibitor cocktail set II (Calbiochem) and disrupted at 10000 psi in a French 
pressure cell. Broken cells were then centrifuged at 18000 rpm (Sorvall RC 5B plus 
centrifuge with SS-34 rotor) for 30 minutes at 4
o
C to remove the cell debris. The 
clarified cell extract was loaded onto a HiTrap chelating column (GE healthcare) 
which had been primed with nickel chloride and equilibrated with 6 column volumes 
of nickel affinity loading buffer. The flow rate used in all purification steps was 
constant at 1.5 ml min
-1
. The loaded column was washed with approximately 20 ml 
nickel affinity loading buffer to remove non-specifically bound protein. An 
imidazole gradient of 20 mM - 500 mM was then applied to elute the hexahis-tagged 
protein. Recombinant NifL proteins typically eluted in 20% - 40% nickel affinity 
elution buffer (~100 mM - 200 mM imidazole). The protein content of fractions 
recovered from affinity chromatography was analysed by SDS-PAGE. Fractions 
containing the protein of interest at high concentration and purity were pooled and 
dialysed into storage buffer. After dialysis, protein samples were stored at -20
o
C until 
required.   
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2.7.4 Bradford assay for protein concentration 
 Bradford assays are widely used for determination of protein concentration 
(Bradford, 1976). Coomassie Plus
TM
 protein assay reagent and BSA standard were 
purchased from Thermo Scientific and the assay was carried out according to the 
manufacturer’s instructions. 
 
2.7.5 Protein buffer exchange  
 When the buffer used for storage of protein samples was not appropriate for a 
particular experiment, an aliquot was taken from the stored sample and exchanged 
into a germane buffer using a Zeba
TM
 desalt spin column (Thermo scientific) as 
directed by the manufacturer.  
  
2.7.6 Size exclusion chromatography (SEC) 
 Size exclusion chromatography is a technique commonly used to estimate the 
molecular mass of proteins in solution. Purified protein samples were run at 0.4 ml 
min
-1
 over a Superose 12 10/300 GL column (GE healthcare) equilibrated with at 
least six column volumes of analytical gel filtration buffer. Proteins were injected at 
a concentration of 104 µM (based on a monomer) unless otherwise stated. Bio-Rad 
gel filtration standards (thyroglobulin (bovine), γ-globulin (bovine), ovalbumin 
(chicken), myoglobin (horse) and vitamin B12) were used for calibration as directed 
by the manufacturer. 
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2.7.7 Dynamic light scattering (DLS) 
 Dynamic light scattering is commonly used to analyse the size distribution of 
proteins in solution. Purified protein samples were buffer exchanged (see section 
2.7.5) into 50 mM Tris-HCl (pH 8.0), 100 mM NaCl. Samples were then centrifuged 
(13000 rpm for 30 seconds in a Thermo Scientific Heraeus Pico microfuge) through 
a 0.1 μm Ultrafree filter (Millipore) to remove particulate material and a 13 μl 
aliquot was pipetted into a microsampling cell (Wyatt technologies). Measurements 
were taken at 293 K using a Dynapro Titan DLS instrument (Protein Solutions Inc.). 
At least 15 scattering measurements were taken for each sample and the resulting 
data were analysed using the DYNAMICS 6.9.2.11 software package (Protein 
Solutions Inc.). 
 
2.7.8 Chemical cross-linking 
 Chemical cross-linking can be used to study subunit stoichiometry in 
multimeric proteins. Samples of purified protein (52 μM based on a monomer) were 
incubated in 50 mM Tris-HCl (pH 8.0), 50 mM NaCl and 0.25% glutaraldehyde for 
10 mins at 30
o
C. The reaction volume was 10 μL. After 10 minutes, 10 μL of SDS-
PAGE sample buffer was added and samples were immediately heated to 100
 o
C for 
4 mins and analysed by SDS-PAGE. Densitometric analysis was performed using 
SynGene GeneTools software (version 3.06.04) from Synoptics Ltd. 
 
2.7.9 Cysteine cross-linking 
 Cysteine cross-linking is a technique routinely used to analyse the tertiary and 
quaternary structures of proteins. Pairs of native or substituted cysteine residues 
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located in close proximity to one another in a folded protein structure can be oxidised 
to form disulphide bridges using catalysts such as copper (II) o-phenanthroline (Cu-
Phe) or iodine solution. This can provide information regarding the relative positions 
of pairs of amino acid residues in a three-dimensional protein structure. For cysteine 
cross-linking experiments on the isolated PAS2 domain of NifL (and its variants), 
protein samples (52 μM, based on a monomer) were incubated in 17 mM Tris-HCl 
(pH 8.0), 17 mM NaCl, 17% (v/v) glycerol and 5 μM Cu-Phe for 10 minutes at 37oC. 
Reactions were stopped by addition N-ethylmaleimide (NEM) to a final 
concentration of 66 mM. NEM irreversibly
 
alkylates thiol groups and thereby 
prevents further disulphide bond formation. This step prevents non-specific 
disulphide bridge formation in the denatured protein samples used for SDS-PAGE 
analysis. Two aliquots were removed from each “stopped” reaction and added to 
either non-reducing SDS-PAGE loading buffer (Expedeon) or loading buffer 
containing 25% (v/v) β-mercaptoethanol. Samples were then analysed by SDS-
PAGE on pre-cast (12%) polyacrylamide gels (Expedeon) as directed by the 
manufacturer.  
 For cysteine cross-linking experiments on the full length NifL protein and its 
variants,  protein samples (8.2 μM based on a monomer) were incubated in 17 mM 
Tris-HCl (pH 8.0), 17 mM NaCl, 17% (v/v) glycerol and Cu-Phe catalyst at the final 
concentrations indicated in Figure 5.6 (i.e. 0 μM, 2.5 μM or 5 μM) for 10 minutes at 
37
o
C. Reactions were stopped by addition of NEM to a final concentration of 50 
mM. Additional control experiments in which NEM was added prior to catalysis 
were carried out to ensure the NEM concentration used was sufficient to fully 
prevent non-specific disulphide bond formation. Samples were analysed by SDS-
PAGE as described above. 
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2.7.10 Analytical ultracentrifugation (AUC) 
 AUC is commonly used to analyse the molecular mass of macromolecules in 
solution. Sedimentation equilibrium experiments were performed in a Beckman 
Optima XL-I analytical ultracentrifuge equipped with absorbance optics and an 
An50Ti rotor. Purified protein samples were diluted to a concentration of 100 μM 
and then buffer exchanged (see section 2.7.5) into 50 mM KH2PO4 (pH 8.0), 100 
mM NaCl. A series of dilutions were prepared for each protein (10-fold, 20-fold and 
100-fold dilutions were prepared). To ensure that the freshest possible protein 
samples were analyzed in the AUC, equilibrium ultracentrifugation experiments 
were performed immediately after the sample preparation; 110 μL of each sample 
was loaded into the sample sector of charcoal-filled Epon double sector cells fitted 
with quartz windows, while 120 μL of buffer was loaded into the reference sector. 
Samples were centrifuged at speeds of 16,000 and 23,000 rpm and the absorbance 
was recorded at 275 nm for the higher concentrations, and 230 nm for the lower 
protein concentrations. The precise concentration of each sample was calculated 
retrospectively using absorbance measured by the AUC and an experimentally (and 
independently) determined absorbance co-efficient. Data analysis was performed 
using Ultrascan II (Demeler, 2005) where profiles of individual samples were 
initially analysed at single speeds using an ideal, single component model. The 
parameters for buffer density and partial specific volume were determined using 
SEDNTERP (Horan et al., 1995).   
 
2.7.11 Spectroscopic analysis of the FAD content of NifL 
 The FAD absorbance spectrum has characteristic peaks at 450 nm and 378 
nm. Incorporation of the FAD molecule into a protein results in alteration of the 
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absorbance spectrum such that these characteristic peaks obtain “shoulders”. It has 
previously been demonstrated that, under oxidising conditions, the absorbance 
spectrum of the FAD-bound NifL protein contains peaks at 358 nm, 362 nm and 446 
nm (Macheroux et al., 1998). The molar absorption co-efficient of the protein was 
calculated to be 12250 M
-1
 cm
-1
 at 446 nm (Macheroux et al., 1998). To analyse the 
FAD content of the NifL protein and its variants, absorption spectra of protein 
samples of known concentration (calculated by Bradford assay, see section 2.7.4) 
were recorded over the 300 nm to 700 nm range of wavelengths using a Perkin-
Elmer lambda 35 spectrophotometer with a 1 cm path length. The FAD concentration 
of each sample was calculated using the following equation. 
A = εcl 
Where A = absorbance at 446 nm (absorbance units) 
ε = molar absorption co-efficient (M-1 cm-1) 
c = FAD concentration (M) 
l = path length (cm) 
The ratio of protein concentration to FAD concentration in each sample was used to 
calculate the number of FAD molecules per NifL dimer. 
 
2.7.12 Limited proteolysis 
 Limited proteolysis is routinely used to study conformational change in 
proteins. Trypsin and chymotrypsin proteolysis were performed in TA buffer at 
25
o
C. Samples were incubated for 1 hour before initiating digestion with α-
chymotrypsin type I-S (Sigma, from bovine pancreas) or trypsin type III (Sigma, 
from bovine pancreas). The protease was diluted from a 0.5 mg/mL stock solution to 
a final protease:NifL weight ratio of 1:60. NifL samples were diluted from a 50 μM 
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(based on a dimer) stock solution to a final concentration of 5 μM. The total reaction 
volume was 120 μL. After 0, 2, 5, 10, 20, 30 and 60 minutes, a 15 μL aliquot of the 
proteolysis reaction was withdrawn and added to microcentrifuge tubes containing 
0.35 μg of trypsin/chymotrypsin inhibitor (Roche, from soybean). An equal volume 
of gel loading buffer (Expedeon 4x sample buffer) was added and samples were 
analysed by SDS-PAGE on 12% pre-cast polyacrylamide gels (Expedeon) as 
directed by the manufacturer. For reducing conditions, all samples and stock 
solutions were prepared in sealed glass bijou tubes and sparged with oxygen-free 
nitrogen for 3 mins before being transferred to a Belle anaerobic chamber (in which 
the oxygen level was maintained below 3.5 ppm). The stock solution of NifL(1-284) 
was reduced with a 100-fold excess of dithionite (5 mM) and a sample removed for 
spectroscopic analysis to confirm that the flavin co-factor was fully reduced. The 
proteolysis experiment was then performed as described above. Where appropriate, 
densitometry analysis was performed using SynGene GeneTools software (version 
3.06.04) from Synoptics Ltd. 
 
2.8 Western blotting and immunodetection 
 To obtain protein extracts, cultures of E. coli strain ET8000 containing the 
plasmid of interest were grown as for the β-galactosidase assays (section 2.9). To 
ensure that cell numbers were equivalent between samples, the volume taken from 
each culture was adjusted according to differences in OD600. The normalised cell 
samples were then centrifuged (13000 rpm for 30 seconds in a Heraeus Pico 
microfuge) and the pellet resuspended in 50 μl SDS-PAGE sample buffer. The 
resuspended samples were then boiled for 3 minutes at 100
o
C and subjected to SDS-
PAGE. After electrophoresis, proteins were electrotransferred onto nitrocellulose 
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membranes (Amersham Biosciences) using an XCell II
TM
 blot module (Invitrogen) 
as directed by the manufacturer. After blotting, membranes were washed in TBS 
buffer (two 10 minute washes) and blocked by incubating overnight in 20 ml 
blocking buffer at 4
o
C. A series of three wash steps was then performed (two 10 
minute washes in TBS-Tween/Triton buffer were followed by a 10 minute wash in 
TBS buffer). Nitrocellulose membranes were then probed with polyclonal antisera 
against NifL. In order to titrate non-specifically binding antibodies out of the rabbit 
antiserum, a 10000-fold dilution was prepared in TBS containing 3% BSA and 
broken ET8000 cells that lacked the plasmid of interest. Membranes were incubated 
for 1 hour in 25 ml of this solution and subsequently washed as after blocking. 
Primary antibodies were detected with alkaline phosphatase-conjugated anti-rabbit 
secondary antibodies raised in goat (Sigma). The membranes were incubated for 45 
minutes in 25 ml TBS containing 3% BSA and a 5000-fold dilution of secondary 
antibody and then washed four times in TBS-Tween/Triton (each wash was 10 
minutes).  Finally, secondary antibodies were detected by staining with 
SigmaFAST
TM
 5-bromo-4-chloro-3-indolylphosphate and nitroblue tetrazolium 
(Sigma) as directed by the manufacturer.  
 
2.9 Experimental assays  
2.9.1 Assay of NifL activity in vivo 
 NifL activity was assayed as the ability of the NifA protein to activate 
transcription of a nifH-lacZ promoter fusion in the presence of NifL under four 
distinct growth conditions. Chemically competent E. coli ET8000 cells carrying the 
reporter plasmid pRT22 (containing the nifH-lacZ fusion) were transformed with 
pPR34 (carrying nifL co-expressed with nifA) or a mutant derivative and spread onto 
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LB agar supplemented with 100 μg ml-1 carbenicillin and 35 μg ml-1 chloramphenicol 
(the pRT22 and pPR34 plasmids carry chloramphenicol and carbenicillin resistance 
markers respectively). Individual colonies were picked and grown at 37
o
C for 8 
hours in LB liquid media containing the same antibiotics. These cultures were used 
to inoculate “assay cultures” grown in NFDM media supplemented with 5% (v/v) 
Hino and Wilson buffer, appropriate antibiotics and either 200 μg ml-1 casein 
hydrolysate (for nitrogen limiting conditions) or 1 mg ml
-1
 (NH4)2SO4 (for conditions 
rich in fixed nitrogen). These cultures were grown at 30
o
C overnight either 
aerobically in 50 ml conical flasks containing 5 ml of medium with vigorous shaking 
(250 rpm), or anaerobically in tightly sealed 7 ml bijou tubes containing 7 ml 
medium. Assays for β-galactosidase activity were then performed as described in 
section 2.9.3.    
 
2.9.2 Bacterial adenylate cyclase two-hybrid analysis 
 The bacterial adenylate cyclase two-hybrid (BACTH) system is commonly 
used to investigate interactions between proteins or protein domains. It relies on 
functional complementation between subunits of the adenylate cyclase (AC) enzyme 
expressed in trans in an AC-deficient E. coli reporter strain. The N-terminal (T25) 
and C-terminal (T18) domains of the hetero-dimeric AC protein are encoded on 
plasmids pT25 and pUT18 respectively (Karimova et al., 1998). These plasmids each 
contain an antibiotic resistance marker and a multiple cloning site to aid the creation 
of two hybrid proteins containing an AC subunit transcriptionally (and 
translationally) fused to the protein of interest. Interaction between the proteins of 
interest results in co-localisation of the AC subunits and functional complementation. 
Thus, protein-protein interactions result in a substantial increase in AC activity 
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(Karimova et al., 1998; Karimova et al., 2000). This, in turn, triggers transcription of 
various reporter genes, including lacZ.  
 The plasmids pT25 and pUT18, or derivatives containing the desired nifL 
sequence, were co-transformed into chemically competent E. coli strain BTH101 
(Karimova et al., 2000) and spread onto LB agar supplemented with X-gal (40 μg ml-
1), chloramphenicol (35 μg ml-1), carbenicillin (100 μg ml-1) and IPTG (0.5 mM). 
Agar plates were incubated at 30
o
C for 72 hours. Colonies were then picked and 
cultured in universal tubes containing 5 ml LB supplemented with chloramphenicol 
and carbenicillin for approximately 8 hours at 30
oC with shaking (250 rpm). 50 μl 
aliquots of these cultures were used to inoculate 7 ml bijou tubes containing 7 ml LB 
supplemented with 1% (v/v) glucose, 0.5 mM IPTG and appropriate antibiotics. 
Bijou tubes were tightly sealed and grown overnight at 30
o
C. Cultures were then 
assayed for β-galactosidase activity as described in section 2.9.3.  
 
2.9.3 β-galactosidase assays  
 After overnight growth of assay cultures (see sections 2.9.1 and 2.9.2) the 
OD600 was recorded. 30 μl of each culture was then added to 970 μl lysis buffer 
containing 2% (v/v) chloroform, vortexed and incubated at 30
o
C for at least 10 
minutes. Assay reactions were started by addition of 200 μl start buffer (4 mg ml-1 2-
nitrophenyl-β-galactopyranoside) and, after a carefully recorded period of incubation 
at 30
o
C, each reaction was stopped by adding 500 μl stop buffer (0.5 M NaCO3). The 
OD420 and OD550 of each reaction tube was then measured and the β-galactosidase 
activity was calculated using the following equation: 
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           OD420 - (1.75OD550)  
β-galactosidase activity (Miller Units) =   _____________________ 
                   vtOD600  
 
Where v = volume (ml) of lysed culture  
OD420 = optical density at 420 nm 
OD550 = optical density at 550 nm 
OD600 = optical density at 600 nm 
t = total reaction time (minutes). 
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Chapter 3 - Influence of the PAS2 domain on NifL function in vivo 
3.1 Introduction 
As discussed in Chapter 1, NifL is a transcriptional anti-activator that regulates the 
expression of genes required for nitrogenase biosynthesis via interaction with its partner 
protein, NifA. NifL controls transcriptional activation by NifA in response to cellular 
levels of oxygen and fixed nitrogen (Martinez-Argudo et al., 2004c). NifL is a modular 
protein that contains four discrete domains: a C-terminal GHKL domain, an H domain and 
two N-terminal PAS domains (Figure 1.22). The C-terminal (H and GHKL) domains are 
important for inhibition of NifA and nitrogen sensing. The first PAS domain, PAS1, is 
located between NifL residues 1-140 and senses changes in redox potential via a FAD co-
factor (Söderbäck et al., 1998). The SMART and Pfam databases recognise the region of 
NifL between residues 151-268 as a second distinct PAS domain, called PAS2. Secondary 
structure predictions using the PSIPRED (http://bioinf.cs.ucl.ac.uk/psipred/) and Jpred 
(http://www.compbio.dundee.ac.uk/www-jpred/) servers and alignments with known PAS 
structures indicate that the PAS2 domain is likely to contain structural elements found in 
other PAS domains (Figure 3.1). This domain has no apparent co-factor and prior to this 
work its function was unknown. As mentioned in Chapter 1, it is common for signalling 
proteins to contain multiple PAS domains in tandem. Despite the abundance of duplicate 
PAS domains, relatively few have been characterised. In the studied examples DcuS and 
KinA, the biological function of the second PAS domain within the tandem pair is often 
unclear due to the apparent lack of any co-factor or ligand binding pocket that might be 
indicative of a role signal perception (Etzkorn et al., 2008; Lee et al., 2008). The N-
terminal PAS domains of NifL are typical in this sense; the PAS1 domain has a role in 
signal perception whilst the function of PAS2 is unclear. This work aimed to elucidate the 
role of the NifL PAS2  
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Figure 3.1. Sequence alignment of the A. vinelandii NifL PAS2 domain with PAS domains 
of known structure (PDB code and protein designation are listed to the left of each 
sequence). Amino acids are coloured according to their level of  Kyte-Doolittle 
hydrophobicity (Kyte and Doolittle, 1982) . The group I (most hydrophobic) residues are 
coloured light red, group II are dark red, group III are dark blue and groups IV and V (the 
least hydrophobic) are light blue. The α-helices are highlighted in yellow and β-strands in 
green. Residues in the conserved PAS dimer interface (Ayers and Moffat, 2008) are 
highlighted in red. The positions of amino acid substitutions in the NifL PAS2 domain 
analysed in this thesis are indicated by arrows above the text. 
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domain in signalling using genetic and biochemical approaches. The first step in this 
analysis was to mutagenise the region of nifL encoding the PAS2 domain to examine 
whether/how substitutions in this domain might influence signalling in NifL.  
 
3.2 Mutagenesis of the NifL PAS2 domain 
 The DNA sequence encoding the PAS2 domain was randomly mutagenised using 
error-prone PCR and the mutant library was inserted into nifL to replace the wild-type 
sequence. The resultant NifL mutants were screened for differences in their ability to 
inhibit NifA activity using the two-plasmid heterologous reporter system described in 
section 2.9. In this system, β-galactosidase activity is measured as an indicator of NifA-
mediated transcriptional activation from a nifH-lacZ reporter. Colonies expressing wild-
type NifL (co-transcribed with NifA) are pale blue on Xgal indicator plates containing 
limiting fixed nitrogen when incubated under aerobic conditions, due to low levels of NifA 
activity. Mutants that appeared white (indicating enhanced repression of NifA activity by 
NifL) or dark blue (suggesting the NifL mutant protein was deficient in its ability to inhibit 
NifA) were selected and the plasmid DNA was recovered and sequenced (see Materials 
and Methods Chapter 2.5.10). Additionally, site-directed mutagenesis was used to 
investigate the role of residues predicted to contribute to a conserved dimerisation interface 
found in many PAS domains of known structure (see section 1.2.6). Single codon changes 
were generated using a two-step PCR method and the presence of the desired mutation was 
then confirmed by DNA sequencing. NifL mutants of known sequence were assayed for 
their ability to inhibit NifA activity in response to redox and fixed nitrogen signals in vivo. 
NifA-mediated transcriptional activation from a reporter plasmid containing a nifH-lacZ 
fusion was measured in the presence of NifL or mutant derivatives using the two-plasmid 
heterologous system mentioned above. However, unlike the indicator plates used in the 
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mutant screens, these are quantitative assays for β-galactosidase expression. Assay cultures 
were grown under four conditions to assess the response of the NifL protein to different 
environmental cues. Cells were grown either aerobically or anaerobically with casein 
hydrolysate (to simulate nitrogen limiting conditions) or ammonium sulphate (for excess 
fixed nitrogen) as the sole nitrogen source (see section 2.9.1 for details). In other words, 
cultures were grown under nitrogen fixing conditions or in the presence of excess oxygen 
or excess fixed nitrogen or a combination of both. Three distinct phenotypes emerged from 
both the random and sire-directed approaches: (i) “locked-on” mutants that constitutively 
inhibited NifA activity, (ii) “redox signalling” mutants that failed to respond to the 
presence of oxygen but inhibited NifA activity in the presence of high levels of fixed 
nitrogen, and (iii) “aerobically inactive” mutants that failed to inhibit NifA under oxidising 
conditions irrespective of fixed nitrogen availability but retained some ability to respond to 
fixed nitrogen under anaerobic conditions (Figure 3.2). 
 
(i) “Locked-on” mutants 
As demonstrated previously, the wild-type NifL protein represses NifA activity in 
discrete responses to oxygen (Figure 3.2A, compare the blue and red bars) and fixed 
nitrogen (Figure 3.2A, compare blue and yellow bars) or a combination of both (Figure 
3.2A, green bars). Control experiments demonstrated that there is no transcription from the 
reporter fusion in the absence of NifA (Figure 3.2A, bars marked “Reporter only”) and that 
NifA is active across all four conditions in the absence of regulation by its partner protein, 
NifL (Figure 3.2A, bars marked “NifA”). The amino acid substitutions V157A, V166M, 
L175A, N177S, L199R, R240W, and L262A apparently lock the NifL protein in the 
inhibitory conformer, causing NifL to inhibit NifA activity in the absence of oxygen and 
  
1
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Figure 3.2. Activity and stability of mutant NifL proteins in vivo. (A) Influence of mutant NifL proteins on transcriptional activation by NifA in 
vivo. Cultures were grown under the following conditions; (1) anaerobically, under nitrogen-limiting conditions (blue bars), (2) anaerobically 
with excess fixed nitrogen (yellow bars), (3) aerobically with limiting fixed nitrogen (red bars) and (4) aerobically when fixed nitrogen was 
replete (green bars). Cultures were assayed for β-galactosidase activity as a reporter of NifA-mediated transcriptional activation from a nifH-lacZ 
fusion. Further experimental detail concerning assays and culture conditions can be found in section 2.9. All experiments were performed at least 
in duplicate with error bars denoting the standard error of the mean. (B) Anti-NifL western analysis of the wild-type and mutant NifL proteins in 
strains grown under the same four conditions (labelled 1-4) as the β-galactosidase assay cultures.  
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fixed nitrogen (Figure 3.2A, blue bars). NifL variants of this sort were termed “locked-on” 
mutants. 
Western analysis indicated that these NifL variants were stable across the four 
assay conditions and a representative example (NifL-L199R) is shown in Figure 3.2B. The 
identification of amino acid substitutions in the PAS2 domain that lock NifL in the 
inhibitory conformer suggests that the PAS2 domain is important to the conformational 
changes that occur when the NifL protein switches between the inhibitory and non-
inhibitory signalling states.   
 
(ii) “Redox signalling” mutants 
Two amino acid substitutions (L153A and F253L) in the PAS2 domain gave rise to 
a form of the NifL protein that is insensitive to redox signals but responds normally to 
fixed nitrogen. In contrast to wild-type NifL, which strongly represses NifA activity in 
response to oxygen, these variants allowed high levels of NifA activity under oxidising 
conditions (Figure 3.2A, red bars). However, NifL-L153A and NifL-F253L retained the 
ability to respond to fixed nitrogen and addition of ammonium to the media results in 
strong inhibition of NifA activity (Figure 3.2A, yellow and green bars). Western blotting 
experiments demonstrated that both mutant proteins were stable under all conditions tested 
and data for NifL-I153A is shown in Figure 3.2B. Thus, the inability of these NifL variants 
to respond to oxygen is not due to a change in stability caused by the substitutions but 
instead indicates a defect in the redox signalling mechanism. Therefore, NifL variants of 
this type were termed “redox signalling” mutants. The identification of this class of mutant 
in the PAS2 domain of NifL suggests that PAS2 is involved in redox signalling. As 
mentioned above, the PAS2 domain has no apparent co-factor and previous studies have 
demonstrated that a truncated form of NifL lacking the PAS1 domain (i.e. containing 
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PAS2 and the C-terminal output domains) is not responsive to changes in redox status. 
Taken together, the available evidence implies that PAS2 may have a role in relaying 
signals from the redox-sensing PAS1 domain to the C-terminal domains of NifL. 
 
(iii)“Aerobically inactive” mutants 
Six NifL variants that were unable to inhibit NifA activity under oxidising 
conditions were also obtained. These where named “aerobically inactive” mutants. NifL-
V165D, NifL-L199P, NifL-L200E, NifL-L235P, NifL-S236P and NifL-C237K allowed 
high levels of NifA activity in the presence of oxygen and little or no reduction in NifA 
activity was observed when fixed nitrogen was added to aerobic cultures (Figure 3.2A, red 
and green bars). In other words, these NifL variants were unable to respond to fixed 
nitrogen under oxidising conditions. However, they retained some nitrogen sensitivity 
under anaerobic conditions as addition of ammonium to anaerobic cultures resulted in 
lower NifA activity (Figure 3.2A, compare blue and yellow bars). Even under these growth 
conditions (when fixed nitrogen is replete and oxygen is limiting) NifA activity was not 
fully repressed (Figure 3.2A yellow bars) and, in most cases, the mutant NifL proteins 
allowed greater NifA activity under nitrogen fixing conditions than the wild-type protein 
(Figure 3.2A, blue bars). Thus, the “aerobically inactive” NifL variants exhibit an impaired 
ability to inhibit NifA. Western analysis indicated that the mutant NifL proteins were 
stable under three of the four test conditions but were relatively unstable under oxidising 
conditions when fixed nitrogen was absent (data for NifL-L199P is shown in Figure 3.2B 
as a representative example). This instability may contribute to the failure of the mutant 
NifL proteins to inhibit NifA activity in the presence of oxygen but cannot account for the 
deficient response to fixed nitrogen under oxidising conditions. Despite the stability of the 
variant proteins when oxygen and fixed nitrogen were in excess, neither stimulus resulted 
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in inhibition of NifA activity (Figure 3.2A, green bars). This implies that the redox 
response is deficient regardless of changes in protein stability. It is worth noting that all 
mutations that result in an “aerobically inactive” phenotype encode substitutions that are 
likely to disrupt the structure of the protein, for example two leucine residues are 
substituted for proline (L199P and L235P). One possible interpretation of this data is that 
the “aerobically inactive” phenotype derives from structural perturbation of the PAS2 
domain. The isolation of “aerobically inactive” mutants in PAS2 provides further evidence 
that this domain is involved in redox signalling and implies that a “mis-functioning” PAS2 
domain can disrupt the nitrogen response. Further, it suggests that the PAS2 domain can 
influence the conformation of the C-terminal domains of NifL. Overall, these data suggest 
that the “aerobically inactive” NifL mutants are competent to interact with GlnK (which 
conveys the nitrogen signal, see section 1.4.3) and undergo the conformational changes 
necessary to inhibit NifA under anaerobic conditions. However, the presence of oxygen 
triggers a deficient redox signalling pathway that somehow perturbs the otherwise 
functional nitrogen response.  
 
3.2.1 Site-directed mutagenesis at positions 199 and 166 
 In order to better understand the phenotypes of mutants isolated by random 
mutagenesis, the importance of some residues was investigated by site-directed 
mutagenesis. It had previously been observed that introduction of charged glutamate or 
arginine residues at position 199 both resulted in a “locked-on” phenotype, despite the 
opposite polarity of their charges (see section 1.5). Therefore, it was postulated that the 
loss of hydrophobicity at this position was responsible for this phenotype. To test this 
hypothesis, site-directed substitutions of L199 were generated using a two-step PCR 
technique. The ability of the resulting NifL variants to inhibit transcriptional activation by  
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Figure 3.3. (A) NifA activity in the presence of mutant NifL proteins with substitutions of 
L199 for residues of varying hydrophobicity. (B) NifA activity in the presence of NifL 
variants with substitutions of V166. Assays and culture conditions in parts A and B are as 
described in Figure 3.2. 
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NifA was tested (Figure 3.3A). The L199Q substitution exhibited a “locked-on” phenotype 
similar to that of NifL-L199E and NifL-L199R (Figure 3.3A). Complete removal of the 
hydrophobic side chain of residue 199 by substitution of the native leucine for glycine also 
gave rise to a “locked-on” form of NifL, indicating that the absence of hydrophobicity at 
this position is sufficient to lock the NifL protein in the inhibitory conformer (Figure 
3.3A). When some hydrophobicity was restored by introducing an alanine or valine residue 
at position 199, a significant increase in NifA activity was detected under nitrogen-fixing 
conditions (Figure 3.3A, blue bars). Moreover, the extent to which NifA activity increased 
(relative to NifA activity in the presence of NifL-L199G, NifL-L199R or NifL-L199E) 
appeared to be proportional to the hydrophobicity of the residue introduced (i.e. NifA 
activity is greater in the presence of NifL-L199V than in the presence of NifL-L199A). 
This suggests that, under nitrogen fixing conditions, L199 participates in a hydrophobic 
interaction which is required in order for NifL to adopt the non-inhibitory conformation. 
 As mentioned above, substitution of V166 for methionine gives rise to a “locked-
on” form of the NifL protein. To investigate the influence of the side chain at this position 
several substitutions were generated using a two-step PCR technique. The activity of NifA 
in the presence of NifL-V166M, NifL-V166A, NifL-V166C and NifL-V166D was then 
determined (Figure 3.3B). As demonstrated previously, NifL-V166M inhibited NifA 
activity under all four conditions, even when oxygen and fixed nitrogen were limiting 
(Figure 3.3B, blue bars). The same phenotype was not observed for any of the other NifL 
variants. NifL-V166C was indistinguishable from the wild-type NifL protein under all 
conditions tested (Figure 3.3B, compare bars marked “NifL-V166C, NifA” with those 
marked “NifL-V166M, NifA”). NifL-V166A responded normally to oxygen and fixed 
nitrogen but allowed approximately 2-fold less NifA activity than the wild-type protein 
under nitrogen fixing conditions (Figure 3.3B, blue bars). The less conservative 
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substitution of V166 for aspartate resulted in an “aerobically inactive” phenotype (Figure 
3.3B), perhaps indicating that this substitution perturbs the structure of the PAS2 domain. 
It is interesting that the two sulphur-containing substitutions at position 166 (V166C and 
V166M) have strikingly different phenotypes. NifL-V166C appears wild type whilst NifL-
V166M is “locked-on”. Since the side chains of methionine and the native valine are both 
hydrophobic, it seems likely that the “locked-on” phenotype of the V166M variant is due 
to steric hindrance when the bulkier methionine side chain is present. This implies that 
V166 (or C166 in the NifL-V166C variant) is tightly packed against another residue when 
NifL is in the non-inhibitory conformation but not when the protein is in the inhibitory 
state. Thus, substitution of V166 for methionine forces the protein into the inhibitory 
conformer, resulting in a “locked-on” phenotype. 
 
3.2.2 Mutagenesis of the Eα helix 
As mentioned in section 3.1, secondary structure predictions indicate that the NifL 
PAS2 domain contains structural elements found in other PAS domains of known 
structure. One such structural element is the Eα helix (Figures 3.1 and 1.4B), which forms 
part of a conserved cleft that accommodates a co-factor in some PAS domains (Möglich et 
al., 2009b). This helix is amongst the most variable features of the PAS superfamily and its 
structure and amino acid sequence are often adapted to suite the biological function of 
specific PAS domains. In the NifL PAS2 domain, Eα is a predicted amphipathic α-helix 
that contains at least one residue important in signalling, L199 (discussed above). It was 
decided to further investigate the function of this helix by site-directed mutagenesis. 
Structural predictions and alignments with PAS domains of known structure indicate that 
the PAS2 Eα helix is likely to extend from residue 196 to residue 201 (Figure 3.1). 
However, in the absence of any direct structural information it is difficult to predict its 
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precise length and position. Additionally, the Eα and Dα helices are merged in some PAS 
domains (e.g. NifL PAS1) to form one extended α-helix. Therefore, substitutions were 
generated throughout the region of PAS2 predicted to form the amphipathic Eα helix and 
extending outwards to its flanking residues (amino acids 192-202). The ability of the 
resulting NifL variants (NifL-S192G, NifL-S193G, NifL-E194K, NifL-S195G, NifL-
L196A, NifL-L199A, NifL-L200A, NifL-L200E, NifL-R201A, NifL-E202A and NifL-
E202K) to inhibit transcriptional activation by NifA was examined in vivo (Figure 3.4).  
Substitution of residues S192, S193 or S195 for glycine did not influence NifL 
activity in vivo (Figure 3.4A). Likewise, the L196A, E202A and E202K substitutions did 
not significantly alter the ability of NifL to inhibit transcriptional activation by NifA. As 
demonstrated previously, NifL-L199A responded normally to changes in redox potential 
and nitrogen status but allowed approximately 5-fold less NifA activity under nitrogen 
fixing conditions when compared to the wild type (Figure 3.4A). NifL-L199A can be 
described as intermediate between the “locked-on” and wild-type proteins. Substitutions of 
two charged residues (R201 and E194) located on the opposite side of the Eα helix (to 
L199) result in a similar phenotype. The NifL-R201A and NifL-E194K proteins are both 
impaired in their ability to release NifA from inhibition when oxygen and fixed nitrogen 
are limiting (Figure 3.4A). Thus, these results cannot be rationalised simply in terms of the 
amphipathic nature of the Eα helix as substitutions on both the hydrophilic and 
hydrophobic sides result in similar phenotypes. However, this mutagenesis yielded an 
interesting NifL variant worthy of further study. NifL-L200A is an “aerobically inactive” 
mutant that appears relatively stable under oxidising conditions when fixed nitrogen is 
limiting (compared to other NifL variants of the same phenotype) (Figure 3.4B). It was not 
certain whether the inability of the “aerobically inactive” mutants to respond to fixed 
nitrogen under oxidising conditions was directly due to a change in the signalling state of
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Figure 3.4. Mutagenesis 
of the Eα helix in the 
PAS2 domain of NifL. 
(A) Helical wheel 
projection of the Eα 
helix with surrounding 
graphs showing NifA 
activity in the presence 
of mutant NifL proteins. 
Arrows indicate the 
appropriate graph for 
each residue in the 
helical wheel. Graph 
legends are as in Figure 
3.2. Control experiments 
measuring NifA activity 
in the absence of NifL 
and transcription from 
the reporter plasmid in 
the absence of NifA 
were performed as 
previously but omitted 
from the figure for 
simplicity. (B) Anti-NifL 
western analysis of NifL 
and NifL-L200A. Lanes 
are labelled as in Figure 
3.2.
E 
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the PAS1 domain or was indirectly caused by physiological differences between cells 
grown under conditions of differing oxygen availability. In order to discern between these 
two possibilities, experiments were performed in which the NifL-L200A protein was 
truncated to remove the redox sensing PAS1 domain (to give NifL(143-519)-L200A) or 
combined with a secondary mutation (E70A) that disrupts redox signalling by PAS1 (see 
section 1.2.3). Removal of the PAS1 domain or introduction of E70A as a secondary 
substitution restored the aerobic nitrogen response of NifL-L200A (data not shown). In 
other words, disruption of redox sensing by PAS1 allowed NifL-L200A to respond 
normally to fixed nitrogen under oxidising conditions. This demonstrates that 
perception/transmission of the redox signal by the PAS1 domain influences the 
conformation of the C-terminal domains in the NifL-L200A variant. As the L200A 
substitution is located in the PAS2 domain, this result implies that the signalling state of 
the PAS1 domain influences the C-terminal region of NifL via conformational changes in 
PAS2. 
 
3.2.3 PAS2 deletions 
 In addition to studying single amino acid substitutions in PAS2, the effect of 
removing the PAS2 domain on the ability of NifL to inhibit NifA activity was also 
investigated. Three plasmids, each encoding a variant form of the NifL protein lacking the 
PAS2 domain (NifLΔ148-270, NifLΔ146-272 and NifLΔ146-275), were constructed as 
described in section 2.6.1. The stability of these NifL variants and their ability to inhibit 
transcriptional activation by NifA in vivo were examined (Figure 3.5). Western analysis 
indicated that the mutant proteins were stable under three of the four conditions tested 
(Figure, 3.5B). However, a reduction in the stability of the NifLΔ146-272 and NifLΔ146-
275 deletions was observed under aerobic conditions when fixed nitrogen was limiting. 
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Figure 3.5. Activity and stability of PAS2 deletion mutants in vivo. (A) Influence of 
mutant NifL proteins on transcriptional activation by NifA. Assay and culture conditions 
are as described in the legend of Figure 3.2. (B) Anti-NifL western analysis of the wild-
type and mutant NifL proteins in strains grown under the same four conditions as used for 
the β-galactosidase assays. Lanes are labelled as in Figure 3.2. 
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NifLΔ148-270 appeared more stable under these conditions (Figure 3.5B). In all cases, the 
truncated proteins where unable to inhibit NifA activity in the absence of fixed nitrogen 
(Figure 3.5A, blue and red bars) but retained some ability to respond to changes in nitrogen 
status (Figure 3.5A, compare the blue and yellow bars or compare the red and green bars). 
Under nitrogen limiting conditions, NifA activity in the presence of the NifL variants was 
similar to that observed when the NifL protein was absent altogether (Figure 3.5A, blue 
and red bars). This strongly implies that, despite slight differences in protein stability under 
the relevant conditions, the PAS2 deletion mutants were not sensitive to changes in redox 
status. Moreover, significant β-galactosidase activity was evident under all conditions, 
suggesting that none of the variant NifL proteins were able to fully repress NifA activity in 
vivo. The response of the PAS2 deletion mutants to fixed nitrogen was slightly more 
efficient under anaerobic conditions than under aerobic conditions (Figure 3.5A). Overall, 
the phenotypes of the PAS2 deletion mutants resemble those of the “anaerobically 
inactive” NifL variants in that both are unable to inhibit NifA in response to oxygen and 
are impaired in their ability to respond to fixed nitrogen. Taken together, these data 
emphasise the importance of PAS2 in redox signalling and imply that the absence of the 
PAS2 domain from the NifL protein results in a conformation of the C-terminal domains 
that is not optimal for inhibition of NifA. These results also demonstrate that the NifL 
protein can sense fixed nitrogen without a functional PAS2 domain, although the efficacy 
of the response is impaired. The ability of the PAS2 deletion mutants to sense fixed 
nitrogen is not surprising given that the nitrogen response is mediated by interaction of the 
GHKL domain with GlnK whilst the reduced efficiency of the response may be 
symptomatic of an altered conformation of the C-terminal domains in the absence of 
PAS2. 
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3.3 Properties of the mutant NifL proteins in vivo 
3.3.1 “Locked-on” mutants require a functional nucleotide binding domain 
It has previously been demonstrated that NifL requires nucleotide binding to the C-
terminal GHKL domain in order to inhibit NifA activity. NifL is incompetent to bind NifA 
in vitro in the absence of nucleotide and the binding of ADP to the GHKL domain has 
been shown to stabilise the NifL-NifA binary complex (Eydmann et al., 1995; Money et 
al., 1999). Mutations in the GHKL domain that prevent binding of adenosine nucleotides 
result in the inability of NifL to inhibit NifA in vivo (Martinez-Argudo et al., 2004c; Perry 
et al., 2005). In order to indirectly assess whether the “locked-on” phenotype of the PAS2 
mutations requires nucleotide binding, “locked-on” mutants were combined with a 
secondary amino acid substitution in the GHKL domain (G480A), that has been fully 
characterised in previous studies and is known to disrupt ADP binding (Perry et al., 2005). 
Plasmid DNA encoding the L199R or V166M substitutions was cleaved at two unique 
restriction sites and transferred into a plasmid carrying G480A (pNLG480A), which had 
been digested with the same enzymes. The new double mutants (encoded on plasmids 
pPS2 and pPS124) were then assayed for their ability to inhibit NifA activity in vivo (Table 
3.1). As demonstrated previously, NifL-G480A failed to inhibit transcriptional activation 
by NifA (Table 3.1, row 4), whilst NifL-V166M and NifL-L199R constitutively inhibited 
NifA activity (Table 3.1, rows 5 and 6 respectively). When either of these PAS2 mutants 
were combined with G480A, the G480A phenotype was dominant, since the NifL-V166M, 
G480A and NifL-L199R, G480A double mutants were severely compromised in their 
ability to inhibit NifA activity under all conditions tested (Table 3.1, rows 7 and 8). 
Western analysis confirmed that all of the mutant proteins were stable under the four test 
conditions (data not shown). Overall, these results suggest that disruption of nucleotide 
binding nullifies the “locked-on” phenotype of V166M and L199R and that the
  14
0
 
 
                                  β-Galactosidase activity in Miller Units (+/- SE)   
        
                          Anaerobic                           Aerobic 
Row Plasmid Protein(s) N- N+   N- N+ 
1 - reporter only 90 (+/- 3) 37 (+/- 14)  154 (+/- 2) 30 (+/-4) 
2 pPR39 NifA 85217 (+/- 5551) 203320 (+/- 35830)  80003 (+/- 2503) 81818 (+/- 6504) 
3 pPR34 NifA, NifL 6115 (+/- 833) 97 (+/- 3)  279 (+/- 0) 51 (+/- 2) 
4 pNLG480A NifA, NifL-G480A 86563 (+/- 634) 90943 (+/- 328)  58257 (+/- 9595) 41418 (+/- 3754) 
5 pPS20 NifA, NifL-V166M 304 (+/- 2) 18 (+/- 18)  163 (+/- 7) 42 (+/- 2) 
6 pNSK2 NifA, NifL-L199R 181 (+/-0) 14 (+/- 4)  138 (+/- 8) 87 (+/- 1) 
7 pPS124 NifA, NifL-V166M, G480A 93644 (+/- 3153) 33592 (+/- 2757)  66683 (+/- 4086) 8108 (+/- 462) 
8 pPS2 NifA, NifL-L199R, G480A 33426 (+/- 4634) 20303 (+/- 66)  40315 (+/- 4372) 28531 (+/- 1517) 
 
Table 3.1. The “locked-on” phenotype of mutations in the PAS2 domain requires a functional nucleotide-binding (GHKL) domain. The data 
presented in Tables 3.1 and 3.2 are derived from at least two independent replicates.  
 
                                 β-Galactosidase activity in Miller Units (+/- SE)   
        
                          Anaerobic                           Aerobic 
Row Plasmid Protein(s) N- N+   N- N+ 
1 - reporter only 15   (+/- 0) 19   (+/- 2)  124   (+/- 15) 99 (+/- 8) 
2 pPR39 NifA 25004   (+/- 9693) 150911   (+/- 3301)  48843   (+/- 2037) 59216 (+/- 2837) 
3 pPR34 NifA, NifL 12583   (+/- 546) 28    (+/- 2)  221   (+/- 10) 93 (+/- 15) 
4 pPS54 NifA, NifL(143-519) 12423   (+/- 471) 93   (+/- 5)  7347   (+/- 286) 565 (+/- 12) 
5 pPR54 NifA, NifL(147-519) 12199 (+/- 2234) 42 (+/- 0)  6515 (+/- 46) 229 (+/- 9) 
6 pPS20 NifA, NifL-V166M 547   (+/- 24) 16   (+/- 1)  114   (+/- 24) 21 (+/- 8) 
7 pNSK2 NifA, NifL-L199R 607 (+/- 63) 18 (+/- 2)  383 (+/- 1) 179 (+/- 7) 
8 pPS77 NifA, NifL(143-519)-V166M 1166   (+/- 57) 17   (+/- 0.3)  609   (+/- 32) 47 (+/- 6) 
9 pPS4 NifA, NifL(147-519)-L199R 460 (+/- 93) 14 (+/- 1)  484 (+/- 49) 165 (+/- 2) 
 
Table 3.2. The PAS1 domain is not required for the “locked-on” phenotype of mutations in the PAS2 domain.  
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conformation of the GHKL domain is therefore important for the constitutive inhibition of 
NifA activity by the “locked-on” PAS2 mutants. This implies that the “locked-on” PAS2 
mutants are similar to the wild type in their requirement for nucleotide binding to the 
GHKL domain in order to inhibit NifA activity. In contrast, substitutions in the H domain 
of NifL that give rise to a “locked-on” phenotype exhibit a decreased requirement for 
nucleotide binding in vitro and are dominant to the G480A substitution in vivo (Martinez-
Argudo et al., 2004a). Thus, these data highlight differences between the “locked-on” 
PAS2 mutants studied in this thesis and previously identified “locked-on” mutants in other 
domains of the NifL protein. 
 
3.3.2 The PAS1 domain is not required for the “locked-on” phenotype 
As mentioned in sections 1.2.3 and 1.4.3, the PAS1 domain of NifL is required for 
the inhibition of NifA activity in response to oxygen (Söderbäck et al., 1998). In order to 
investigate whether the phenotype of the “locked-on” PAS2 mutants is influenced by the 
redox sensing PAS1 domain, the V166M and L199R substitutions were introduced to 
truncated forms of the NifL protein that lack the PAS1 domain. The various truncated NifL 
proteins and variant forms of the truncated proteins containing “locked-on” substitutions in 
the PAS2 domain were assayed for their ability to inhibit transcriptional activation by NifA 
(Table 3.2). As expected, forms of the NifL protein that lack the PAS1 domain (NifL(143-
519) and NifL(147-519)) did not inhibit NifA in response to oxygen, but responded normally to 
fixed nitrogen (Table 3.2, rows 4 and 5) and NifL-V166M and NifL-L199R inhibited NifA 
activity under all four conditions tested (Table 3.2, rows 6 and 7). However, when the 
V166M or L199R substitution was present in the truncated proteins, constitutive inhibition 
of NifA activity was retained (Table 3.2, rows 8 and 9). These data suggest that PAS1 is 
not required for inhibition of NifA by the “locked-on” PAS2 mutants. This conclusion is 
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supported by further experiments demonstrating that when the V166M substitution is 
combined with a secondary substitution in the PAS1 domain (E70A, see section 1.2.3) that 
blocks redox sensing (resulting in a form of NifL that does not inhibit NifA activity under 
oxidising conditions), the “locked-on” phenotype of the PAS2 mutant is dominant (data 
not shown). Taken together, the available information clearly shows that the “locked-on” 
phenotype of the PAS2 mutations is independent of the PAS1 domain. This does not 
eliminate the possibility that the PAS2 and PAS1 domains interact during signalling, 
rather, it indicates that the PAS2 mutants interfere with signal relay downstream of PAS1.     
 
3.4 Discussion 
In order to understand the role of the PAS2 domain of NifL in signal transduction, 
this domain was extensively mutagenised using site-directed and random approaches. All 
mutant NifL proteins were tested for their ability to inhibit NifA activity in response to 
redox and fixed nitrogen signals in vivo. The data presented in this Chapter suggest that the 
PAS2 domain can exist in at least two discrete signalling states, as exemplified by 
mutations that stabilise NifL in either the “on” (inhibitory) or the “off” (non-inhibitory) 
conformation. The “locked-on” mutations in PAS2 result in a form of NifL that is 
competent to inhibit NifA, irrespective of the redox state of the FAD co-factor in the PAS1 
domain. In contrast, the “redox signalling” mutants apparently fail to communicate the 
redox state of PAS1 to the C-terminal domains of NifL, but remain responsive to the fixed 
nitrogen signal. Two NifL variants of this class were identified, NifL-I153A and NifL-
F253L. I153 is likely to be positioned in the A’α helix of PAS2 and structural modelling of 
the PAS2 domain suggests that the F253 may point outwards from the central β-sheet. 
However, the location of these residues does not yield an obvious explanation for the 
“redox-signalling” phenotypes observed. “Redox signalling” mutations may act by 
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stabilising/mimicking the “off” conformation of the PAS2 domain or they may simply 
disrupt PAS2 function resulting in defunct relay of redox signals in NifL.  Whatever the 
mechanism, these results suggest an important role for PAS2 in redox signal relay from 
PAS1 to influence the interaction of the C-terminal domains of NifL with NifA.  
In addition to the “locked-on” and “redox signalling” mutants, a third class of 
mutation in the PAS2 domain was identified (called “aerobically inactive” mutants). These 
mutations result in impairment of the redox response and the aerobic fixed nitrogen 
response. This lends further credence to the idea that PAS2 can influence the conformation 
of the C-terminal domains of NifL in a signal dependant manner. PAS2 deletion 
experiments demonstrate that inhibition of NifA in response to redox signals requires a 
functional PAS2 domain whereas nitrogen sensing does not. Therefore, the ability of the 
GHKL domain of NifL to bind GlnK and the subsequent conformational changes in the H 
and GHKL domains that promote NifA inhibition do not strictly require the PAS2 domain. 
However, NifL variants in which the PAS2 domain is absent or is not functional (as is 
likely to be the case for the “aerobically inactive” mutants) often exhibit an impaired 
ability to inhibit NifA activity, suggesting that the PAS2 domain may stabilise the C-
terminal domains in a conformation that is optimal for inhibition of NifA.    
 Substitutions that give rise to a “locked-on” phenotype are distributed throughout 
the PAS2 domain (Figure 3.1). However, structural predictions indicate that four of the 
seven “locked-on” substitutions identified (V157A, V166M, L175A and L262A) are 
located in a dimerisation interface that includes the A’α helix and extends throughout the 
central β-sheet in many PAS domains of known structure (Figure 3.1). The V166M variant 
was obtained via random mutagenesis of PAS2 whilst the V157A, L175A and L262A 
variants were subsequently generated using the site-directed approach. V166, L175 and 
L262 correspond to residues in the conserved β-sheet interface and V157 is likely to be 
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located in the A’α helix (Figure 3.1). The “locked-on” phenotype of substitutions at these 
positions implies a connection between the quaternary structure of the PAS2 domain and 
the signalling state of NifL. Given the importance of PAS2 in transduction of the redox 
signal, it is possible that the “locked-on” variants identified here simulate the oxidised 
(inhibitory) conformer of the wild-type NifL protein, particularly as nucleotide binding to 
the GHKL domain is required for inhibition of NifA in both cases. However, the evidence 
for these hypotheses is highly speculative and a full biochemical analysis is required. Thus, 
biochemical experiments on the NifL PAS2 domain are the focus of the next chapter in this 
thesis.   
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Chapter 4 - Oligomerisation states of the PAS2 domain of NifL 
4.1 Introduction 
 At the time of writing, the structures of 36 PAS domains from prokaryotic 
organisms had been deposited in the protein data bank (PDB).  Of these, 27 form homo-
dimers in the crystal structure. PAS domains contain multiple surfaces that can mediate 
interaction between subunits and, as a result, they can pack together to form dimers in 
several different ways (Möglich et al., 2009b). Some PAS domains have even been shown 
to adopt multiple quaternary structures within a single crystal lattice (Ayers and Moffat, 
2008; Lee et al., 2008). Despite this plasticity with respect to quaternary arrangement, the 
residues that comprise the dimer interface are found in conserved structural locations in 
most PAS domains. Specifically, this dimerisation interface involves the central β-sheet, 
which can pack against either the central β-sheet of the opposite protomer or its flanking 
helices. However, a conserved patch of hydrophobic residues on the outer surface of the β-
sheet provides inter-subunit contacts in both scenarios (Möglich et al., 2009b). A common 
structural arrangement of prokaryotic PAS dimers involves the N-terminal α-helix (the A’α 
helix) that flanks the PAS core (see Chapter 1). In these structures, the N-terminal helices 
(one from each subunit) associate to form α-helical bundles and pack against the central β-
sheet of the opposing protomer (Key et al., 2007a; Key and Moffat, 2005; Kurokawa et al., 
2004; Lee et al., 2008; Ma et al., 2008; Park et al., 2004; Verger et al., 2007). In this 
quaternary arrangement, residues at conserved positions in both the A’α helix and the 
central β-sheet mediate dimerisation (Möglich et al., 2009b). As mentioned in section 3.4, 
seven substitutions were identified in the PAS2 domain of NifL that lock the protein in the 
active/inhibitory conformation. Structural predictions indicated that four of these 
substitutions are positioned in regions of the central β-sheet and the A’α helix that 
contribute to the conserved dimerisation interface discussed above. Therefore, the 
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oligomerisation state of the isolated PAS2 domain and the influence of various 
substitutions on oligomerisation were investigated. 
 
4.2 Effect of substitutions on the quaternary structure of the PAS2 domain 
4.2.1 Bacterial adenylate cyclase two-hybrid analysis of oligomerisation of the PAS2 
domain  
The bacterial adenylate cyclase two-hybrid (BACTH) system is commonly used to 
analyse interactions between proteins or protein domains. The Adenylate cyclase (AC) 
enzyme contains two discretely folded domains and the BACTH system relies on 
functional complementation between AC subunits expressed in trans (in an AC deficient 
E. coli reporter strain). Each subunit is transcriptionally fused to a protein of interest to 
create two hybrid proteins. Interaction between the proteins of interest results in co-
localisation of the AC subunits, enabling functional complementation. Thus, protein-
protein interactions result in a substantial increase in AC activity (Karimova et al., 1998; 
Karimova et al., 2000). The AC enzyme catalyses the conversion of ATP to cAMP. 
Production of the second messenger, cAMP, triggers transcription of various reporter 
genes, including lacZ. This enables detection of protein-protein interactions via assays of 
β-galactosidase activity. 
The BACTH system was used to investigate interactions between subunits of the 
isolated PAS2 domain of NifL (Figure 4.1). A strong interaction was detected between 
subunits of the wild-type PAS2 domain (Figure 4.1, bars marked “WT”), suggesting that 
the domain is multimeric. This interaction was perturbed in variant forms of the PAS2 
domain containing “locked-on” substitutions; each of the seven “locked-on” substitutions 
indentified by the mutagenic studies described in Chapter 3 was tested and, in every case, 
the interaction between PAS2 protomers was impaired (Figure 4.1, compare  
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Figure 4.1. Bacterial adenylate cyclase two-hybrid (BACTH) analysis of PAS2 
oligomerisation. Hybrid proteins containing the T18 or T25 subunit of adenylate cyclase 
fused to the NifL PAS2 domain (NifL(147-284)) or variants of the PAS2 domain were 
constructed and expressed as described in sections 2.6.2 and 2.9.2. Data for each NifL 
variant is shown as a block of 3 bars; the blue bars represent interactions between fusion 
proteins while the green and black bars are controls in which the T18-PAS2 fusion protein 
is expressed with the T25 subunit only (green bars) or the T25-PAS2 fusion protein is 
expressed with the T18 subunit only (black bars). Graphs show an average of at least two 
replicates and error bars indicate the standard error of the mean. 
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blue bars marked “WT” with those marked “V157A”, “V166M”, “L175A”, “N177S”, 
“L199R”, “R240W” and “L262A”). By contrast, variant forms of the PAS2 domain 
containing the “redox signalling” substitutions (I153A and F253L) were competent to 
maintain the interaction. Overall, this data demonstrates a correlation between the “locked-
on” phenotype and perturbation of the interaction between PAS2 subunits, suggesting that 
the “locked-on” substitutions may influence NifL activity by disrupting oligomerisation of 
the PAS2 domain.        
 
4.2.2 Biochemical analysis of oligomerisation of the PAS2 domain 
 In order to conduct biochemical investigations into the oligomeric state of the 
PAS2 domain, protein preparations of high purity and concentration were needed. To this 
end, a DNA fragment encoding NifL residues 143 - 284 (or its mutant derivatives) was 
cloned into the plasmid pETM11 to create a hexahistidine tagged PAS2 fusion protein for 
overexpression using the pET expression system. This system utilises the evolved ability 
of T7 bacteriophage to produce high levels of viral protein in host cells and requires E. coli 
strains such as BL21 (DE3) which contain a chromosomal copy of the gene for T7 RNA 
polymerase. The presence of a lac operator site upstream of the T7 promoter (and on the 
pET plasmids) allows IPTG (or lactose) inducible expression of target genes (Studier et al., 
1990). The His-tagged PAS2 domain was overexpressed and purified by nickel affinity 
chromatography (see section 2.7). Two variants were selected from each phenotypic class 
(i.e. two “locked-on” variants and two “redox signalling” variants) and the oligomeric state 
of the wild-type and variant proteins was analysed using size exclusion chromatography, 
dynamic light scattering, chemical cross-linking and analytical ultracentrifugation. 
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(i) Size exclusion chromatography 
 Size exclusion chromatography (SEC) is a technique commonly used to separate 
macromolecules on the basis of their hydrodynamic volume. Briefly, the molecules are 
passed through a column containing a porous matrix. Smaller molecules can penetrate the 
pores whilst larger molecules cannot. Thus, the smaller molecules are exposed to a greater 
percentage of the total column volume (i.e. they take a longer route through the matrix) 
than the larger molecules. As a result, elution of the macromolecules from the column is 
dependent on their size (and shape). This enables analysis of the molecular weight and 
oligomeric state of a purified protein sample via comparison with protein standards of 
known molecular weight.         
 Size exclusion chromatography was used to analyse the oligomeric state of the 
PAS2 domain and its mutants (Figure 4.2). When loaded onto the column at various 
concentrations, the wild-type PAS2 domain eluted in a single peak with an apparent 
molecular mass somewhat lower than that predicted for a spherical dimeric species (38.56 
kDa). Retention volumes were clearly concentration dependent within the range 26 - 519 
µM (Figure 4.2A, chromatogram marked “WT”) with apparent molecular weights ranging 
from 32.3 kDa to 37.2 kDa (Table 4.1). The concentration dependence of the elution 
profile suggests rapid inter-conversion between the monomeric and dimeric forms during 
the timescale of chromatography. Variant PAS2 domains containing the F253L 
substitution, which gives rise to a “redox signalling” phenotype in the full-length protein, 
also eluted in a concentration dependent manner (Figure 4.2A, chromatogram marked 
“F253L”). However, the elution volumes and apparent molecular weights observed where 
shifted slightly (relative to wild-type PAS2) towards the value expected for a dimer. The 
apparent molecular weight of samples injected at concentrations of 26 - 519 µM ranged  
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Figure 4.2. Analysis of PAS2 dimerisation by size exclusion chromatography. (A) 
Calibration and elution profiles for the wild-type PAS2 domain (chromatogram labelled 
“WT”) and the “redox signalling” variants PAS2-I153A (chromatogram labelled “I153A”) 
and PAS2-F253L (chromatogram labelled “F253L”) when injected at five different 
concentrations as indicated in the legend. (B) Calibration and elution profiles of the wild-
type PAS2 domain (black line on the chromatogram) and the “locked-on” variants PAS2-
V166M (blue line) and PAS2-L175A (red line) injected at a concentration of 104μM. The 
elution volumes and apparent molecular weights of all species in this figure are tabulated 
in Table 4.1. 
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Experiment Protein & concentration 
Elution 
Volume (ml) 
Apparent Mw 
(kDa) 
A WT 26 μM 13.68 32.3 
  WT 52 μM 13.58 34.2 
  WT 130 μM 13.56 34.7 
  WT 259 μM 13.55 34.9 
  WT 519 μM 13.44 37.2 
B I153A 26 μM 13.41 37.7 
  I153A 52 μM 13.33 39.6 
  I153A 130 μM 13.33 39.6 
  I153A 259 μM 13.36 39.1 
  I153A 519 μM 13.33 39.6 
C F253L 26 μM 13.56 34.7 
  F253L 52 μM 13.5 35.8 
  F253L 130 μM 13.44 37.2 
  F253L 259 μM 13.42 37.6 
  F253L 519 μM 13.38 38.6 
D
a
 WT 104 μM 13.30 33.4 
  WT 519 μM 13.18 39.3 
  L175A 104 μM 13.84 23.9 
  L175A 519 μM 13.58 31.0 
  V166M 104 μM (major peak) 13.90 23.1 
 
V166M 104 μM (minor peak) 12.83 48.5 
 
a 
Note that the data shown in part D were obtained separately and using a different calibration to that shown 
in the other sections. 
 
Table 4.1. Size exclusion chromatography of the NifL PAS2 domain (NifL(143-284)) and 
variant PAS2 domains.  
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from 34.7 kDa to 38.6 kDa, compared to the spread of 32.3 kDa to 37.2 kDa observed for 
the wild-type PAS2 domain (Table 4.1, compare experiments A and C). However, this  
relatively small difference may not be significant given the resolution of SEC; the data 
may reflect a small change in shape caused by the F253L substitution rather then altered 
stability of the PAS2 dimer. The second “redox signalling” variant tested, PAS2-I153A, 
also eluted as a dimer on gel filtration (Figure 4.2A, chromatogram marked “I153A”), but 
the profile was less concentration dependent than the wild-type PAS2 domain and above 
26 µM, the retention volume remained constant with an apparent molecular weight of 39.6 
kDa (Table 4.1, experiment B). This suggests that the I153A substitution may shift the 
monomer-dimer equilibrium towards the dimeric state. 
In contrast to the behaviour of wild-type PAS2 and the “redox signalling” mutants, 
the variant form of the PAS2 domain containing the L175A substitution, which gives rise 
to a “locked-on” phenotype in the full-length protein, eluted with an apparent molecular 
weight of 23.9 kDa (when injected at 104 μM), similar to that expected for a monomer 
(Figure 4.2B, red line). The wild-type PAS2 domain eluted as a species of 33.4 kDa when 
injected at the same concentration (Table 4.1, experiment D and Figure 4.2B, black line). 
The elution profile of PAS2-L175A was concentration dependent but did not approach that 
of the dimeric form when injected at a higher concentration. The apparent molecular 
weight of PAS2-L175A shifted from 23.9 kDa when injected at 104 μM to 31 kDa when 
injected at 519 μM, compared to a shift from 33.4 kDa to 39.3 kDa for the wild-type 
domain when injected at the same concentrations (Table 4.1, experiment D). The second 
“locked-on” variant tested, PAS2-V166M, sieved as a mixture of two oligomeric species of 
23.1 kDa and 48.5 kDa (Figure 4.2B, blue line), which are likely to represent the 
monomeric and dimeric forms respectively of the variant PAS2 domain. Overall, these data 
suggest that the monomer-dimer equilibrium is shifted towards the monomeric state in the 
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“locked-on” variants, consistent with the observation that the subunits of these mutant 
PAS2 domains fail to interact in the bacterial two-hybrid system.  
 
(ii) Dynamic light scattering 
 Dynamic light scattering (DLS), also known as photon correlation spectroscopy, is 
often used to analyse the homogeneity and the approximate size of macromolecules in 
solution. This technique involves shining a beam of polarised light through a sample 
solution and measuring scattering of the light upon collision with the solute. The solute 
particles are in Brownian motion and the speed of Brownian motion is dependent on the 
size of the particles (larger particles move more slowly than smaller ones). Scattering of 
the monochromatic light upon contact with the dissolved macromolecules (which are 
assumed to be spherical) is dependent on the speed of Brownian motion and thus DLS can 
be used to approximate the hydrodynamic radius, molecular weight and size distribution of 
the macromolecules.         
 DLS was used to investigate oligomerisation of the NifL PAS2 domain and its 
mutants (Figure 4.3). The DLS analysis demonstrated a high level of purity in all protein 
samples as a single species contributed 98.9 - 99.9% of the total mass of each sample 
(Figure 4.3, inset). Analysis of the wild-type PAS2 domain at a concentration of 104 μM 
indicated a single species with a hydrodynamic radius of 2.8 nm, which corresponds to a 
molecular weight of approximately 37 kDa, accounting for 99.8% of the sample mass. This 
species is likely to represent the PAS2 dimer. Variant forms of the PAS2 domain 
containing the “redox signalling” substitutions I153A and F253L appeared fully dimeric at 
the same concentration, with 99.9% of the sample mass forming a single species in both 
cases (Figure 4.3, inset). PAS2-I153A and PAS2-F253L had hydrodynamic radii of 3.3 nm 
and 3.1 nm respectively. Given that both the “redox signalling” variants and the wild-type  
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Figure 4.3. Dynamic light scattering of the NifL PAS2 domain and selected PAS2 
variants. Graphs show the percentage mass of the sample (%Mass) on the y-axis versus the 
hydrodynamic radius (R) on the x-axis. Data is given for the wild-type PAS2 domain 
(labelled “WT”), the “locked-on” variants L175A and V166M and the “redox signalling” 
variants I153A and F253L. All protein samples were analysed as described in section 2.7.7 
at a concentration of 104 μM. Data for the major peak in each sample is tabulated in the 
inset (%Pd = % polydiversity and MW-R = molecular weight). 
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domain appeared to be fully dimeric at the concentration tested, the increased 
hydrodynamic radius of the variant domains may indicate a less compact conformation.  
The “locked-on” variants PAS2-L175A and PAS2-V166M both exhibited a reduced 
hydrodynamic radius and molecular weight compared to the wild-type domain (Figure 4.3, 
inset). Approximately 98.9% of the total mass of the PAS2-L175A sample formed a 
species with a hydrodynamic radius of 2.3 nm and a molecular weight of 24 kDa. Data for 
PAS2-V166M indicated that 99.7% of the sample mass was consistent with spherical 
particles with a radius of 1.9 nm and a molecular weight of roughly 15 kDa. These results 
suggest that, at a concentration of 104 μM, the L175A and V166M substitutions both cause 
an almost complete dissociation of PAS2 subunits. Overall, the DLS data concur with 
results obtained from the SEC and BACTH analyses.  
 
 (iii) Chemical cross-linking 
 Chemical cross-linking involves the use of a chemical reagent to covalently link 
two or more macromolecules. This process has many biological applications including the 
fixation of biological samples and the study of protein-protein or protein-DNA 
interactions. There are many chemical reagents (known as cross-linking reagents) available 
for covalent linkage of biological molecules and these reagents can have differing 
specificities and modes of action. Commonly used cross-linking reagents include 
formaldehyde, which is able to form protein-protein and protein-nucleic acid cross-links, 
and glutaraldehyde, which efficiently cross-links amine groups (Baumert and Fasold, 
1989). In addition to its application in the study of interactions between macromolecules 
and complex formation, chemical cross-linking can also be used to investigate 
oligomerisation and protomer interactions in multi-subunit proteins. Purified protein 
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samples can be exposed to a cross-linking reagent and the formation of covalent links 
between subunits can be determined. 
To investigate the subunit stoichiometry of the isolated PAS2 domain and its 
variants, protein samples were chemically cross-linked with glutaraldehyde as described in 
section 2.7.8 and the products were analysed by SDS-PAGE (Figure 4.4). The amount of 
protein in each band was quantified by densitometry and the relative amounts of monomer 
and dimer were calculated as a percentage of the total protein in each lane. These 
experiments indicated that the isolated PAS2 domain and all the variants tested can be 
cross-linked in the dimeric form (Figure 4.4). No cross-linked species corresponding to 
higher order oligomers could be detected by SDS-PAGE. It was evident from the 
appearance of duplicate bands upon addition of the cross-linking reagent that, in addition 
to the inter-molecular cross-links, glutaraldehyde was also catalysing the formation of 
intra-molecular cross-links. However, for the purposes of quantitation, the protein densities 
of these duplicate bands were pooled to give the total density of protein in either the 
monomeric or dimeric state. The “locked-on” PAS2 variants exhibited a reduction in the 
percentage of cross-linked protein, suggesting a shift in the monomer-dimer equilibrium 
towards the monomeric form. The V166M and L175A substitutions caused a reduction in 
the percentage of the cross-linked (dimeric) species from 64% in the wild type to 33% and 
40% respectively in the “locked-on” variants (Figure 4.4, compare lanes marked “WT”, 
“V166M” and “L175A”). The PAS2-I153A variant showed increased cross-linking (78% 
cross-linked) relative to the wild-type domain, implying that this substitution may shift the 
equilibrium towards the dimeric state. However, the F253L variant did not differ greatly 
from the wild-type domain (60% of the total protein was cross-linked). This difference 
between the I153A and F253L substitutions, in terms of their influence on PAS2  
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Figure 4.4. Chemical cross-linking of the PAS2 domain (NifL(143-284)) and the V166M, 
L175A, I153A and F253L variant domains. Protein samples (52 μM, based on a monomer) 
were cross-linked with glutaraldehyde as described in Chapter 2.7.8 and analysed by SDS-
PAGE. Lanes are grouped into pairs whereby the cross-linking reactions (even numbered 
lanes) are shown adjacent to controls where glutaraldehyde was absent from the reaction 
mixture (odd numbered lanes). Each band was quantified using SynGene densitometry 
software. For each reaction the amount of dimeric (cross-linked) protein is shown as a 
percentage of the total protein in the lane. 
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dimerisation, conforms to the trends identified by SEC. Overall, the results from the 
chemical cross-linking experiments are in concurrence with results from SEC, DLS and 
BACTH analysis; the data obtained using all of these techniques indicate that the “locked-
on” variants disrupt PAS2 dimerisation while the “redox signalling” variants do not. 
 
(iv) Analytical ultracentrifugation  
 Analytical ultracentrifugation (AUC) is a technique commonly used to analyse the 
molecular mass (and thus the association state) of macromolecules in solution. The 
analytical ultracentrifuge contains an optical detection system that allows the user to 
observe the distribution of sample concentration over time, upon application of a 
centrifugal force. The migration of macromolecules through the centrifugal field is 
proportional to their molecular mass and AUC is broadly considered to be the “gold 
standard” for molecular weight determination. The experiments performed using the 
analytical ultracentrifuge fall into two categories: sedimentation velocity and 
sedimentation equilibrium experiments. Sedimentation velocity experiments involve the 
application of a large centrifugal force, sufficient to generate relatively rapid sedimentation 
of the sample. The rate at which this sedimenting “band” of solute moves through the cell 
can be measured and used to determine the sedimentation co-efficient of the sample. The 
sedimentation co-efficient provides information regarding the mass and shape of 
macromolecules in solution. Sedimentation equilibrium experiments require the 
application of a slightly weaker centrifugal force. In these experiments, sedimentation of 
the sample results in increasing solute concentration towards the bottom of the cell but 
sedimentation is antagonised by the force of diffusion “pushing” against the concentration 
gradient. When the system reaches equilibrium, there is no net movement of the sample 
over time (i.e. the solute distribution is constant), and these opposing forces are balanced. 
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Spectroscopic determination of the sample concentration at different points in the 
equilibrated cell enable precise determination of the molecular weight and, if applicable, 
the change in molecular weight as a function of solute concentration. Thus, AUC is a 
valuable tool for analysing the kinetics of subunit association in multimeric proteins and 
protein complexes. 
AUC was used to investigate the dynamic equilibrium between the monomeric and 
dimeric forms of the NifL PAS2 domain (Figure 4.5). Sedimentation equilibrium profiles 
of PAS2 indicated that the solution molecular mass varied between 24 kDa and 35 kDa 
over a concentration range of 10 - 100 μM.  In contrast, equilibrium profiles of PAS2-
L175A showed a variation of 22 - 28 kDa over a concentration range of 7 - 70 μM.  
Plotting the sedimentation equilibrium profiles in terms of log absorbance versus radius
2
/2 
is expected to give a straight line, where the gradient of the line is proportional to the 
molecular mass of the protein in solution (Horan et al., 1995). The difference in apparent 
molecular mass of the two forms can be observed in Figure 4.5, where the larger gradient 
of the data corresponding to the wild-type protein demonstrates a shift towards the dimeric 
species at the higher protein concentration (Figure 4.5A, triangles), in contrast to the 
predominance of the monomeric form at the lower protein concentration (Figure 4.5B, 
triangles). The sedimentation data for each species fitted best to a monomer-dimer model 
with a dissociation constant (Kd) of 34 μM for the wild type, and 120 μM for the L175A 
variant. Thus, substitution of L175 for alanine results in a 3.5-fold reduction in the affinity 
between PAS2 subunits. This reflects the difference between the L175A variant and wild-
type forms of the PAS2 domain observed in the BACTH, SEC, DLS and chemical cross-
linking experiments. It is noteworthy that the dissociation constants derived from the AUC 
analysis correlate quite precisely with the results from DLS; at the protein concentration of 
104 μM used in the DLS experiments we would expect the wild-type PAS2 domain to be  
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Figure 4.5. Analytical ultracentrifugation analysis of the NifL PAS2 domain. 
Sedimentation equilibrium profiles of the wild-type PAS2 domain (triangles) and the 
“locked-on” variant PAS2-L175A (circles) at a rotor speed of 23,000 rpm. Lower panels: 
(A) 100 μM PAS2 and 70 μM PAS2-L175A measured at 275 nm. (B) 10 μM PAS2 and 7 
μM PAS2-L175A measured at 230 nm. The lines represent a fit to both data sets for each 
sample using a 20 kDa monomer-dimer equilibrium model and Kd values of 34 and 
120 μM for the wild type domain and L175A variant respectively. Upper panels: residual 
absorbance between the experimental data and the fitted lines. This Figure was kindly 
provided by Dr. Thomas A. Clarke, UEA.  
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predominantly dimeric and the L175A variant to be predominantly monomeric based on 
dissociation constants of 34 μM and 120 μM respectively. The congruence between these 
techniques, in combination with results form BACTH, SEC and chemical cross-linking 
experiments, strongly supports the assertion that the “locked-on” PAS2 substitutions act by 
disrupting dimerisation of the PAS2 domain.               
 
4.3 Substitutions in the PAS2 domain do not influence the overall oligomerisation 
state of NifL  
 Given that the “locked-on” substitutions apparently alter the quaternary structure of 
the isolated PAS2 domain, it was questioned whether these substitutions influence 
oligomerisation of the full length NifL protein. In other words, it is important to establish 
whether the PAS2 domain is an oligomerisation determinant of NifL or whether the 
oligomerisation state of this domain is important for relaying structural signals between 
domains. Assessing this experimentally is complicated by the presence of two additional 
oligomerisation interfaces in the NifL protein, since the PAS1 and H domains both contain 
dimerisation surfaces. The crystal structure of the NifL PAS1 domain indicates that this 
domain is dimeric (Key et al., 2007a) and the H domain is predicted to form a coiled-coil 
structure homologous to the dimerisation interface of the histidine protein kinases (Little et 
al., 2007). Therefore, the oligomeric states of the “locked-on” PAS2 variants were 
analysed in the context of the full length NifL protein as well as various truncated forms of 
the protein containing different domain combinations. SEC and BACTH analysis were 
used to investigate the influence of “locked-on” substitutions on the oligomerisation of 
these constructs.  
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Figure 4.6. Domain architectures of the three NifL constructs for SEC analysis.   
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4.3.1 Chromatographic analysis of NifL domain combinations 
 SEC was used to analyse the oligomeric state of three different NifL domain 
combinations: (i) constructs containing only the two N-terminal PAS domains (lacking the  
H and GHKL domains), (ii) constructs containing the PAS2, H and GHKL domains 
(lacking the PAS1 domain) and (iii) the full length NifL protein (the domain architectures 
of each of these constructs are illustrated in Figure 4.6). For each domain combination, the 
behaviour of the “locked-on” variant V166M on SEC was compared to that of the wild-
type protein (Table 4.2). The V166M substitution had no effect on oligomerisation in any 
of the constructs tested. The full length proteins, NifL and NifL-V166M, both eluted as 
trimers with apparent molecular weights of 197.7 kDa and 196.7 kDa respectively (Table 
4.2, rows 1 and 2). Similarly, when only the PAS2, H and GHKL domains were present 
(i.e. when the dimerisation interface in the PAS1 domain was absent), the V166M 
substitution did not influence oligomerisation; the behaviour of NifL(143-519) and  NifL(143-
519)-V166M on SEC were consistent with spherical particles of 108.1 kDa and 110.4 kDa 
respectively (Table 4.2, rows 3 and 4). These molecular weights are closer to that predicted 
for a dimer (90.6 kDa on the basis of sequence) then to that predicted for a trimer (135.9 
kDa). NifL(1-284), which contains only the two N-terminal PAS domains (also referred to as 
the “PAS1-PAS2 fragment”) and lacks the predicted dimerisation interface present in the H 
domain, eluted as a trimer with an apparent molecular mass of 96.3 kDa (Table 4.2, row 5). 
The variant proteins NifL(1-284)-I153A (which belongs to the “redox signalling” class of 
mutants) and NifL(1-284)-V166M (“locked-on” class) also sieved as trimers with apparent 
molecular masses of 92.5 kDa and 92.8 kDa respectively (Table 4.2, rows 6 and 7). Thus, 
the presence of the “locked-on” V166M substitution does not appear to influence 
oligomerisation of the PAS1-PAS2 fragment of NifL. Although most of the constructs 
tested appear trimeric, the true association state is likely to be dimer or tetramer 
  16
4
 
 
 
 
 
 
 
 
Table 4.2. Size exclusion chromatography of NifL domain combinations. 
 
Protein Construct Domains Present Apparent Mw (kDa) Expected Monomeric Mw (kDa) Apparent Oligomerisation state 
NifL PAS1, PAS2, H, GHKL 197.7 61.1 Trimer 
NifL-V166M PAS1, PAS2, H, GHKL 196.7 61.1 Trimer 
NifL(143-519) PAS2, H, GHKL 108.1 45.3 Dimer 
NifL(143-519)-V166M PAS2, H, GHKL 110.4 45.3 Dimer 
NifL(1-284) PAS1, PAS2 96.3 35.0 Trimer 
NifL(1-284)-V166M PAS1, PAS2 92.5 35.0 Trimer 
NifL(1-284)-I153A PAS1, PAS2 92.8 35.0 Trimer 
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(Söderbäck et al., 1998) and elution of this these proteins from the SEC column may be 
aberrant, since sedimentation velocity experiments on the PAS1-PAS2 fragment suggest 
that this protein is dimeric, irrespective of its redox state (Little and Dixon, unpublished 
data). Overall, the SEC experiments clearly demonstrate that in the presence of either the 
PAS1 dimerisation surface or the predicted interface in the H domain (or a combination of 
both), substitutions that disrupt dimerisation of the isolated PAS2 domain no longer 
influence the association state. That is, the PAS2 dimerisation interface, which is 
apparently disrupted by the “locked-on” substitutions, is not important for oligomerisation 
in the full length NifL protein. 
 
4.3.2 BACTH analysis of oligomerisation of the PAS1-PAS2 fragment 
  In order to corroborate the results obtained by SEC analysis of the PAS1-PAS2 
fragment, a second independent technique was used to analyse oligomerisation of the 
tandem PAS domains. Using the bacterial two-hybrid system, self-association of the 
isolated PAS1 and PAS2 domains was detected as anticipated (Figure 4.7, bars marked 
“PAS1” and “PAS2”). Oligomerisation of the longer construct in which both domains are 
present in tandem was also detectable (Figure 4.7, bars marked “PAS1, PAS2”). As shown 
previously (in section 4.2.1), the “locked-on” substitutions V157A and V166M disrupt 
oligomerisation of the isolated PAS2 domain (Figure 4.7, bars marked “PAS2”, “PAS2-
V157A” and “PAS2-V166M”). However, when the PAS1 domain was also present, the 
effect of these substitutions on oligomerisation was nullified and the variant proteins 
showed the same level of interaction as the wild-type PAS1-PAS2 fragment (Figure 4.7, 
compare bars marked “PAS1, PAS2”, “PAS1, PAS2-V157A” and “PAS1, PAS2-
V166M”). This demonstrates that the dimerisation interface present in PAS1 (Ayers and 
Moffat, 2008; Key et al., 2007a) is sufficient to maintain oligomerisation of the PAS1- 
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Figure 4.7. BACTH analysis of the influence of substitutions in the PAS2 domain on 
oligomerisation of the PAS1-PAS2 fragment of NifL. Hybrid proteins containing the PAS1 
(NifL(1-146)), PAS2 (NifL(147-284)) and PAS1-PAS2 (NifL(1-284)) fragments of NifL fused to 
either subunit of adenylate cyclase were constructed and expressed as described in Chapter 
2. The graph legend is as in Figure 4.1.  
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PAS2 construct when PAS2 dimerisation is impaired. The BACTH analysis was performed 
under oxygen-limiting conditions in vivo, unlike the SEC experiments, which were carried 
out under aerobic conditions. As the PAS1 domain was sufficient to maintain 
oligomerisation of the PAS1-PAS2 fragment in both experiments, it appears that the 
association state of this protein is maintained irrespective of redox status (and regardless of 
the integrity of the PAS2 dimerisation interface). The PAS2 dimerisation interface, 
therefore, is not important in maintaining the oligomeric state of NifL but instead seems to 
function in intra-molecular signal transduction. 
 
4.4 Discussion 
 Taken together, data from BACTH, SEC, DLS, chemical cross-linking and AUC 
experiments indicate that the isolated PAS2 domain and variant forms of this domain 
containing “redox signalling” substitutions are dimeric in solution. The data presented in 
this chapter demonstrate that substitutions in the PAS2 domain that give rise to a “locked-
on” phenotype in the full length NifL protein disrupt dimerisation of the isolated PAS2 
domain. In other words, when dimerisation of the PAS2 domain is impaired NifL is 
apparently locked in the inhibitory conformer. This implies that the PAS2 domain is 
dimeric when NifL adopts the non-inhibitory (or “off”) conformer and monomeric when 
NifL is in the inhibitory (or “on”) conformation.  
Figure 4.8 shows the positions of all substitutions identified in Chapter 3 on a 
structural model of the NifL PAS2 domain. The model presented in Figure 4.8 is based on 
the NifL PAS1 domain (2GJ3) but similar results were obtained using the several other 
PAS structures as templates for modelling. Residues I153 and F253, which give rise to a 
“redox signalling” phenotype when substituted for alanine and leucine respectively, are 
located on opposite ends of the molecule. The position of these residues does not provide  
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Figure 4.8. Structural model of the dimeric NifL PAS2 domain. The ribbon diagram shows 
the NifL PAS2 domain modelled on the NifL PAS1 domain. Similar results can be 
obtained by modelling on other PAS structures (e.g. EcDOS PASA). Subunits are coloured 
blue and yellow and amino acids substituted in Chapter 3 are shown as sticks on the yellow 
subunit; residues that give rise to a “locked-on” phenotype when substituted are coloured 
red and residues that give rise to a “redox signalling” phenotype when substituted are 
coloured cyan. Note that all “locked-on” substitutions apart from L199 cluster around the 
putative dimerisation interface. 
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an obvious explanation of their phenotype. However, SEC and chemical cross-linking 
analyses suggest that the I153A substitution may stabilise dimerisation of the isolated 
PAS2 domain and the close proximity of this residue to the putative dimerisation interface 
in the structural model of the PAS2 domain is consistent with this experimental evidence. 
F253 is oriented outward from the globular domain and is located in a loop connecting two 
β-strands in the central β-sheet (Hβ and Iβ). It is possible that this residue forms a contact 
between PAS2 and another domain of NifL, especially given that SEC and chemical cross-
linking experiments indicate that the F253L substitution does not significantly influence 
dimerisation of the isolated PAS2 domain. That is, F253 may be involved in inter-domain 
communication in NifL. As mentioned in section 3.4, structural predictions indicate that at 
least four of the seven “locked-on” substitutions identified are positioned in a dimerisation 
interface that is conserved in many PAS domains and are therefore likely to directly disrupt 
interaction between PAS2 protomers (Figure 4.8). One of the remaining three “locked-on” 
substitutions (N177S), whilst not located in this conserved interface, is positioned close to 
it and is likely to directly influence the stability of the PAS2 dimer. By contrast, one of the 
remaining two “locked-on” substitutions, L199R, is distal to the putative dimerisation 
interface and is therefore unlikely to disrupt subunit interactions directly (Figure 4.8) (the 
position of the other substitution, R240W, cannot be predicted with a high level of 
confidence). Despite this, the L199R substitution impairs the interaction between PAS2 
subunits as measured by the BACTH system. These seemingly contradictory data can be 
reconciled if we hypothesise that a global change in conformation accompanies switching 
of the PAS2 domain from the dimeric “off” state to the monomeric “on” state. According 
to this scenario, amino acid changes at positions that are remote to the dimerisation 
interface (such as L199 and possibly R240) could favour the “on” conformation and 
thereby influence the interaction between PAS2 subunits. Tenuous support for this 
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assertion can be derived from the BACTH data; in contrast to the other “locked-on” 
substitutions which completely eliminate interaction between subunits of the PAS2 
domain, L199R exhibits a low level of interaction (Figure 4.1). These results are consistent 
with (but do not demonstrate) an indirect influence of the L199R substitution on PAS2 
oligomerisation compared to a direct effect exerted by the other substitutions. Whatever 
the mechanism, it is clear that changes in the quaternary structure of the PAS2 domain are 
important for signal transduction in NifL. 
 Further SEC and BACTH experiments demonstrate that, despite its importance in 
signalling, the PAS2 dimerisation interface is not an oligomerisation determinant for the 
full length NifL protein. Hence, changes in the association state of the PAS2 domain do 
not control the assembly of NifL subunits but instead facilitate switching between 
alternative quaternary arrangements. As these alternative arrangements represent the 
inhibitory and non-inhibitory signalling states, it is likely that switching between them is 
responsive to environmental cues. Given that the PAS2 domain itself does not appear to 
have a role in sensing, we may speculate that the signalling state of the PAS2 domain (and 
thus its association state) is responsive to signal perception by other domains. Taken 
together, the above postulation and the importance of the PAS2 domain in relaying redox 
signals from the PAS1 domain to the C-terminal domains of NifL (see Chapter 3) imply 
that PAS2 may be sensitive to signal perception by PAS1. To investigate this possibility 
further it is necessary to probe the signal dependent conformational changes that occur in 
the N-terminal domains of NifL and investigate the influence of substitutions in the PAS2 
domain on these changes. These issues are the focus of the next Chapter of this thesis. 
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Chapter 5 - Redox signal relay between the NifL PAS domains 
5.1 Introduction 
 The data presented in the previous two Chapters imply that the PAS2 domain of 
NifL undergoes a change in quaternary structure in response to the perception of redox 
signals by the PAS1 domain. That is, the signalling state of the PAS1 domain appears to be 
communicated to the PAS2 domain, resulting in the movement of PAS2 subunits relative 
to one another. It appears that the “locked-on” substitutions in the PAS2 domain lock the 
NifL protein in the oxidised conformer by impairing PAS2 dimerisation. In order to verify 
these hypotheses, it is necessary to examine the influence of redox signals on the 
quaternary structure of the PAS2 domain in NifL constructs in which the PAS1 domain is 
also present. As the association state of the PAS1 domain remains constant irrespective of 
redox conditions, it is not possible to achieve this by studying changes in oligomerisation. 
Therefore, it was necessary to assess the quaternary structure of the PAS2 domain 
indirectly, via analysis of the redox dependent conformational changes that occur in NifL 
and the influence of substitutions in PAS2 on these changes. Several experimental 
techniques were employed to this end, including limited proteolysis, BACTH analysis and 
cysteine cross-linking. Further, the inter-domain region linking the NifL PAS domains was 
mutagenised in order to investigate the transmission of redox signals between PAS1 and 
PAS2. Probing conformational changes in NifL also enables comparison between the 
oxidised wild-type protein and the “locked-on” variant proteins. Thus, such experiments 
can provide evidence to support or counter the assertion that the “locked-on” substitutions 
in the PAS2 domain lock NifL in the oxidised conformation.  
 
5.2 Analysis of conformational changes in NifL using limited proteolysis 
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Limited proteolysis is a technique commonly used to examine conformational 
change in proteins. When a protein is exposed to a small amount of peptidase, the pattern 
and rate of proteolytic digestion depend upon the accessibility of the various cleavage sites 
within the protein. Hence, changes in the conformation of a protein will alter the rate and 
pattern of its digestion (also known as its proteolytic footprint). Peptidases such as trypsin 
and chymotrypsin are routinely used for proteolytic footprinting to probe conformational 
changes in proteins.        
 
5.2.1 Redox dependent conformational changes in the N-terminal PAS domains of 
NifL 
The analysis of the variant proteins and domains presented thus far suggests that a 
large conformational change, involving a shift in the quaternary structure of the PAS2 
domain, accompanies redox signal transduction in NifL. It was desirable to investigate this 
conformational change in a wild-type context and check for congruence with the findings 
obtained using variant proteins. To this end, limited chymotrypsin proteolysis was used to 
analyse the conformation of the PAS1-PAS2 fragment of NifL (Figure 4.6, NifL(1-284)) and 
its variants under oxidising and reducing conditions in vitro (Figure 5.1A). These 
experiments were carried out under anaerobic conditions in a glove box using sodium 
dithionite to reduce the FAD co-factor in PAS1 (Hill et al., 1996) where appropriate (see 
section 2.7.12). Protein samples were incubated with chymotrypsin for time periods of 0, 2, 
5 and 10 minutes and the progress of the proteolysis reaction at each time point was 
analysed by SDS-PAGE (Figure 5.1A). When the FAD co-factor was reduced with sodium 
dithionite, the wild-type protein fragment, NifL(1-284) , showed a similar rate and pattern of 
digestion to the “redox  signalling” variant, NifL(1-284)-I153A (Figure 5.1A, compare panels 
A and B). In both cases the undigested protein (indicated by arrows to the right of each  
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Figure 5.1. Limited chymotrypsin proteolysis and spectroscopic analysis of the PAS1-
PAS2 fragment of NifL. (A) NifL(1-284) and two variants were digested with chymotrypsin 
under oxidising conditions and after reduction with dithionite as described in section 
2.7.12. The progress of the proteolysis reaction after 0, 2, 5 and 10 minutes (Lanes 1, 2, 3 
and 4 respectively) was analysed by SDS-PAGE. Arrows indicate the uncleaved protein 
and empty arrow-heads mark putative cleavage products. Data shown is representative of 
at least three independent replicates. (B) Spectroscopic analysis of NifL fragments before 
and after reduction. The spectroscopic data were used to calculate the FAD concentration 
and thus the FAD incorporation for each sample (as described in section 2.7.11) and the 
results are tabulated in part C.   
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panel in Figure 5.1A) persisted after a 5 minute incubation with protease (Figure 5.1A, 
compare lane 3 of panels A and B) but was no longer present after 10 minutes incubation 
(Figure 5.1A, lane 4 in panels A and B). In contrast, a different proteolysis pattern was 
observed with NifL(1-284)-V166M which was largely digested within 2 minutes of exposure 
to chymotrypsin (Figure 5.1A, the undigested band is absent from lanes 2, 3 and 4 in panel 
C). This suggests that, under reducing conditions, NifL(1-284) adopts a similar conformation 
to NifL(1-284)-I153A, whilst differing in conformation to NifL(1-284)-V166M. However, 
when the FAD co-factor was oxidised, there was a change in the proteolytic footprint of 
NifL(1-284) (Figure 5.1A, the undigested band is present in lanes 2 and 3 of panel B but 
absent in the same lanes of panel E). In contrast to the digestion pattern observed under 
reducing conditions, the proteolytic footprint of the oxidised NifL(1-284) protein closely 
resembled that of NifL(1-284)-V166M (Figure 5.1A, compare panels E and F). Similar 
results were obtained from limited proteolysis analysis of a second “locked-on” variant, 
NifL(1-284)-L175A (data not shown). For both NifL(1-284) and the NifL(1-284)-V166M variant, 
the band corresponding to the uncleaved protein was digested within 2 minutes of addition 
of the protease under oxidising conditions (Figure 5.1A, lanes 2, 3 and 4 of panels E and 
F). The shift in the proteolysis pattern of wild-type NifL(1-284), when comparing the results 
obtained under oxidising and reducing conditions, implies a redox dependent change in 
protein conformation (Figure 5.1A, compare panels B and E). Moreover, the proteolytic 
footprint of NifL(1-284) resembles that of the “redox signalling” variant under reducing 
conditions and that of the “locked-on” variant protein under oxidising conditions. A similar 
redox dependent conformational change was not evident in either of the variant proteins 
(Figure 5.1A, compare panels A and D or panels C and F). As an additional control, the 
oxidation state of the FAD group was monitored spectroscopically to ensure that the 
dithionite concentration used was sufficient to fully reduce the co-factor in all of the 
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protein constructs (Figure 5.1B). In each case, protein samples were fully reduced after 
addition of dithionite, as determined by quenching of the spectral features characteristic of 
the oxidised flavin group (peaks at 360 nm and 445 nm and shoulders at 420 nm and 470 
nm). To eliminate the possibility that the PAS2 substitutions influence the incorporation of 
FAD into PAS1, the FAD content of each construct was determined (Figure 5.1C). All 
proteins exhibited 59 - 63% FAD incorporation, indicating that there were no significant 
differences in folding between the wild-type and variant proteins. Taken together, these 
data indicate that oxidation-reduction of the FAD group in PAS1 triggers a shift between 
two distinct conformations of the PAS1-PAS2 construct and that substitutions in the PAS2 
domain cause the protein to favour one of these conformers over the other (regardless of 
signal perception by the PAS1 domain). It is also worth noting that the rate of digestion of 
NifL(1-284) was faster under oxidising conditions than under reducing conditions (Figure 
5.1, panels B and E). This is consistent with the hypothesis that PAS2 subunits dissociate 
in response to oxidation of the PAS1 co-factor, leading to a more open conformation.  
Overall, the results from limited proteolysis of the PAS1-PAS2 fragment of NifL support 
the hypothesis that the “locked-on” and “redox signalling” substitutions in the PAS2 
domain lock the NifL protein in either the oxidised or reduced conformer. 
 
5.2.2 Conformational changes in longer NifL constructs 
In order to discern whether the “locked-on” NifL variants adopt the bona fide 
oxidised conformer or promote inhibition of NifA via some alternative mechanism (as is 
the case for some H domain variants (Martinez-Argudo et al., 2004a)), it was important to 
analyse the influence of the “locked-on” substitutions on the conformation of the C-
terminal domains of the protein. It has previously been shown that nucleotide binding 
strongly influences the conformation of the GHKL domain of NifL (see section 1.4.3). The 
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addition of ADP to the reaction buffer in limited trypsin proteolysis experiments results in 
a conformational change in the C-terminal domains of the full length NifL protein 
(Söderbäck et al., 1998) and variant forms of NifL that are unable to bind nucleotide, 
and/or undergo the shift in conformation that accompanies nucleotide binding, fail to 
inhibit NifA activity in vivo (Perry et al., 2005). Therefore, limited trypsin proteolysis was 
used to probe conformational changes associated with ADP binding in wild-type NifL and 
a variant form of the protein containing the “locked-on” substitution, V166M (Figure 5.2). 
Protein samples were incubated with trypsin as described in section 2.7.12 and aliquots 
were removed after 0, 2, 5, 10, 20, 30 and 60 minutes of exposure to the protease. Aliquots 
were added to eppendorf tubes containing a trypsin inhibitor and subsequently analysed by 
SDS-PAGE. The response of two NifL constructs to nucleotide was analysed; proteolysis 
reactions were performed using both the full length NifL protein and NifL(143-519) (which 
lacks the redox sensing PAS1 domain, see Figure 4.6), either in the absence of nucleotide 
or in the presence of 2 mM ADP. All reactions were carried out under aerobic conditions, 
when the FAD co-factor in the PAS1 domain of NifL is assumed to be oxidised 
(Söderbäck et al., 1998). The proteolytic footprint of the full length NifL protein is shown 
in Figure 5.2A. The percentage of protein that remained uncleaved at each time point was 
quantified using Syngene densitometry software and plots of percent undigested NifL 
protein versus time are shown below the SDS-PAGE analysis in Figure 5.2 as an indication 
of the rate of proteolytic digestion in each reaction. In the absence of nucleotide, different 
rates of proteolysis were observed for the wild-type and variant proteins. The band 
representing the full length protein (indicated by an arrow on the right of each panel in 
Figure 5.2) is degraded more rapidly when the V166M substitution is present, although 
proteolysis of both proteins yields similar cleavage products (Figure 5.2A, compare panels 
A and B). This difference in the rate of digestion is also apparent in 
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Figure 5.2.  Limited trypsin proteolysis of (A) NifL and (B) NifL(143-519). Proteolytic 
digestion was analysed in either the presence of 2 mM ADP or the absence of nucleotide 
(as indicated). Samples were removed from the reaction mixture after 0, 2, 5, 10, 20, 30 
and 60 minutes (Lanes 1 - 7 respectively) and analysed by SDS-PAGE. Arrows indicate 
the uncleaved protein and empty arrow-heads indicate putative cleavage products. The rate 
of proteolysis of each sample was studied using densitometry analysis as described in 
section 2.7.12 and plots of percent uncleaved protein (relative to t = 0) versus time are 
shown below the appropriate gel. The data shown is representative of at least two 
independent replicates.   
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the densitometry analysis (Figure 5.2A, compare the dashed blue line and the full blue 
line), suggesting a difference in conformation between NifL and NifL-V166M when 
nucleotide is absent. However, a nucleotide dependent conformational change is evident in 
both the wild-type and variant proteins. As shown previously (Perry et al., 2005; 
Söderbäck et al., 1998), addition of ADP to the reaction buffer results in increased 
protection of the C-terminal domains from proteolysis in the wild-type NifL protein 
(Figure 5.2A compare panels A and C). A similar conformational change was observed for 
the V166M variant protein (Figure 5.2A compare panels B and D). In both cases, two 
putative cleavage products generated when the proteolysis reaction was performed in the 
absence of nucleotide (marked by open arrowheads in Figure 5.2A) were not apparent 
when 2 mM ADP was present in the reaction mixture (Figure 5.2A compare panels A and 
B with panels C and D). In contrast to results obtained in the absence of nucleotide, the 
wild-type and variant proteins exhibit a similar pattern and rate of digestion when ADP is 
present (Figure 5.2A, compare panels C and D). The densitometry analysis indicated that 
the rate of digestion of NifL and NifL-V166M was similar (Figure 5.2A, compare the 
dashed and full red lines). These data suggest not only that NifL and NifL-V166M both 
undergo a nucleotide dependent change in conformation and but also that, in the presence 
of ADP, the wild-type and “locked-on” variant proteins adopt a similar conformational 
state. 
 Limited trypsin proteolysis was also used to analyse the conformation of NifL(143-
519) and NifL(143-519)-V166M (which lack the redox sensing PAS1 domain) and the response 
of these proteins to adenosine nucleotides (Figure 5.2B). A similar proteolytic footprint 
was observed for the wild-type and “locked-on” variant proteins in the absence of 
nucleotide (Figure 5.2B, compare panels A and B). Densitometry analysis indicated that 
the V166M substitution did not significantly influence the rate of proteolysis (Figure 5.2B, 
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dashed and full blue lines). Thus, NifL(143-519) and NifL(143-519)-V166M  appear to adopt 
similar conformational states when nucleotide is absent. Addition of ADP to the reaction 
buffer apparently triggers a conformational change in both proteins, thereby increasing 
their susceptibility to trypsin proteolysis (Figure 5.2B, compare panels A and B to panels C 
and D). For example, NifL(143-519) is fully digested after a 20 minute incubation with trypsin 
in the presence of ADP (Figure 5.2B, panel C, lane 5) whilst a small proportion (~20%) 
remains undigested after 30 minutes incubation when nucleotide is absent (Figure 5.2B, 
panel A, lane 6). When compared to NifL(143-519), the V166M variant protein appears more 
resistant to proteolysis in the presence of ADP (Figure 5.2B, compare panels C and D). 
This difference is apparent in the densitometry analysis (Figure 5.2B, compare the full and 
dashed red lines). For example, approximately 60% of the NifL(143-519)-V166M protein 
remains undigested after a 2 minute incubation with trypsin whereas approximately 30% of 
the NifL(143-519) protein remains undigested after the same time. Overall, limited proteolysis 
analysis of NifL constructs lacking the PAS1 domain indicates that the wild-type and 
“locked-on” variant protein fragments adopt a similar conformation in the absence of 
nucleotide and that ADP binding induces a conformational change in both proteins. 
However, the resulting ADP-bound conformers of these proteins are not equivalent. That 
is, the V166M substitution results in an altered conformation of the truncated NifL protein 
(lacking PAS1) provided ADP is present. For completeness, the limited trypsin proteolysis 
experiments described in this section were repeated using chymotrypsin and similar results 
were obtained (data not shown).   
 Results obtained from the limited proteolysis experiments, particularly those 
conducted in the presence of nucleotide, correlate well with the available data concerning 
the behaviour of the various protein fragments and variants in vivo. The full length, 
nucleotide-bound form of NifL exhibits an inhibitory signalling state under oxidising 
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conditions in vivo, as does the V166M variant (Figure 3.2). Thus, we might expect these 
two forms of the NifL protein to adopt similar conformations when ADP is present and the 
FAD co-factor is oxidised, as observed in the limited proteolysis experiments. By contrast, 
the NifL(143-519) and NifL(143-519)-V166M proteins adopt different signalling states in vivo; 
truncated forms of the NifL protein, lacking the PAS1 domain, are unable to sense the 
cellular redox state and fail to inhibit NifA activity under oxidising conditions whereas 
removal of the PAS1 domain from the V166M variant protein does not alter its “locked-
on” phenotype and NifL(143-519)-V166M strongly inhibits NifA activity under oxidising 
conditions (Table 3.2). Based on the in vivo data, NifL(143-519) is expected to adopt the non-
inhibitory conformer and NifL(143-519)-V166M is expected to adopt the inhibitory 
conformer under the 2 mM ADP condition. Hence, the difference in conformation between 
the two truncated forms of NifL apparent in the proteolysis experiments reflects known 
differences in phenotype.    
The wild-type and “locked-on” variant forms of the NifL protein both fail to inhibit 
NifA activity in vivo when nucleotide binding is impaired (Table 3.1). Therefore, both 
proteins are expected to adopt a non-inhibitory conformation in the absence of adenosine 
nucleotides. However, it is important to note that the conformer adopted in the absence of 
nucleotide is not equivalent to that adopted by the nucleotide-bound form of NifL under 
reducing conditions. Thus, despite the data from limited proteolysis clearly indicating that 
NifL and NifL-V166M are in different conformations when ADP is absent, it is not clear 
what the physiological relevance of this might be. Interestingly, the difference in 
conformation between the wild-type protein and the V166M variant in absence of 
adenosine nucleotides is not apparent in truncated constructs lacking the PAS1 domain.  
Previous studies have suggested that the PAS1-PAS2 fragment is resistant to cleavage by 
trypsin (Söderbäck et al., 1998). Taken together, these data imply that the oxidised PAS1 
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domain exerts a different influence on the conformation of the C-terminal domains in the 
wild-type protein compared to the V166M variant, provided adenosine nucleotides are 
absent.  
 
5.3 Influence of signals from PAS1 on the PAS2 dimerisation interface  
5.3.1 Cysteine cross-linking analysis  
 Cysteine cross-linking is a technique routinely used to analyse the tertiary and 
quaternary structures of proteins (Bass et al., 2007). The side chains of cysteine residues 
located in close proximity to each other in a folded protein can be oxidised to form a 
disulphide bridge and the presence of covalent disulphide bonds can then be determined 
using SDS-PAGE. Thus, cysteine cross-linking analysis has the potential to indentify 
contacts between pairs of positions in a three-dimensional protein structure. These 
positional pairs can consist of a single cysteine residue from each subunit in a multimeric 
protein or sets of two cysteine residues within a single polypeptide chain. In order to 
perform cysteine cross-linking analysis, it is first necessary to generate a functional 
“cysteine-free” form of the protein of interest, in which the native cysteines have been 
removed via site-directed mutagenesis of the coding sequence (known as cysteine 
replacement mutagenesis). Cysteine residues can then be introduced at positions of 
interest, informed by structural data or modelling, and contacts between these positions can 
be indentified.  
Using structural models of the PAS2 domain in combination with the results from 
mutagenic analysis, it was intended to substitute residues in the putative PAS2 
dimerisation interface for cysteines and analyse disulphide bond formation between PAS2 
subunits in the isolated PAS2 domain and the full length NifL protein. Further, it was 
intended to examine the influence of the signalling state of the PAS1 domain on disulphide 
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bond formation between PAS2 subunits. The wild-type NifL protein contains four cysteine 
residues (C181, C237, C380 and C507). Colleagues in the Dixon laboratory systematically 
substituted these cysteines for other residues to create a “cysteine-free” form of the NifL 
protein that is similar to the wild type in its response to oxygen and fixed nitrogen signals 
(Figure 5.3). The cysteine-free form of the NifL protein, NifL-C181S, C237F, C380S, 
C507T, will be referred to as NifL(cys-free) for the rest of this Chapter. Although NifL(cys-free) 
allowed greater NifA activity than the wild type under nitrogen fixing conditions (Figure 
5.3, blue bars), the variant protein strongly inhibited NifA activity in response to excess 
fixed nitrogen (Figure 5.3, yellow bars), oxygen (Figure 5.3, red bars) or a combination of 
both (Figure 5.3, green bars). Western analysis indicated that the “cysteine-free” form of 
the NifL protein was stable under the four assay conditions (data not shown). In addition to 
the full length NifL protein, a cysteine-free form of the isolated PAS2 domain (NifL(143-
284)-C181S, C237F) was generated. This construct will be referred to as PAS2(cys-free). 
Individual cysteine substitutions were then generated at positions 157, 166 and 240 in 
PAS2(cys-free) in order to examine inter-subunit disulphide bond formation in the isolated 
PAS2 dimer. Cysteine cross-liking experiments were then performed as described in 
section 2.7.9. Variant forms of the PAS2 domain containing either the V157C or the 
R240C substitution formed disulphide bonds in the presence of 5 μM copper 
phenanthroline, suggesting that these residues are located in close proximity to their 
counterparts in the opposite protomer in the assembled PAS2 dimer (Figure 5.4). 
Alternatively, residues that are surface exposed can be cross-linked when molecules collide 
in solution. It may also be possible for cysteine substitutions in the dimerisation interface 
to disrupt PAS2 dimerisation and still form disulphide bridges when PAS2 monomers  
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Figure 5.3. Influence of NifL(cys-free) on NifA activity in vivo. Cultures were grown under 
the following conditions; (1) anaerobically, under nitrogen-limiting conditions (blue bars), 
(2) anaerobically with excess fixed nitrogen (yellow bars), (3) aerobically with limiting 
fixed nitrogen (red bars) and (4) aerobically when fixed nitrogen was replete (green bars). 
Cultures were assayed for β-galactosidase activity as a reporter of NifA-mediated 
transcriptional activation from a nifH-lacZ fusion. All experiments were performed at least 
in duplicate with error bars denoting the standard error of the mean. 
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Figure 5.4. Cysteine cross-linking of the PAS2 domain of NifL. A “cysteine-free” variant 
of the PAS2 domain (NifL(143-284)-C181S, C237F) was generated and cysteine residues 
were then introduced at several positions (157, 166 and 240). Copper phenanthroline 
catalysed disulphide bridge formation in each variant protein was analysed as described in 
Chapter 2.7.9. Products from the cross-linking reactions were then added to either reducing 
SDS-PAGE sample buffer (odd numbered lanes) or non-reducing sample buffer (even 
numbered lanes) and analysed by electrophoresis. Lanes were loaded as follows: the 
cysteine-free PAS2 domain in lanes 1 and 2, the V157C variant in lanes 3 and 4, the 
V166C variant in lanes 5 and 6 and the R240C variant in lanes 7 and 8. 
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collide. Overall, the results from cysteine cross-linking analysis of the isolated PAS2 
domain imply, in congruence with the data presented in Chapter 4, that residues 157 and 
240 are positioned in the vicinity of the PAS2 dimerisation interface.   
In order to analyse the influence of signals from the PAS1 domain on the cross-
linking of PAS2 subunits, it was first necessary to perform phenotypic analysis of the 
variant proteins. When the V157C, V166C and R240C substitutions were introduced into 
the full-length NifL(cys-free) protein and assessed for their ability to inhibit NifA-mediated 
transcriptional activation in vivo, only the V157C substitution had a phenotype similar to 
the wild-type protein (Figure 5.5). NifL(cys-free)-V157C allowed high NifA activity under 
nitrogen fixing conditions (Figure 5.5, blue bars) but inhibited NifA in discrete responses 
to oxygen (Figure 5.5, red bars) and fixed nitrogen (Figure 5.5, yellow bars), or a 
combination of both (Figure 5.5, green bars). That is, the phenotype of NifL(cys-free)-V157C 
appeared similar to that of NifL(cys-free). By contrast, the V166C and R240C substitutions 
apparently influenced the activity of NifL(cys-free). NifL(cys-free)-V166C failed to inhibit NifA 
activity under all conditions tested (Figure 5.5, bars marked “NifL(cys-free)-V166C, NifA”). 
The null phenotype of V166C may be a consequence of instability of the variant protein, 
but this possibility was not investigated further. NifL(cys-free)-R240C exhibited a “redox 
signalling” phenotype and failed to inhibit NifA activity in the presence of excess oxygen 
but responded normally to fixed nitrogen (Figure 5.5, bars marked “NifL(cys-free)-R240C, 
NifA”). As NifL(cys-free)-V157C responded to oxygen and fixed nitrogen, this variant was 
selected for use in further experiments aimed at investigating cysteine cross-linking 
between PAS2 subunits in the full length NifL protein. As mentioned above, it was 
intended to examine the influence of the redox signalling state of the PAS1 domain on 
disulphide bond formation between PAS2 subunits. However, it was not possible to 
compare oxidising and reducing conditions directly because the presence of a reductant 
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Figure 5.5. Influence of cysteine substitutions in the PAS2 domain on the ability of the 
NifL(cys-free) protein to inhibit transcriptional activation by NifA in vivo. Cultures were 
grown under the following conditions; (1) anaerobically, under nitrogen-limiting 
conditions (blue bars), (2) anaerobically with excess fixed nitrogen (yellow bars), (3) 
aerobically with limiting fixed nitrogen (red bars) and (4) aerobically when fixed nitrogen 
was replete (green bars). Cultures were assayed for β-galactosidase activity as a reporter of 
NifA-mediated transcriptional activation from a nifH-lacZ fusion. All experiments were 
performed at least in duplicate with error bars denoting the standard error of the mean. 
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would influence disulphide bond formation. Therefore, a substitution in the PAS1 domain 
that prevents transmission of the redox signal was utilised. The crystal structure of NifL 
PAS1 suggests that E70 might be involved in the initial conformational changes associated 
with oxidation of the FAD co-factor (Key et al., 2007a). When this glutamate residue was 
substituted for alanine, the resultant NifL variant failed to inhibit NifA activity in response 
to oxygen in vivo (Salinas, Little and Dixon, unpublished data). Purified NifL-E70A 
contains a normal complement of FAD that can be reduced by sodium dithionite (Little and 
Dixon, unpublished data) suggesting that the phenotype of this mutation arises from a 
defect in structural propagation of the redox signal rather than a defect in redox chemistry. 
The ability of V157C to participate in disulphide bond formation between PAS2 subunits 
under oxidising conditions was investigated, in either the presence or absence of the E70A 
substitution in PAS1. Appropriately positioned cysteine side chains are oxidised by 
ambient dissolved oxygen to form disulphide bonds (Bass et al., 2007). However, this 
reaction often proceeds slowly unless stimulated by the addition of a redox catalyst, such 
as copper phenanthroline. The presence of disulphide bridges can then be detected as a 
change in the apparent molecular mass of the protein when analysed by SDS-PAGE. As an 
additional control, a fraction of the cross-linked sample is often incubated with a reductant, 
such as β-mercaptoethanol, to demonstrate that this change in molecular mass is reversed 
upon reduction (and therefore must be due to disulphide bond formation). Protein samples 
were exposed to varying levels of copper phenanthroline and the formation of covalent 
cross-links was analysed by SDS-PAGE (Figure 5.6). In the absence of the E70A 
substitution (i.e. when NifL(cys-free)-V157C was in the oxidised conformer) only small traces 
of the dimeric cross-linked species could be resolved and there was no obvious decrease in 
the amount of the monomeric (non cross-linked) protein as the oxidant concentration was  
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Figure 5.6. Cysteine cross-linking analysis of NifL(cys-free)-V157C and NifL(cys-free)-V157C, 
E70A. Cysteine cross-linking reactions were performed as described in section 2.7.9 and 
samples were analysed by SDS-PAGE. Lanes were loaded as follows: 1 = NifL(cys-free)-
V157C with NEM added prior to oxidation with 5 μM copper phenanthroline, 2 = NifL(cys-
free)-V157C, 3 =  NifL(cys-free)-V157C with 2.5 μM copper phenanthroline, 4 = NifL(cys-free)-
V157C with 5 μM copper phenanthroline, 5 = NifL(cys-free)-V157C with 5 μM copper 
phenanthroline and β-mercaptoethanol in the loading dye, 6 = NifL(cys-free)-V157C, E70A 
with NEM added prior to 5 μM copper phenanthroline, 7 = NifL(cys-free)-V157C, E70A, 8 = 
NifL(cys-free)-V157C, E70A with 2.5 μM copper phenanthroline, 9 = NifL(cys-free)-V157C, 
E70A with 5 μM copper phenanthroline, 10 = NifL(cys-free)-V157C, E70A with 5 μM copper 
phenanthroline and β-mercaptoethanol in the loading dye. 
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increased (Figure 5.6, lanes 3 and 4). In contrast, introduction of the secondary E70A 
substitution in PAS1 resulted in a large increase in disulphide bond formation and, in the 5 
μM copper phenanthroline condition, the protein was almost entirely in the cross-linked 
form (Figure 5.6, lanes 8 and 9). This disulphide bridge could be fully removed by addition 
of β-mercaptoethanol to the SDS sample dye (Figure 5.6, lane 10) and control experiments 
in which N-ethylmaleimide (NEM) reagent (which irreversibly
 
alkylates thiol groups) was 
added to samples prior to the copper-phenanthroline catalysed oxidation indicated that no 
non-specific cross-linking occurred between denatured polypeptides during preparation of 
samples for SDS-PAGE analysis (Figure 5.6, lanes 1 and 6). These experiments were 
repeated using the PAS1-PAS2 fragment rather then the full length NifL protein and 
similar results were obtained (data not shown). Hence, NifL(cys-free)-V157C cross-links 
efficiently only in the presence of a secondary substitution in the PAS1 domain that blocks 
transduction of the oxygen signal. These results indicate that signals from the PAS1 
domain influence the efficiency of disulphide bridge formation between subunits of the 
PAS2 domain in the context of the full length NifL protein.  
Overall, the data appears to indicate that oxidation of the FAD co-factor in the 
PAS1 domain induces a conformational change in PAS1 that, in turn, triggers a change in 
the quaternary structure of the PAS2 domain. However, when the ability of the NifL(cys-
free)-V157C, E70A protein to inhibit NifA activity in response to the oxygen and fixed 
nitrogen signals in vivo was checked, the protein was indistinguishable from NifL(cys-free)-
V157C, which lacks the E70A substitution (Figure 5.7A). That is, contrary to expectation, 
substitution of E70 for alanine did not result in increased NifA activity under oxidising 
conditions when V157C and the four cysteine replacement substitutions in NifL were 
present. This puzzling result prompted investigation of the influence of the V157C 
substitution (and the V157C, E70A double substitution) on NifL activity in the absence of 
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Figure 5.7. Influence of the V157C and E70A substitutions on the ability of (A) NifL(cys-
free) and (B) NifL to inhibit NifA activity in vivo. Cultures were grown under the following 
conditions; (1) anaerobically, under nitrogen-limiting conditions (blue bars), (2) 
anaerobically with excess fixed nitrogen (yellow bars), (3) aerobically with limiting fixed 
nitrogen (red bars) and (4) aerobically when fixed nitrogen was replete (green bars). 
Cultures were assayed for β-galactosidase activity as a reporter of NifA-mediated 
transcriptional activation from a nifH-lacZ fusion. All experiments were performed at least 
in duplicate with error bars denoting the standard error of the mean.  
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the four cysteine replacements (i.e. in a wild-type background) (Figure 5.7B). As 
demonstrated previously, NifL-E70A failed to inhibit NifA activity in response to excess 
oxygen (Figure 5.7B, bars marked “NifL-E70A, NifA”). In contrast to results obtained in 
the cysteine-free background, NifL-V157C and NifL-V157C, E70A both exhibited a 
“locked-on” phenotype (Figure 5.7B). That is, the V157C substitution results in a “locked-
on” form of the NifL protein and is dominant over the E70A substitution. Although this 
result provides some explanation as to why the NifL(cys-free)-V157C and NifL(cys-free)-
V157C, E70A variants  exhibit the same phenotype (Figure 5.7A), it appears to contradict 
the biochemical data and raises further questions regarding the influence of the cysteine 
replacements on NifL function. For example, why does the V157C substitution not give 
rise to a “locked-on” phenotype in the cysteine-free background? It is clear, however, that 
the NifL(cys-free) protein does not behave in the same manner as the wild-type protein and 
that differences between the two forms are likely to be responsible for the discrepancies 
discussed above. In other words, the cysteine replacements somehow alter the 
conformation of NifL and thus substitution of V157 for cysteine has different effects in the 
cysteine-free background compared with the wild type. Given these uncertainties, it is 
difficult to draw any firm conclusions from the cysteine cross-linking experiments. 
Nevertheless, despite the lack of congruence between the phenotypes of the variant 
proteins in vivo and the biochemical data, substitutions in the PAS1 domain can influence 
disulphide bridge formation between PAS2 subunits in vitro. 
 
5.3.2 BACTH analysis 
 The bacterial two-hybrid system was used to investigate the influence of signals 
from the PAS1 domain on the interaction between subunits of the PAS2 domain. The 
results presented in Chapter 4 demonstrate that the interaction between PAS2 subunits is 
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detectable using BACTH analysis. Preliminary experiments demonstrated that an 
interaction between the isolated PAS2 domain and a longer construct containing the PAS1 
and PAS2 domains in tandem (the PAS1-PAS2 fragment) could also be detected using 
BACTH analysis (data not shown). Moreover, control experiments suggested that this 
interaction was due to PAS2 oligomerisation, rather than interaction between the PAS1 and 
PAS2 domains (data not shown). We questioned whether signals from the PAS1 domain 
could influence interaction of the PAS1-PAS2 fragment with the isolated PAS2 domain, 
thereby indicating that the signalling state of PAS1 can influence PAS2 dimerisation. Of 
course, the context of this experiment differs substantially from signalling events in the 
wild-type NifL protein as only one PAS2 subunit is receiving a signal from PAS1. 
However, appropriate controls can be performed by introducing a “locked-on” PAS2 
substitution to the PAS1-PAS2 fragment to perturb the interaction in just one of the two 
interacting PAS2 subunits; preliminary experiments demonstrated that this substantially 
reduced, but did not eliminate, the interaction between PAS2 subunits (data not shown). 
This implies that conformational changes in a single PAS2 subunit can elicit a measurable 
difference in the interaction and provides a suitable control by simulating the “on state” of 
the PAS1-PAS2 fragment.    
 Initially, an attempt was made to investigate the PAS1-PAS2 versus PAS2 
interaction under both oxidising and reducing conditions. However, western analysis using 
anti-NifL anti-sera indicated that the fusion proteins were unstable in cells grown under 
oxidising conditions (data not shown). Therefore, a substitution that locks the PAS1 
domain in the “on” state was utilised. Substitution of M132 for alanine gives rise to a form 
of the NifL protein that inhibits NifA activity under reducing conditions in vivo (Little and 
Dixon, unpublished data). In other words, the M132A substitution locks the PAS1 domain 
in the oxidised (or “on”) signalling state and thus causes NifL to inhibit NifA activity in 
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the absence of an oxygen signal. The interaction between the PAS1-PAS2 fragment and 
the isolated PAS2 domain was examined under reducing conditions and the influence of 
the “locked-on” substitutions M132A (in PAS1) and V166M (in PAS2) were analysed 
(Figure 5.8). As observed previously in the preliminary experiments, interaction between 
the wild-type PAS1-PAS2 fragment and the isolated PAS2 domain was detected. The 
strength of this interaction, as quantified by β-galactosidase assays, was 1,536 Miller units 
(Figure 5.8, experiment A). Introduction of the M132A substitution resulted in a decrease 
in the strength of this interaction by approximately 500 Miller units (or one third) to 1050 
Miller units (Figure 5.8, experiment B). Control experiments indicated that introduction of 
the V166M substitution (which inhibits PAS2 oligomerisation, see Figure 4.1), into the 
PAS1-PAS2 fragment (but not the isolated PAS2 domain) resulted in a slightly larger 
decrease in interaction strength of approximately 700 Miller units (Figure 5.8, experiment 
C). When both constructs contained the V166M substitution, the interaction was reduced to 
approximately 250 Miller units (Figure 5.8, experiment D). However, negative controls 
measuring the interaction of each fusion protein with the opposing AC subunit suggested a 
background interaction of 273 Miller units in experiments utilising the T18:NifL(1-284)-
V166M fusion protein (Figure 5.8, controls column for experiments C and D). Therefore, 
the true level of interaction in experiments C and D is likely to be lower than the measured 
interaction. Nevertheless, these results suggest that substitutions in the PAS1 domain can 
influence the affinity of PAS2 association. As mentioned above, the data presented in the 
previous Chapters suggests that the transition of the PAS1 domain from the reduced (or 
“off”) state to the oxidised (or “on”) state is communicated to the PAS2 domain, resulting 
in a decrease in the affinity between PAS2 subunits. Based on this hypothesis, it was 
expected that the interaction between the PAS1-PAS2 fragment and the isolated PAS2 
domain would be stronger when the PAS1 domain is in the “off” state compared to the 
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Figure 5.8. BACTH analysis of the influence of signals from the PAS1 domain on the 
association of PAS2 subunits. Cells were grown under anaerobic conditions and 
interactions between hybrid proteins were measured as described in section 2.9.2. The data 
shown are based on at least three independent replicates.      
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“on” state. The BACTH results support this prediction. The ability of the PAS1-PAS2 
fragment containing the M132A substitution in PAS1 to interact with the isolated PAS2 
domain is intermediate between that of the wild-type PAS1-PAS2 fragment and the 
fragment containing the V166M substitution in PAS2. That is, when the PAS1 domain is 
locked in the “on” state there is a reduction in the affinity between PAS2 subunits although 
this reduction is less substantial than that induced by “locked-on” substitutions in the PAS2 
domain. Overall, data from the BACTH analysis supports the hypothesis that redox sensing 
by the PAS1 domain impacts upon the stability of the PAS2 dimer. It should be 
remembered that clear interpretation of these results is hindered by a lack of information 
regarding the oligomerisation state of the hybrid proteins; each of the fusion proteins 
studied here can presumably form a homodimer (as the PAS1 and PAS1-PAS2 fragments 
of NifL both dimerise) whereas heterologous association between the hybrid proteins must 
take place in order to yield a measureable interaction. Thus, the data obtained may 
represent the gross output from several competing dynamic equalibria. Additionally, the 
possibility that hybrid protein homodimers interact to form heterologous higher order 
oligomers cannot be eliminated. 
 
5.4 Mutagenesis of the α-helix linking the NifL PAS domains 
 Secondary structure predictions using the PSIPRED server indicate that the region 
of NifL between the PAS1 and PAS2 domains forms an α-helix. This helix could be 
considered a C-terminal extension of the PAS1 domain, an N-terminal extension of the 
PAS2 domain or a helical linker joining the two PAS domains. As mentioned in Chapter 1, 
PAS domains often have helical extensions protruding outward from, or flanking, the core 
α/β fold (Möglich et al., 2009b). However, a recent study investigating signalling in 
chimeric PAS-based sensor proteins indicated that tandem PAS domains are commonly 
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linked by short amphipathic α-helices (Möglich et al., 2010) and, in this section, the helix 
connecting the NifL PAS domains will be referred to as a helical linker. Taken together, 
secondary structural predictions and the crystal structure of the NifL PAS1 domain (Key et 
al., 2007a) suggest that this linker helix is likely to start between residues 137 and 139. In 
the absence of structural data concerning the other NifL domains, it is difficult to predict 
with confidence where the C-terminal end of the linker may be. However, predictions 
using the COILS server (http://www.ch.embnet.org) indicate that the region of NifL 
between residues 139 and 159 may form an α-helical coiled-coil in the NifL dimer (a 
helical wheel projection of this is shown in Figure 5.9A). This region overlaps with the 
proposed A’α helix in the PAS2 domain (discussed in sections 3.4 and 4.1) and without 
detailed structural information it is not possible to discern whether there are (i) two distinct 
helices, (ii) one extended helix or (iii) the structural predictions and modelling are 
incorrect. Given that the results presented in this thesis suggest that redox signals are 
communicated between the NifL PAS domains, it is possible that the inter-domain region 
may have a role in signal relay. Therefore, alanine scanning mutagenesis was used to 
analyse the function of the putative helical linker.  
 
5.4.1 Alanine Scanning 
 Twelve residues in the putative helical linker connecting the NifL PAS domains 
were substituted for alanine and the ability of the resultant NifL variants to inhibit 
transcriptional activation by NifA in response to oxygen and fixed nitrogen signals was 
analysed in vivo (Figure 5.9B). Three previously studied alanine substitutions in this region 
(L151A, I153A and V157A) were included for comparison. Western analysis indicated 
that all of the variant NifL proteins were stable under the four reaction conditions (data not 
shown). As demonstrated previously, NifA is active under all conditions in the absence of  
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Figure 5.9. Alanine scanning of the linker helix that connects the PAS1 and PAS2 
domains of NifL. (A) Helical wheel projection of NifL residues 139-159. (B) Influence of 
alanine substitutions in the linker helix on the ability of NifL to inhibit NifA-mediated 
transcriptional activation from a nifH-lacZ reporter fusion in vivo. The graph legend is as 
in Figure 5.7. 
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the NifL regulatory protein (Figure 5.9B, bars marked “NifA”) and wild-type NifL inhibits 
NifA activity in discrete responses to oxygen and fixed nitrogen (Figure 5.9B, bars marked  
 “NifL, NifA”). Seven of the twelve alanine substitutions (L139A, L142A, R145A, 
V146A, N148A, Q149A and I153A) gave rise to a form of the NifL protein that failed to 
inhibit NifA activity under oxidising conditions (Figure 5.9B, red bars). That is, over half 
of the NifL variants examined exhibited a “redox signalling” phenotype. Three of the 
twelve substitutions (E143A, R150A and L151A) exhibited wild-type phenotypes whilst 
the remaining two substitutions (E154A and V157A) inhibited NifA activity under all four 
conditions tested (Figure 5.9B, bars marked “NifL-E154A, NifA” and “NifL-V157A, 
NifA”). Interestingly, these two “locked-on” substitutions are positioned at the C-terminal 
end of the inter-domain region and could be considered part of the A’α helix in the PAS2 
domain rather than the helical linker, particularly as the V157A substitution is known to 
influence dimerisation of the NifL(147-284) fragment (i.e. the isolated PAS2 domain) (Figure 
4.1). Helical wheel projections for residues 139-159 suggested an electrostatic repulsion 
between residues R145 and R150 (Figure 5.9A, red dashed lines). However, NifL-R145A 
was a “redox signalling” variant and NifL-R150A was wild type. Thus, the alanine 
scanning mutagenesis indicated that this repulsion, if present, is not important in signalling 
as the R145A and R150A substitutions are phenotypically different and one might 
anticipate that breaking an important interaction from either side would result in the same 
phenotype. One plausible explanation of the above data is that the region of NifL 
mutagenised in this section includes two helices; the helical linker could be located 
between residues 139 and 149-151 whilst the A’α helix of PAS2 could start between 
residues 151 and 153. In this scenario, there would be no electrostatic repulsion between 
R145 and R150 as these residues would be located in different helices and, more 
importantly, V157 and I153 would be located in the PAS2 domain, explaining the 
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influence of the V157A and I153A substitutions on oligomerisation of the isolated PAS2 
domain (in NifL fragments containing residues 143-284 or 147-284) (see Chapter 4). This 
postulation is also consistent with the structural model of the NifL PAS2 domain presented 
in chapter 4 (Figure 4.8).   
 Overall, the frequency at which “redox signalling” variants were obtained by 
alanine scanning of the putative linker helix connecting the PAS1 and PAS2 domains of 
NifL (six of the eight substitutions generated between residues 139 and 150 or seven of the 
twelve residues substituted between 139 and 159, depending on the true length of the 
helix) suggests that this region is important in redox signal transduction.  
 
5.4.2 Deletion mutants 
 A recent bioinformatic analysis examined the linker sequences that connect tandem 
PAS domains in 5002 proteins (Möglich et al., 2010). As mentioned above, this study 
indicated that the linkers adopt a well-defined, largely α-helical structure. Moreover, it was 
found that approximately half (48%) of the putative linkers analysed were 28 residues long 
and that linkers that deviate from this length commonly differ by sets of three or four 
residues. For example, the shorter helical linkers were often 24, 21, 17 or 14 residues long. 
This pattern implies that the periodicity of PAS-PAS helical linkers may be important for 
their function. That is, the length and conformation of the linker between PAS domains is 
likely to define their relative orientation and thus influence PAS-to-PAS signalling. These 
findings are reminiscent of results obtained from the study of signal transmission between 
sensory PAS domains and effector domains via the connecting amphipathic (Jα) helix 
(discussed in section 1.2.4.). Experiments examining the influence of various amino acid 
deletions and insertions in the Jα helices of chimeric PAS sensor proteins have  
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Figure 5.10. (A) Influence of deletions in the linker helix that connects the PAS1 and 
PAS2 domains of NifL on the ability of the NifL protein to inhibit transcriptional 
activation by NifA in vivo. (B) Requirement of the N-terminal region of NifL for the 
“locked-on” phenotype of the ΔN147-L151 deletion. Graph legends are as in Figure 5.7. 
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demonstrated a precise correlation between the phenotype (or signalling state) and the 
helical length (Möglich et al., 2009b).  
 To investigate the importance of the length of the putative helical linker connecting 
the N-terminal NifL PAS domains in redox signal transduction, a series of amino acid 
deletions was generated and the influence of these deletions on the ability of NifL to 
inhibit NifA activity in response to oxygen was analysed in vivo (Figure 5.10A). Five 
variant forms of the NifL protein were created: NifLΔL151, NifLΔR150-L151, 
NifLΔQ149-L151, NifLΔN148-L151 and NifLΔN147-L151 (deletions of 1-5 residues). 
Western analysis indicated that all proteins were stable under the four assay conditions 
(data not shown). Four of the five NifL variants failed to inhibit NifA activity in the 
presence of excess oxygen (Figure 5.10A, red bars) but responded normally to fixed 
nitrogen (Figure 5.10A, yellow bars). That is, four of the deletions (NifLΔL151, 
NifLΔR150-L151, NifLΔQ149-L151 and NifLΔN148-L151) gave rise to a “redox 
signalling” phenotype. As mentioned above, NifL-L151A and NifL-R150A respond 
normally to oxygen and fixed nitrogen (Figure 5.9B, bars marked “NifL-L151A, NifA” 
and “NifL-R150A, NifA”). This indicates that the side chains of L151 and R150 are not 
required for redox signal transduction in NifL. Nevertheless, deletion of either L151, or 
L151 and R150, resulted in a form of NifL that failed to inhibit NifA activity under 
oxidising conditions (Figure 5.10A, bars marked “NifLΔL151, NifA” and “NifLΔR150-
L151, NifA”). Taken together, these data imply that a shortening of the helical linker, 
rather than the removal of key amino acid side chains, is responsible for the “redox 
signalling” phenotype of NifLΔL151 and NifLΔR150-L151. These results emphasise the 
importance of the inter-domain linker to redox signalling in NifL. However, it is difficult 
to distinguish between mutations that result in a loss of function (i.e. block redox signalling 
via perturbation of protein structure) and those that give rise to a form of NifL that is 
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locked in the “off state” (i.e. favour the reduced conformation). It is possible that the 
“redox signalling” variants obtained here act by either of these mechanisms. Interestingly, 
the NifLΔN147-L151 variant inhibited NifA activity under all four conditions, even when 
oxygen and fixed nitrogen were limiting (Figure 5.10, bars marked “NifLΔN147-L151, 
NifA”). In other words, the deletion of five residues (N147-L151) from the PAS-PAS 
linker helix in NifL gave rise to a “locked-on” phenotype. Structural damage in this region 
of NifL would be expected to result in a “redox signalling” phenotype and thus the 
identification of this “locked-on” variant cannot be explained by structural perturbation of 
the linker helix. Hence, the deletion appears to simulate a conformational state normally 
induced by oxygen signals from the PAS1 domain. This implies that conformational 
changes in the helical linker are important for transmission of redox signals between the 
NifL PAS domains.  
 All “locked-on” NifL variants identified to date, containing substitutions in the 
PAS2 or H domains, do not require the PAS1 domain in order to inhibit NifA activity (see 
section 3.3.2). In other words, they retain a “locked-on” phenotype when the N-terminal 
region of NifL (residues 1-142) is removed. To further investigate the properties of the 
newly identified “locked-on” variant, NifLΔN147-L151, the N147-L151 deletion was 
introduced to a truncated form of the NifL protein that lacked the first 142 amino acids. 
The ability of the variant proteins to inhibit NifA-mediated transcriptional activation was 
then analysed in vivo (Figure 5.10B). As shown previously, NifLΔN147-L151 inhibited 
NifA activity under all four assay conditions (Figure 5.10B, bars marked “NifLΔN147-
L151, NifA”). By contrast, NifL(143-519)ΔN147-L151 responded normally to fixed nitrogen 
(Figure 5.10B,  yellow and green bars) but failed to inhibit transcriptional activation by 
NifA in response to excess oxygen (Figure 5.10B, red bars) or when oxygen and fixed 
nitrogen were limiting (Figure 5.10B, blue bars). The NifL(143-519)ΔN147-L151 protein 
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exhibited a “redox signalling” phenotype, indicating that the N-terminal truncation 
overrides the effect of the deletion in the linker helix. This demonstrates that, unlike 
“locked-on” substitutions in the PAS2 domain, the “locked-on” phenotype of the N147-
L151 deletion is context dependent and requires the N-terminal region of the NifL protein. 
Overall, the data presented in this section indicate that the properties (i.e. the phasing, 
conformation or energetics) of the helical linker connecting the PAS1 and PAS2 domains 
are important to the redox signalling mechanism in NifL and that signal relay between the 
PAS domains is likely to depend upon structural alterations in this region.    
 
5.5 Discussion 
 The limited proteolysis experiments presented in this Chapter demonstrate that a 
redox-dependent conformational change occurs in the N-terminal PAS domains of NifL. 
Moreover, these experiments suggest that substitutions in the PAS2 domain are able to 
lock the NifL protein in either the oxidised or the reduced conformer. Data from previous 
Chapters imply that changes in the quaternary arrangement of the PAS2 domain modulate 
NifL activity and that the quaternary structure of the PAS2 domain is responsive to redox 
signal perception by the PAS1 domain. Several approaches were taken to test this 
hypothesis. These included cysteine cross-linking studies and BACTH analysis of domain 
interactions in NifL. Although the results from each set of experiments were not entirely 
conclusive, taken together, all approaches provide a body of evidence that is consistent 
with the hypothesis that the signalling state of the PAS1 domain influences the quaternary 
structure of PAS2. The cysteine cross-linking experiments provide strong biochemical 
evidence that substitutions in the PAS1 domain can influence disulphide bridge formation 
between PAS2 subunits. However, the cysteine replacement substitutions appeared to 
interfere with NifL activity when measured in vivo. The BACTH analysis suggests that the 
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signalling state of the PAS1 domain influences the affinity of the interaction between 
PAS2 subunits but the assay conditions were artificial. Nevertheless, when viewed in 
conjunction with the limited proteolysis experiments and the mutational and biochemical 
analyses of the PAS2 domain presented in this and previous Chapters, there is strong 
evidence to support the proposed mechanism of redox signal relay in NifL. 
Mutagenic analysis of the linker between the NifL PAS domains indicated that this 
region of the NifL protein is important in redox signal transduction. Alanine scanning 
mutagenesis yielded numerous “redox signalling” variants. Moreover, a series of five 
sequential amino acid deletions gave rise to four “redox signalling” variants and one 
“locked-on” variant protein. Each deletion results in a specific change in the helix angle 
and these were plotted against NifL activity (measured as NifA activity in the presence of 
NifL). The results are shown in Figure 5.11. The deletion of five residues resulted in a 
helix angle of -140
o
 and gave rise to a form of the NifL protein that adopts an inhibitory 
conformation irrespective of the signalling state of the PAS1 domain. At helix angles 
between -150
o
 and -50
o
, oxygen availability had little influence on NifL activity. In the 
presence of oxygen, there appeared to be some periodicity in the relationship between helix 
angle and NifL activity (Figure 5.11, blue line). Taken together, these results indicate that 
the phasing and conformation of the PAS-PAS linker helix are important in inter-domain 
redox signal relay. However, the precise mechanism underpinning the transmission of 
redox signals between the NifL PAS domains remains unclear. Based on the available 
information from this work and other studies of PAS-containing proteins, several potential 
mechanisms can be envisaged.  
Firstly, the linker helices may act as rigid “spacers” between tandem PAS domains. 
These “spacers” could ensure that the PAS domains are properly orientated with respect to 
one another, facilitating direct PAS-PAS interactions. Additionally, quaternary structural  
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Figure 5.11. Influence of changes in helix angle in the PAS1-PAS2 linker on the ability of 
NifL to inhibit NifA activity in vivo. The data shown here is derived from the results 
presented in Figure 5.10. Cultures were assayed for β-galactosidase activity as a reporter of 
NifA-mediated transcriptional activation from a nifH-lacZ fusion under aerobic (blue line) 
or anaerobic (red line) conditions.  
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changes in the first PAS domain may generate a movement of the two linker helices 
relative to each other within a dimeric protein. In other words, rigid helical linkers could 
enable signal transmission either by “tugging” the PAS2 domain in response to changes in 
the signalling state of PAS1 or by facilitating a direct interaction between the NifL PAS 
domains which is required for signal relay. 
 Alternative mechanisms of signal transduction involve conformational and/or 
energetic changes in the linker region. These may take the form of a helical rotation within 
a coiled-coil linker or changes in the association state of the linker helix. For example, the 
helices may form a “zipper” that “zips” or “unzips” depending on the signalling state of the 
PAS1 domain. However, the available data, although limited, perhaps favour a model 
whereby signals are transmitted along a coiled-coil linker in the form of torque or helical 
rotation. Such movements may be triggered, for example, by a partial unwinding of the 
linker helix in response to signals form the sensory domain. This mechanism has been 
proposed for several PAS-containing proteins (Möglich et al., 2010; Möglich and Moffat, 
2007b; Taylor, 2007). In a recent study that combined experiments on chimeric PAS 
sensor proteins with the available structural data on tandem PAS domains, Moffat and 
colleagues observed that multiple PAS domains are commonly arranged along a linear axis 
such that the N-terminus of the second domain is adjacent to the C-terminus of the first 
(i.e. they are oriented “head-to-tail”). The authors postulate that addition/reduction of 
torques along this axis provides a means of integrated signal output from multiple sensory 
PAS domains (Möglich et al., 2010). It has been proposed that the C-terminal Jα helices 
protruding from the sensory PAS domains of the YtvA and FixL proteins relay signals to 
effector domains via a similar mechanism (Möglich et al., 2009b; Möglich and Moffat, 
2007). Thus, the torque (or helical rotation) hypothesis conveniently couples signal 
transmission between PAS domains to the regulation of effector domain activity in these 
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systems. However, some PAS-containing proteins lack Jα helices. For example, the N-
terminal PAS domains and the output domains of the NifL protein are connected by a 
glutamine rich linker. Structural predictions indicate that this region is likely to be 
disordered (http://prdos.hgc.jp/). Hence, signalling between the PAS domains and C-
terminal domains of NifL is unlikely to occur via helical rotation. This does not eliminate 
the possibility that signals from the PAS1 domain generate torque in the linker helix to 
impact the signalling state of PAS2, but instead limits the potential of the helical rotation 
hypothesis to explain how signals from PAS1 influence NifL activity.  
The length of the helical linker connecting the NifL PAS domains is clearly 
important in signalling as amino acid deletions in this region influence NifL activity, 
presumably via affects on the relay of redox signals to the PAS2 domain. However, the 
available information regarding the PAS1-PAS2 linker region in NifL is not sufficient to 
discriminate between the models of signal transduction discussed above. Nevertheless, 
each of the proposed mechanisms of PAS-to-PAS signal relay satisfies an important 
criterion; they are responsive to (or utilise) the quaternary structural changes that 
characterise PAS signalling. 
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Chapter 6 - General Discussion 
 The data presented here demonstrate that the PAS2 domain of NifL can exist in two 
discrete states, as exemplified by substitutions that stabilise NifL in either the “on” or the 
“off” conformation. The “on” substitutions in PAS2 result in a form of NifL that is 
competent to inhibit NifA, irrespective of the redox state of the FAD co-factor in the PAS1 
domain. Limited proteolysis experiments suggest that these substitutions lock NifL in a 
conformation similar to that of the oxidised form. By contrast, the “off” mutants in PAS2 
apparently fail to communicate the redox state of PAS1 to the C-terminal domains of NifL, 
but the variant proteins remain responsive to the fixed nitrogen signal conveyed by 
interaction with the signal transduction protein, GlnK (Little et al., 2002; Rudnick et al., 
2002). The “off” or “redox signalling” variants might influence redox signal transduction 
in NifL by several different mechanisms including: (i) disrupting interactions between the 
PAS1 and PAS2 domains, (ii) perturbing interactions between PAS2 and the C-terminal 
domains of NifL or (iii) stabilising the reduced conformation relative to the oxidised 
conformer. Evidence from SEC and chemical cross-linking experiments suggests that one 
of the two “redox signalling” substitutions identified (I153A) acts by stabilising the PAS2 
dimer whilst the other substitution (F253L) influences NifL activity via an alternative 
mechanism. Further evidence for the involvement of the PAS2 domain in redox signalling 
was obtained from in vivo analysis of variant forms of the NifL protein that lack this 
domain; removal of the PAS2 domain gives rise to a form of NifL that is not competent to 
respond to changes in redox potential. These results directly demonstrate an important role 
for PAS2 in redox signal relay from PAS1 to influence the interaction of the C-terminal 
domains of NifL with NifA. 
 The quaternary arrangement of the PAS2 subunits within NifL is apparently an 
important component in redox signal transduction. The isolated PAS2 domain is a dimer in 
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solution and the “off” state variants are also dimeric, whereas all of the “on” state variants 
analysed appear to influence the association state of the isolated PAS2 domain towards the 
monomeric form. However, these changes in association state are not apparent when PAS2 
is combined with other domains, suggesting that PAS2 does not contribute to 
oligomerisation of NifL, but instead provides an interface for alternative quaternary 
arrangements. Most of the “locked-on” substitutions identified are apparently located 
within a conserved dimerisation interface recently recognised in PAS domains of known 
structure (Ayers and Moffat, 2008). Although no structural data is available for the NifL 
PAS2 domain, structural modelling indicates that four of the seven “locked-on” 
substitutions indentified in this work are located in the proposed interface and at least one 
of the remaining three substituted residues are likely to stabilise the PAS2 dimer (Figures 
3.1 and 4.8). BACTH analysis demonstrates that all seven of the “locked-on” substitutions 
disrupt the interaction between PAS2 subunits (Figure 4.1). Thus, all of the “locked-on” 
substitutions identified in this work perturb dimerisation of the PAS2 domain, regardless of 
their proximity to the putative dimerisation interface.  
 Taken together, the data presented in this thesis suggest a model of signal 
transduction in NifL whereby changes in the quaternary structure of the PAS2 domain 
mediate the transmission of redox signals from the PAS1 domain to the C-terminal 
domains of NifL (Figure 6.1). In this model, oxidation of the FAD co-factor induces a 
conformational change in the PAS1 domain that is communicated to the PAS2 domain via 
the inter-domain linker helix (see Chapter 5.4). This, in turn, triggers a shift in the 
monomer-dimer equilibrium to favour the dissociation of PAS2 subunits. Movement of the 
PAS2 protomers is likely to generate re-organisation of the H and GHKL domains of NifL 
to promote binding of NifL to NifA. However, there are several aspects of the redox signal 
transduction pathway in NifL that remain unclear. For example, how do changes in the 
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Figure 6.1. Model of redox signal transduction in NifL. Under reducing conditions, when 
the FAD co-factor is fully protonated, the PAS2 domain is maintained in the dimeric state 
and the H and GHKL domains are in a conformation that prevents NifA from accessing the 
surfaces of NifL that mediate the interaction with NifA. Under these conditions, NifA 
escapes inhibition by NifL. Oxidation of the FAD co-factor generates a conformational 
change in the PAS1 domain, which is communicated to the PAS2 domain, triggering a 
movement of PAS2 protomers. This shift in the quaternary structural arrangement of the 
PAS2 domain results in a re-organisation of the H and GHKL domains of NifL to promote 
inhibition of NifA activity. 
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association state of the PAS2 domain influence the activity of the C-terminal domains? 
The nature of the interaction between PAS2 and the output domains of NifL is ill-defined 
and although it is clear that changes in the signalling state of the PAS2 domain must 
impact upon the conformation and/or quaternary arrangement of the H and GHKL 
domains, the mechanism requires elucidation. The transmission of signals between the 
NifL PAS domains is another aspect of signal transduction that requires further 
investigation. Mutagenic analysis indicates that the inter-domain region is important in 
signal relay but the precise mechanism is not known. Finally, it is likely that switching of 
the PAS2 domain between the “on” (monomeric) and “off” (dimeric) signalling states 
involves a conformational change, particularly given that one of the “on” substitutions 
identified in this domain (L199R) apparently influences oligomerisation despite being 
located some distance from the dimerisation interface (see Chapter 4.4). However, the 
nature of this conformational change remains unclear. An improved understanding of each 
aspect of signal transduction discussed here might, perhaps, arise from further structural 
data on the NifL protein.     
PAS domains have been shown to undergo signal-dependant conformational 
changes, particularly in the C-terminal beta sheet regions (Card et al., 2005; Erbel et al., 
2003; Evans et al., 2009), that may provoke alterations in quaternary structure (see Chapter 
1). The Bacilus subtilis YtvA protein provides a well-studied example of a PAS domain 
that exhibits a stimulus dependant quaternary structural change. YtvA regulates responses 
to blue-light illumination and contains an N-terminal PAS domain that binds an FMN co-
factor. This domain forms a stable dimer, the subunits of which rotate by 4-5
o
 relative to 
one another in response to blue light illumination (Möglich and Moffat, 2007). Similarly, 
oxidation of the heme iron in the dimeric PAS-A domain from the E. coli direct oxygen 
sensor (EcDOS) protein leads to a 3
o 
rotation of the subunits with respect to each other 
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(Kurokawa et al., 2004) and ligand binding to the heme co-factor in the sensory PAS 
domain from bjFixL results in a ~ 2
o 
rotation of the protomers (Ayers and Moffat, 2008). 
Each of these proteins is discussed in detail in Chapter 1.2. A similar rotation may enable 
the subunits of the NifL PAS1 domain to undergo a “scissor-like” movement with respect 
to one another in response to redox changes, to influence in turn the quaternary structure of 
PAS2 (Figure 6.1). Since redox signal transduction by PAS1 appears to alter the 
oligomerisation state of PAS2, resulting in dissociation of the PAS2 dimer under oxidising 
conditions, it is possible that this provides a mechanism for amplifying the signal to effect 
the conformational movements necessary to switch the activity of the C-terminal domains 
of NifL. The importance of the monomer-dimer equilibrium in signal relay by the PAS2 
domain mirrors the properties of other PAS domains in which homo or hetero-dimerisation 
plays an important role in the signalling mechanism. Examples include the light-sensing 
proteins Vivid and phototropin (Nakasone et al., 2008; Zoltowski et al., 2007), the 
mammalian transcription factors AhR and ARNT (Perdew, 1988; Reisz-Porszasz et al., 
1994) and the B. subtilis KinA protein (Lee et al., 2008). Thus, the importance of 
alterations in quaternary structure has been demonstrated in the signalling mechanisms of 
evolutionarily distant PAS domains of diverse function. In this respect, the findings 
presented in this thesis are congruent with previous research and highlight the importance 
of quaternary structural plasticity in the signalling mechanism of PAS domains.  
 The properties of the NifL PAS2 domain suggest that it is a representative of an 
emerging subclass of PAS domains that are apparently involved in signal relay rather than 
sensing. The presence of multiple PAS domains within a single protein is surprisingly 
common; the SMART (http://smart.embl.de/) and Pfam (Finn et al., 2006) databases both 
indicate that a total of over 21,000 PAS domains are present in around 14,000 proteins. Of 
the relatively few PAS domains characterised to date, it is often the case that no obvious 
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sensory function can be attributed to the additional PAS domain(s) within a tandem pair (or 
triplet). There are several examples of well-studied PAS domains that may belong to this 
subclass. DcuS is a membrane-embedded histidine protein kinase that contains a 
periplasmic C4-dicarboxylate-sensing PAS domain (PASp), which transmits signals to a 
cytoplasmic PAS domain (PASc) via two transmembrane helices. The PASc domain has 
no known role in signal perception but the structural plasticity of this domain is believed to 
be important for signal transduction to the histidine kinase domains. When substitutions in 
PASc resulting in ligand-independent (constitutive) activation of DcuS were modelled on 
the dimeric crystal structure of the NifL PAS1 domain, it was observed that these residues 
were located close to the A’α helix that forms part of the extended dimerisation interface 
(Etzkorn et al., 2008). This suggests a model in which signal perception by the PASp 
domain in DcuS impacts upon the stability of the PASc dimer interface, analogous to the 
influence of the NifL PAS1 domain on the quaternary structure of NifL PAS2. Another 
example of the potential role of PAS domains in signal relay is provided by KinA, a 
cytoplasmic histidine protein kinase that regulates sporulation in B. subtilis in response to 
an unknown signal(s). KinA has an N-terminal sensory region that consists of three PAS 
domains. The oligomerisation state of the most N-terminal of these PAS domains, PAS-A, 
is important for histidine kinase function. A combination of biophysical and biochemical 
experiments indicate that this domain exhibits considerable structural plasticity and 
substitutions that favour the monomeric state of the isolated PAS-A domain activate 
autokinase activity in the full length KinA protein (Lee et al., 2008). Intriguingly, 
structural predictions indicate that the substitution in PAS-A giving rise to the greatest 
level of kinase activity, Y29A, is located at a position equivalent to L175 in the NifL PAS2 
domain (Figure 3.1). The Y29A and L175A substitutions both strongly disrupt 
dimerisation of their respective PAS domains. Further analogies can be drawn between the 
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sensory regions of KinA and NifL in that both contain duplicate PAS domains that have no 
known role in signal perception yet can influence the conformation of downstream 
domains via changes in quaternary structure. Other examples of this class may include the 
redox sensing region of MmoS, which contains an N-terminal FAD-binding sensory PAS 
domain and a more C-terminal PAS domain that has no apparent co-factor or ligand-
binding pocket (Ukaegbu and Rosenzweig, 2009) and EcDOS, which contains an N-
terminal heme-binding PAS domain in tandem with a second PAS domain of unknown 
function (Sasakura et al., 2006). 
 Another pertinent example of a “signal relay” PAS domain has been provided by 
recent mutagenic and crystallographic studies of the DctB protein from S. meliloti (Nan et 
al., 2010; Zhou et al., 2008). DctB is a dimeric, membrane-bound histidine protein kinase 
that regulates the transcription of C4-dicarboxylate transport (dct) genes in rhizobia. The 
histidine kinase output domains are located in the cytoplasm whilst the sensory region of 
the DctB protein (DctBp) is periplasmic and contains two PAS domains, known as the 
membrane-proximal (PASp) and membrane-distal PAS (PASd) domains (Figure 6.2). 
Crystal structures of DctBp in both the apo and ligand-bound states indicate that the PASd 
domain binds C4-dicarboxylates whereas the membrane-proximal PASp domain is not 
associated with any co-factor or ligand (Zhou et al., 2008). In the absence of C4-
dicarboxylate ligands, both PAS domains form homo-dimers to maintain DctBp in the 
dimeric form. Ligand binding results in a large decrease in affinity between DctBp 
subunits, imparted predominantly by monomerisation of the PASp domain (Nan et al., 
2010). That is, ligand binding to the PASd domain induces a conformational change that is 
relayed to the PASp domain, resulting in dissociation of PASp subunits. Using directed 
mutational analysis, the authors were able to identify substitutions in the PASp domain that 
lock the DctB protein in the active conformer, presumably by destabilising the PASp dimer  
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Figure 6.2. Crystal structure of the periplasmic region of DctB (DctBp) in the succinate-
bound form (Zhou et al., 2008). One subunit of the DctB dimer is shown as a space-filling 
model and the other as a ribbon diagram. The membrane-distal (red) and membrane-
proximal (blue) PAS domains are circled. The 2-fold crystallographic axis of symmetry 
and the approximate position of the inner membrane are marked and the succinate 
molecule is represented as a ball diagram.  
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(Nan et al., 2010). It has been postulated that changes in the association state of this 
domain mediate transmission of signals from the ligand-binding periplasmic sensor region 
to the cytoplasmic histidine kinase effector domains (Nan et al., 2010). The signal 
transduction mechanism of DctB has clear parallels with that proposed for NifL and, 
together with the available data regarding the function and abundance of tandem PAS 
domains, these model systems provide strong evidence to support the existence of an 
emergent class of “signal relay” PAS domains. 
 The data presented in this thesis demonstrate that the two PAS domains in NifL 
function in tandem and that the quaternary structure of PAS2 is responsive to signal 
perception by PAS1. In addition, substitutions in NifL PAS2 are sufficient to either block 
the relay of signals from PAS1 or mimic the active state in the absence of a signal. 
However, for cytoplasmic proteins, the benefits of having an additional PAS domain solely 
for signal relay are not readily apparent. In the examples discussed above multiple PAS 
domains might be advantageous for amplification of structural signals, thus driving 
appropriate conformational changes in the C-terminal DHp (or H in the case of NifL) and 
GHKL domains. Current models for histidine kinase autophosphorylation and phospho-
transfer, based on crystal structures, suggest that large movements of the DHp and GHKL 
domains relative to one another are required for signalling (Albanesi et al., 2009; Marina et 
al., 2005). However, not all histidine protein kinases have multiple PAS domains and, for 
example, experiments with chimeric proteins demonstrate that the single light-sensing PAS 
domain from YtvA is sufficient to provide input signal specificity and regulate the activity 
of the C-terminal kinase domains of FixL in response to light (Möglich and Moffat, 2007). 
Both YtvA and FixL contain an -helical coiled-coil linker, connecting their input and 
output domains, comprising the J helix often found associated with PAS domains. Signal-
dependent unfolding of this coiled-coil sequence may result in rotational movements that 
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regulate kinase activity (Harper et al., 2004; Harper et al., 2003; Möglich et al., 2009a; 
Möglich and Moffat, 2007). In proteins such as NifL, DcuS and KinA it is possible that 
this -helical coiled-coil mechanism is replaced by the “signal relay” PAS domain, which 
provides conformational flexibility associated with the inter-conversion between the 
dimeric and monomeric forms. Additionally, duplicate PAS domains may provide a 
fulcrum for conformational changes in large, multi-domain proteins. Speculative evidence 
to support this notion can be found by comparing the FixL proteins from B. japonicum and 
S. meliloti. As mentioned in Chapter 1.2, the domain architectures of these proteins are not 
identical. S. meliloti FixL (SmFixL) is a membrane-bound protein containing an N-terminal 
transmembrane region, a PAS domain and C-terminal histidine kinase effector domains. 
By contrast, B. japonicum FixL (BjFixL) is a cytoplasmic protein that lacks the 
transmembrane region found in SmFixL but instead contains an additional N-terminal PAS 
domain. This additional PAS domain may replace the membrane anchor as a fulcrum for 
conformational changes, particularly as removal of the domain narrows the output range of 
the protein (Möglich et al., 2010). That is, although the N-terminal PAS domain has no 
apparent role in signal perception, the presence of this domain facilitates higher activity 
from the output domains under inducing conditions and lower activity in the absence of a 
signal. Hence, the efficacy of signal transduction is aided by the presence of a non-sensory 
PAS domain in BjFixL. However, examples of cytoplasmic histidine kinases containing a 
single PAS domain can be readily found in the SMART and Pfam databases. Given the 
abundance of PAS domains and their diversity of function, it seems unlikely that duplicate 
PAS domains perform identical roles in all proteins in which they are found. Rather, it is 
probable that these highly adaptable modules are utilised for wide ranging purposes that 
extend beyond the functions identified to date. Moreover, since the number of proteins 
containing multiple PAS domains of unknown function vastly exceeds the relatively few 
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studied examples, there remains a possibility that some of these additional PAS domains 
respond to as yet undiscovered stimuli and can modulate signal relay accordingly. In other 
words, there is potential for some “signal relay” PAS domains to act as biological “logic 
gates” to aid the integration of multiple signals within complex modular proteins.  
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